starter_ID,receiver_ID,relation_type,subtype_name,pathway_source,credibility,weight
hsa:10298,hsa:3984,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:137362,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:8503,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:596,hsa:581,PPrel,inhibition,path:hsa05222 Small cell lung cancer,1,0.8
hsa:10392,hsa:3552,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5296,hsa:208,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2475,hsa:1978,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:5934,hsa:1870,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:593,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1553,hsa:374875,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5567,hsa:1388,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5338,hsa:54979,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5530,hsa:956,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00480,path:hsa00770,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2939,hsa:2786,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:8835,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:2953,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3158,hsa:3032,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:3688,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:3725,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:207,hsa:1548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:5894,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5567,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:1549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:153,hsa:2778,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:2033,hsa:5608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:841,hsa:836,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:84618,hsa:4329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:4731,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5600,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:207,hsa:8517,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:2952,hsa:1029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57506,hsa:7187,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:84532,hsa:31,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:128,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6502,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:54578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3290,hsa:1978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2571,path:map00460,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:4690,hsa:644150,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:94235,hsa:135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:9365,PPrel,binding/association,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:81873,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:5606,hsa:5600,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5330,cpd:C01245,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:6772,hsa:4939,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:208,hsa:2475,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5330,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10449,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:652,hsa:658,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:7366,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:51764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:10681,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5533,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2791,hsa:2791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3265,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:3845,hsa:10096,no_relation,no_relation,no_relation,no_relation,0.0
hsa:978,hsa:6470,no_relation,no_relation,no_relation,no_relation,0.0
hsa:218,hsa:339896,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:3661,hsa:3445,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:5604,hsa:5594,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2776,hsa:5331,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:2099,hsa:2252,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:27123,hsa:7476,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:956,hsa:56953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5338,hsa:5322,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:111,hsa:1514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5530,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:65985,hsa:3158,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:6777,hsa:8651,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:1553,hsa:574537,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:1807,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:196883,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:217,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
cpd:C00076,hsa:124583,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1788,hsa:51384,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:1499,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:5608,hsa:5601,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:196883,cpd:C00575,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2100,hsa:9618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:861,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:207,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,6,0.8
hsa:1548,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:148327,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5331,hsa:5580,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5602,hsa:3725,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:4790,hsa:3447,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:5535,hsa:200186,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:10096,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:10672,hsa:9826,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:27121,hsa:7475,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5532,hsa:4772,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5156,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2773,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:5599,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
cpd:C00025,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:1978,PPrel,inhibition,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:1577,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:56924,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:9586,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:714,hsa:38,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:5296,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:219,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2549,hsa:8503,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:56953,hsa:3553,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3725,hsa:7124,GErel,expression,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:5582,hsa:369,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:957,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:2953,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2793,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:7372,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:27123,hsa:6093,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81579,hsa:113675,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1553,hsa:54657,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:1432,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:673,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:8398,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4217,hsa:5606,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5579,hsa:38,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:3551,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5608,hsa:5603,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
cpd:C01996,hsa:1137,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5566,hsa:1388,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5880,hsa:124583,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:1131,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5747,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:207,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
cpd:C00002,hsa:5024,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2773,hsa:5594,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:2786,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:54600,hsa:5023,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:375,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:83549,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:885,path:map00950,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:1978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:3665,hsa:3456,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:6714,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:3690,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:4830,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5567,hsa:1385,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:6483,hsa:256435,ECrel,compound,path:hsa00512 Mucin type O-glycan biosynthesis,1,0.5
hsa:5608,hsa:5095,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27306,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:53632,hsa:32,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:30814,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10672,hsa:23365,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:6300,hsa:1029,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
cpd:C00076,hsa:5530,PCrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:284958,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5898,hsa:51020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:7363,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5579,path:map00950,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3105,hsa:3805,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
cpd:C00008,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:53632,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5571,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2308,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5053,path:hsa00240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:64600,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5566,path:hsa00250,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:572,hsa:54205,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
cpd:C00334,hsa:55879,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:9138,hsa:119391,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5970,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1036,hsa:2806,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2330,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7364,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2034,hsa:7042,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:10000,hsa:5970,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:1549,hsa:5019,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5894,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2771,hsa:108,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1432,hsa:2353,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
cpd:C00780,hsa:5582,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:221264,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1111,hsa:7157,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:153,hsa:593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:3948,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:208,hsa:8517,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2353,hsa:3383,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5532,hsa:4775,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:163688,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,hsa:5894,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:55748,hsa:224,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1500,hsa:5880,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:30833,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:122618,hsa:255189,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:84532,path:hsa00071,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:27306,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:8936,hsa:10109,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:10810,hsa:10096,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5566,hsa:148327,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:221264,hsa:955,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:805,hsa:5534,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5315,hsa:3939,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C00788,hsa:151,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:816,hsa:998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:84699,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:84699,hsa:1029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:4325,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1431,path:hsa00620,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:102723407,hsa:2212,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:3945,hsa:63826,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00240,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:4792,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2100,hsa:2253,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:654364,hsa:124583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2549,hsa:5296,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:2778,hsa:107,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5600,hsa:2353,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05161 Hepatitis B,2,0.8
hsa:5595,hsa:54576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:55967,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2949,hsa:55062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:3726,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5293,cpd:C05981,PCrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:6654,hsa:3845,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:54331,hsa:3726,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22978,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:5027,no_relation,no_relation,no_relation,no_relation,0.0
hsa:955,hsa:56953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2950,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:124583,hsa:30833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:283106,hsa:1499,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5604,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1843,hsa:5601,PPrel,inhibition,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:27244,hsa:51422,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:223,hsa:7364,no_relation,no_relation,no_relation,no_relation,0.0
hsa:489,hsa:817,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:4832,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
cpd:C00027,hsa:5608,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
cpd:C00165,hsa:1890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:114,hsa:5567,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:4790,hsa:3383,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:816,hsa:6300,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:5734,hsa:51764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6093,hsa:10398,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:8743,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:1591,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:5743,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:3665,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7124,hsa:7132,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:54600,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:55970,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00076,hsa:91860,PCrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:2952,hsa:9021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8471,hsa:5296,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:801,hsa:5535,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5608,hsa:5603,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:10000,hsa:3551,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:6885,hsa:8517,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:7124,hsa:54578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54577,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1392,hsa:56267,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2626,hsa:10758,GErel,expression,path:hsa04218 Cellular senescence,1,0.5
hsa:5568,hsa:221,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7479,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:27244,hsa:1737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:6347,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:2778,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3443,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:160287,hsa:5160,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5565,hsa:2475,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2932,hsa:3798,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3665,hsa:3442,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:2787,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3716,hsa:373156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:119391,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:9451,hsa:1965,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:883,hsa:2806,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5894,hsa:5604,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:151056,hsa:79799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:3551,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5331,hsa:3486,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3827,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,hsa:3441,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:2778,hsa:112,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5970,hsa:3569,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5062,hsa:3984,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2778,hsa:108,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:7083,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5601,hsa:2353,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5566,hsa:51806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4830,hsa:2846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:207,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2784,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
cpd:C00518,hsa:8835,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5167,hsa:7083,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1549,hsa:574537,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5731,hsa:2788,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4893,hsa:5894,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00745,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:593,hsa:7186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:2330,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5568,hsa:84699,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:6772,hsa:3479,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:111,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:501,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23411,hsa:84618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2953,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:55970,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:223,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,cpd:C00076,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:111,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:8743,hsa:8797,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2770,hsa:10681,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:8976,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:3362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:2788,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:1738,hsa:5162,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:7263,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:151531,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5733,hsa:4129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:36,hsa:1629,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:873,hsa:54578,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:52,hsa:1499,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5606,hsa:1432,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:4190,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:10398,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:387,hsa:54578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3569,hsa:3570,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5319,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8936,hsa:10093,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
cpd:C00076,hsa:846,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:54577,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:801,hsa:5136,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:6416,hsa:5602,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3725,hsa:5154,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:56953,hsa:1854,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:4780,hsa:2952,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:801,hsa:5153,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5594,hsa:3725,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:94235,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:387,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5567,hsa:2998,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5338,hsa:50487,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5332,cpd:C01245,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
cpd:C00076,hsa:805,PCrel,binding/association,path:hsa04740 Olfactory transduction,1,0.5
hsa:2786,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:841,hsa:836,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:85465,hsa:8612,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:111,cpd:C00575,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5594,hsa:84699,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:6655,hsa:3265,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5338,hsa:581,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1549,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4907,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5914,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:489,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:3939,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:1432,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4137,hsa:4694,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:7040,hsa:7048,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1388,hsa:54576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124583,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:405,hsa:3091,PPrel,binding/association,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:953,hsa:106821730,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:5062,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:3665,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51733,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:5568,hsa:148327,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:862,hsa:3728,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:1543,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8797,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4215,hsa:5608,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:4790,hsa:405,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:955,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1646,hsa:79799,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:7368,hsa:85465,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1576,hsa:10094,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:79799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:2939,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7157,hsa:143686,GErel,expression,path:hsa04211 Longevity regulating pathway,1,0.5
hsa:374875,path:hsa00600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,path:map00680,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:3685,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5291,cpd:C05981,PCrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:4833,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5568,hsa:148327,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:160287,hsa:5161,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:815,hsa:1432,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:10000,hsa:572,PPrel,inhibition,path:hsa05161 Hepatitis B,1,0.8
hsa:5594,hsa:90993,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:207,hsa:8517,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:123745,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3710,hsa:810,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5567,hsa:148327,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:7298,hsa:339896,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25,hsa:55740,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
cpd:C05981,hsa:207,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5921,hsa:3265,PPrel,inhibition,path:hsa04360 Axon guidance,1,0.8
hsa:6655,hsa:3845,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5291,hsa:10000,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:3667,hsa:5296,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5609,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4128,hsa:25945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5925,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7298,hsa:84618,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:2778,hsa:108,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2775,hsa:2783,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:2534,hsa:1020,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:38,hsa:64064,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:956,hsa:124583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2946,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:23411,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1737,hsa:219,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7474,hsa:7976,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5568,hsa:1385,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4216,hsa:5606,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5602,hsa:2353,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3553,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1788,hsa:1846,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:51733,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
hsa:23659,hsa:5468,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:22854,cpd:C00027,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:107,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:93034,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:224,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10672,hsa:9138,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3708,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:2783,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6093,hsa:10627,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5335,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2983,cpd:C00942,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5610,hsa:3667,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3845,hsa:369,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:6774,hsa:993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2941,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2785,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C01245,hsa:3710,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",2,0.8
hsa:1890,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:4893,hsa:5894,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:3717,hsa:399694,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4646,hsa:71,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:587,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5241,hsa:7248,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3661,hsa:1978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:472,hsa:11200,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
cpd:C00076,hsa:805,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5291,hsa:208,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:6608,hsa:6714,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:5567,hsa:90993,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:10365,hsa:2952,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5608,hsa:5600,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:7368,hsa:8612,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:218,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:3665,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5468,hsa:6256,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:1565,hsa:7367,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:31,path:map01056,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5291,hsa:10000,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:6885,hsa:5604,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5595,hsa:391,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:1890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:7472,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:29119,hsa:3661,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:54659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7249,hsa:6009,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:5481,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:112714,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2770,hsa:51422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:2952,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:1815,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:147179,hsa:8976,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2778,hsa:55811,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1432,hsa:3725,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:3717,hsa:5336,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1846,hsa:5594,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:53632,hsa:894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:6714,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
path:hsa00480,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54657,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:71,hsa:7422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:8517,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1544,hsa:9,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,4,0.5
hsa:3265,hsa:369,PPrel,activation,path:hsa05219 Bladder cancer,2,0.8
hsa:10488,hsa:8600,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:8976,hsa:81873,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:4846,cpd:C00533,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5894,hsa:7298,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:1646,hsa:7365,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:373156,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:801,hsa:5532,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C05981,hsa:10000,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1491,hsa:137362,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,2,0.5
hsa:54331,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:137362,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1540,hsa:51727,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:4636,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:4790,hsa:2002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3439,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:5879,hsa:8826,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:1562,hsa:4257,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1511,hsa:56288,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5869,hsa:65082,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:1036,hsa:56267,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:998,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:51764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5293,hsa:207,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:91860,hsa:5533,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:94235,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5468,hsa:948,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:9446,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5608,hsa:5603,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4137,hsa:6778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7482,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2770,hsa:953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:119391,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
cpd:C00338,hsa:837,PCrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:8399,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00076,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54579,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6934,hsa:3984,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1806,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10365,hsa:9021,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4651,hsa:8440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:8639,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:1141,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2947,hsa:55811,no_relation,no_relation,no_relation,no_relation,0.0
hsa:586,path:hsa00260,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5894,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:2912,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4233,hsa:2549,PPrel,phosphorylation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:107987479,hsa:54659,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5169,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5175,hsa:5293,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5605,hsa:5594,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:221264,hsa:3984,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:5600,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:5566,hsa:64764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:64902,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1495,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2952,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:208,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:10681,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2932,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2778,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987479,hsa:54576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:9586,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:574537,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283748,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:7378,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1549,hsa:7366,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:2773,hsa:5091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3446,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
cpd:C06124,hsa:8698,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3551,hsa:406889,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:7056,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:207,hsa:7248,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:27128,hsa:355,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1564,hsa:7367,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:1562,hsa:2946,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
path:map01056,hsa:4329,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:23236,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:955,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5530,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5337,hsa:255189,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:54331,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5594,hsa:1958,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4259,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6300,hsa:3725,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:8681,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2950,hsa:574537,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3988,hsa:5467,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
cpd:C00076,hsa:817,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5566,hsa:1386,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5534,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C06124,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2099,hsa:2251,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:1432,hsa:890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:5162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:112,cpd:C00575,PCrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:84618,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1019,hsa:595,PPrel,binding/association,path:hsa04218 Cellular senescence,3,0.5
hsa:4790,hsa:4318,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:808,hsa:5532,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5582,hsa:1435,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6934,hsa:1499,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:56477,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:148,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2770,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:126,hsa:8772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:4775,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2017,hsa:119391,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:1956,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2309,hsa:6648,GErel,expression,path:hsa04211 Longevity regulating pathway,1,0.5
hsa:5291,hsa:208,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2773,hsa:5600,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:3716,hsa:125,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:10000,PCrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:8976,hsa:10552,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:54657,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:653689,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1565,hsa:54576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2947,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:221357,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:23411,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:2939,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:100137049,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2786,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:25,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4907,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10298,hsa:8440,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:5169,hsa:93034,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:8741,hsa:608,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
hsa:5595,hsa:3939,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7850,hsa:4217,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:1432,hsa:9586,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5567,hsa:10488,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5606,hsa:5600,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:440275,hsa:1965,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:3554,hsa:3551,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:142680,hsa:9368,PPrel,binding/association,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:208,hsa:111,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3725,hsa:318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05161 Hepatitis B,2,0.8
hsa:7297,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00900,hsa:3155,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1036,hsa:1491,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5605,hsa:5594,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3661,hsa:3442,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:222,hsa:2571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
cpd:C00025,hsa:6776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:4088,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5600,hsa:3725,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5594,hsa:10488,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2785,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:3709,hsa:810,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:1559,hsa:6688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:108,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5567,hsa:468,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:64902,hsa:189,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:84699,hsa:8399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:26100,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:10298,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4191,path:hsa00620,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,2,0.5
hsa:2806,hsa:4191,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:4790,hsa:5743,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:3661,hsa:3439,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:2778,hsa:115,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5290,hsa:998,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:2549,hsa:85464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:2932,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:10000,hsa:3551,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4301,hsa:83549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:653689,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7298,hsa:4907,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5295,hsa:3690,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:353376,hsa:148022,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:109,hsa:5566,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:586,hsa:2729,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5869,hsa:55823,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:4832,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:2771,hsa:112,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5568,hsa:9586,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:10381,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:6655,hsa:4893,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2792,hsa:441925,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:163688,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5571,hsa:2309,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5331,hsa:5578,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1555,hsa:1558,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4257,hsa:377841,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:153,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2950,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:284958,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:2846,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6654,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:54331,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5603,hsa:84699,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5731,hsa:10681,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5567,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,2,0.8
hsa:805,hsa:318,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00600,hsa:93408,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:87,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9583,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10390,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00410,hsa:367,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:6752,hsa:2773,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5599,hsa:1557,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:1277,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,hsa:113675,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",4,0.5
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:3815,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54658,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6197,hsa:2100,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5595,hsa:1432,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
path:hsa00640,path:hsa00290,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5925,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2571,hsa:2788,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2946,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:862,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:314,hsa:10681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10095,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:387,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2778,hsa:574537,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1019,hsa:894,PPrel,binding/association,path:hsa04218 Cellular senescence,3,0.5
hsa:3265,hsa:5894,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:85465,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10365,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:955,hsa:7371,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:4594,path:hsa00020,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:377841,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:284958,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:2771,hsa:113,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:7186,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:836,hsa:4137,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2571,hsa:223,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:4792,hsa:1849,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:1950,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:55626,hsa:441925,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1431,hsa:53632,no_relation,no_relation,no_relation,no_relation,0.0
hsa:63826,path:hsa00600,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:1576,hsa:4258,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:57571,hsa:2571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:8503,hsa:207,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:1460,hsa:1499,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5313,hsa:160287,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3661,hsa:3442,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
cpd:C00165,hsa:5579,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",2,0.8
hsa:51764,hsa:623,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,hsa:8310,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:406888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122618,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81579,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5291,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:316,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:6773,hsa:4939,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:4216,hsa:5608,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:369,hsa:5604,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,2,0.8
hsa:5606,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4696,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:54963,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5568,hsa:64764,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:8503,hsa:2308,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:1545,hsa:4258,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:91860,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:2034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:406933,hsa:23411,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2953,hsa:1232,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1788,hsa:1849,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:5338,hsa:84647,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2786,hsa:84532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1386,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:23130,hsa:55062,PPrel,binding/association,path:hsa05010 Alzheimer disease,1,0.5
cpd:C05981,hsa:10000,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,6,0.8
hsa:2767,hsa:5332,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5599,hsa:5599,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:91860,hsa:2113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5481,hsa:293,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:10000,hsa:2475,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:5894,hsa:2252,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124583,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1559,hsa:2938,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2775,hsa:113,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5879,hsa:5063,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:7189,hsa:10454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1576,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122618,hsa:81579,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C01245,hsa:3710,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5106,hsa:2628,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5878,hsa:64601,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:108,hsa:55748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:818,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:259307,hsa:5053,ECrel,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:10810,hsa:10552,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:7297,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:10010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7476,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6416,hsa:5601,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10094,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:71,hsa:1496,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:221,hsa:189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55902,hsa:223,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
path:hsa00250,hsa:7378,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2571,hsa:55748,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:953,hsa:83549,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:6777,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:842,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4776,hsa:405,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:399694,hsa:6654,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:81873,hsa:7082,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2952,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:51764,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:137362,hsa:160287,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:23365,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2952,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2889,hsa:5906,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:27123,hsa:7471,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3290,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3448,hsa:4329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:658,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:1432,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:4257,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:207,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:998,hsa:10298,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:1443,hsa:2690,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2792,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:805,hsa:2731,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:6822,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
cpd:C00788,hsa:153,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5970,hsa:331,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5322,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1738,hsa:217,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:5564,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:873,hsa:1549,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:834,hsa:3553,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5601,hsa:8471,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:91860,hsa:5532,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5105,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5603,hsa:10488,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:653689,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:30814,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1854,hsa:3119,no_relation,no_relation,no_relation,no_relation,0.0
hsa:373156,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:54575,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2783,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:7494,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5535,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3551,hsa:7473,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,path:hsa00130,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2890,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4233,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:84699,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5330,cpd:C01245,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:956,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:9475,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:5293,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3445,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:3665,hsa:3440,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:2793,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:808,hsa:817,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5879,hsa:5062,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
path:map01056,hsa:38,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:3661,hsa:3456,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:801,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3309,hsa:3155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23308,hsa:29851,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
hsa:2788,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:955,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:223,hsa:125,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5567,hsa:51422,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1559,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:7298,hsa:56953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5604,hsa:5599,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:27123,hsa:54963,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:8517,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:51727,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:84699,hsa:501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:90993,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5338,hsa:144811,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:93408,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:5599,hsa:3725,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
cpd:C01996,hsa:1143,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5481,hsa:7419,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5605,hsa:5594,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1555,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
cpd:C00038,hsa:4257,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4831,hsa:957,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6654,hsa:3265,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5568,hsa:148327,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5568,hsa:9586,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2099,hsa:2249,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:10000,hsa:4694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:3717,hsa:6772,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:1910,hsa:2771,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2100,hsa:8817,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:2783,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5601,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10720,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5315,hsa:92483,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:85465,hsa:8605,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4893,hsa:8503,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:10365,hsa:9446,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5579,hsa:673,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5881,hsa:10298,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:3667,hsa:5295,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1565,hsa:1557,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7132,hsa:1616,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:3685,hsa:3693,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:3665,hsa:3444,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:5595,hsa:2938,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:2330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:353376,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:8503,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:189,hsa:6470,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:956,hsa:7371,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5567,hsa:10488,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:113,cpd:C00575,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:836,hsa:1630,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:1386,hsa:2783,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:5580,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10993,hsa:189,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:163688,hsa:818,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5578,hsa:25945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10163,hsa:10093,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:4833,hsa:124583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5567,hsa:54490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:596,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:2941,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5295,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:2775,hsa:284958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3309,hsa:22926,PPrel,inhibition,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:9261,hsa:240,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:2326,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1564,hsa:27330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:4939,no_relation,no_relation,no_relation,no_relation,0.0
hsa:883,hsa:137362,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:54205,hsa:842,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2944,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4793,hsa:221357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:2938,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5605,hsa:1432,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2081,hsa:7494,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5241,hsa:595,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:60,hsa:1495,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:637,hsa:578,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:7368,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4780,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:7249,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:5568,hsa:1388,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:51806,hsa:817,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
cpd:C00942,hsa:56924,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100137049,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00076,hsa:5295,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:30833,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1495,hsa:1499,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:1500,hsa:5879,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:2322,hsa:5296,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5568,hsa:1386,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:653857,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:7297,hsa:6772,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:9564,hsa:5829,PPrel,phosphorylation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5608,hsa:1432,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:51806,hsa:5153,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:3718,hsa:6772,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:54331,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5970,hsa:4843,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:84735,hsa:3113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:223,hsa:10552,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:330,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:32,hsa:998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:22926,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:3708,hsa:163688,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:6470,hsa:2628,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:10681,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6794,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
hsa:972,hsa:3108,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:2775,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:112,hsa:5567,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:115,cpd:C00575,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:407021,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:255189,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2475,hsa:6198,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:51733,hsa:54577,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2997,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5567,hsa:148327,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:314,hsa:54498,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:84617,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5567,hsa:1388,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5970,hsa:54658,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:4772,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5564,hsa:2308,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
cpd:C00780,hsa:3351,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2322,hsa:608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10093,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,cpd:C00575,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:501,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:369,hsa:5605,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:5501,hsa:1965,PPrel,inhibition,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:6469,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10163,hsa:57180,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:10000,hsa:57521,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1910,hsa:163688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5590,hsa:111,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10000,hsa:4790,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5567,hsa:10094,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4205,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2952,hsa:653857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:151056,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:9365,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:3845,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:7297,hsa:9138,no_relation,no_relation,no_relation,no_relation,0.0
hsa:18,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3708,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",2,0.8
hsa:1432,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3451,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
cpd:C00076,hsa:51806,PCrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:1559,hsa:2952,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:137362,hsa:3939,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5315,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:587,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5880,hsa:10298,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:79799,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:808,PCrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:2775,hsa:114,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5602,hsa:5599,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:11145,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:9583,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5745,hsa:2778,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
path:map00680,path:map00460,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:3845,path:map00940,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00745,hsa:1139,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:71,hsa:1495,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:54963,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:106821730,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2628,hsa:54658,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:55748,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3939,hsa:5160,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5970,hsa:5747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:2353,PPrel,activation,path:hsa05133 Pertussis,1,0.8
path:map01056,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5894,PPrel,activation,path:hsa05210 Colorectal cancer,2,0.8
hsa:5603,hsa:2353,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5997,hsa:109,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
hsa:5058,hsa:3984,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:5732,hsa:2770,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4259,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:208,hsa:7039,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:2793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7371,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5881,hsa:5058,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:79861,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2791,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
path:map01056,hsa:5579,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00640,hsa:1591,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51733,hsa:55748,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5970,hsa:1906,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2641,hsa:2740,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2549,hsa:5291,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:23236,cpd:C00165,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3032,hsa:3033,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:10365,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4548,hsa:259307,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:7099,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5019,hsa:3155,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:673,hsa:5605,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:189,hsa:1738,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:5970,hsa:4313,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2353,hsa:1514,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:7367,hsa:56302,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:5602,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:56267,hsa:137362,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:369,hsa:3601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:2113,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:54961,hsa:1073,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2773,hsa:196883,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:64750,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4790,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:4780,hsa:25828,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:7368,hsa:8611,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5879,hsa:9170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7372,path:hsa00030,maplink,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
cpd:C01245,hsa:3710,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5293,path:hsa00620,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3725,hsa:3383,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:4780,hsa:2938,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:4233,hsa:200186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,cpd:C05981,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,6,0.8
hsa:7378,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3845,hsa:673,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5567,hsa:468,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:487,hsa:816,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:5568,hsa:1388,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1553,hsa:54578,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:1956,hsa:5595,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5970,hsa:406884,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4792,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
cpd:C00334,hsa:9568,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:27121,hsa:1902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3059,hsa:1785,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5332,hsa:5580,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:7976,hsa:5293,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:654364,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:189,hsa:1610,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5594,hsa:2353,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:8660,hsa:5293,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5602,hsa:2353,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:6482,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5734,hsa:2775,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
path:hsa00260,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7481,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:817,hsa:2308,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:196883,cpd:C00575,PCrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:2778,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:262,hsa:6723,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:217,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1553,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5600,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:4137,hsa:4698,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3449,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:3157,hsa:30,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2788,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:56994,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3667,hsa:4318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,path:map00940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5338,hsa:5319,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5320,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:53358,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5568,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:51422,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:54979,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00076,hsa:801,PCrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:6197,hsa:2099,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:3443,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:3265,hsa:5296,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2784,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2940,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3718,hsa:6777,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5594,hsa:5600,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:1557,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:6300,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:6093,hsa:93408,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:10390,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,2,0.5
cpd:C00020,hsa:6794,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4137,hsa:7846,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:51764,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
path:hsa00900,hsa:54511,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1398,hsa:2889,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:2775,hsa:196883,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:2771,hsa:5290,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4780,hsa:7879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2308,hsa:4087,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:122618,hsa:151056,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:406933,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2768,hsa:9138,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:1386,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5594,hsa:1388,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5601,hsa:8660,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:207,hsa:2309,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:387,hsa:669,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,path:hsa00360,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,hsa:2731,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:998,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5331,hsa:5578,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5733,hsa:10681,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C16844,hsa:5608,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4329,path:hsa00640,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5566,hsa:1388,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1959,hsa:356,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:1543,hsa:2947,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:6416,hsa:4205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1959,path:hsa00130,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00250,hsa:5091,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:130,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:208,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
path:hsa00600,path:map00460,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:3443,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
cpd:C00780,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3945,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5091,hsa:4190,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5566,hsa:5315,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5290,hsa:207,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:22943,hsa:1958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4790,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1432,hsa:64764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:84699,hsa:5747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1555,hsa:9826,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2746,hsa:2752,ECrel,compound,path:hsa00910 Nitrogen metabolism,1,0.5
hsa:2081,hsa:7186,PPrel,binding/association,path:hsa05010 Alzheimer disease,1,0.5
cpd:C00745,hsa:1136,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:3445,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5530,hsa:4776,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:51727,hsa:54963,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:1137,hsa:3717,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:3600,hsa:185,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:7422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:60,hsa:1496,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:5599,hsa:4089,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:3551,hsa:54947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2329,path:hsa00260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:409,hsa:6714,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1564,hsa:10720,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:218,hsa:314,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5332,hsa:5925,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1843,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5534,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:10720,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:207,hsa:2947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:7189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00665,hsa:8789,PCrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5609,hsa:284958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:2940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:219,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3440,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23411,hsa:2308,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5175,hsa:5567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5534,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1432,hsa:9261,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:7157,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:824,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2100,hsa:28514,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:5745,hsa:2770,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2778,hsa:217,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,hsa:1869,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:836,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2770,hsa:115,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:1629,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4193,hsa:7157,PPrel,inhibition,path:hsa05219 Bladder cancer,1,0.8
hsa:1549,hsa:10941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5606,hsa:5600,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:5608,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1844,hsa:5594,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:208,hsa:2932,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1373,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:32,hsa:1737,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2308,hsa:6648,GErel,expression,path:hsa04211 Longevity regulating pathway,1,0.5
hsa:5566,hsa:3709,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:7297,hsa:6777,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:4893,hsa:369,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:2792,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5595,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:6773,hsa:4938,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:6237,cpd:C00027,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5879,hsa:5602,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:10552,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:3661,hsa:3439,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:2549,hsa:5781,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:2932,hsa:1646,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,path:hsa00130,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:841,hsa:119391,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55102,hsa:26100,PPrel,binding/association,path:hsa05014 Amyotrophic lateral sclerosis,1,0.5
hsa:355,hsa:1854,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1843,hsa:5600,PPrel,inhibition,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5332,cpd:C00165,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4137,hsa:57180,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2475,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:558,hsa:9844,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:594,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,cpd:C05981,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:114,cpd:C00575,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2771,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00547,hsa:147,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2953,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2778,hsa:246,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2628,path:hsa00230,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:2731,hsa:4985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:27006,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:55970,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5566,hsa:148327,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:208,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1036,hsa:2805,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:3157,hsa:3155,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:5590,hsa:5598,PPrel,inhibition,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:955,hsa:4907,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:54575,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:3708,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:8471,hsa:6347,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1385,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:4893,cpd:C16844,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:6654,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3452,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:4258,hsa:653857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2327,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2783,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4893,hsa:5894,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:3728,hsa:51176,PPrel,binding/association,path:hsa05221 Acute myeloid leukemia,1,0.5
cpd:C06124,hsa:53637,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2770,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:4259,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5595,hsa:4609,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:377841,hsa:30833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5819,hsa:5818,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:3157,hsa:10449,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:122618,hsa:123745,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3551,hsa:8660,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1432,hsa:5599,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5563,hsa:57521,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5566,hsa:9586,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:808,hsa:818,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2628,hsa:2731,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:2947,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7371,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:4790,hsa:3569,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:2782,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4780,hsa:2940,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:7852,hsa:54578,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00083,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2572,hsa:1072,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1843,hsa:6300,PPrel,inhibition,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:143686,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5315,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2776,hsa:5331,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:218,hsa:8639,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
cpd:C00076,hsa:810,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:387,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:2786,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5566,hsa:1388,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2946,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3032,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1562,hsa:2944,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5970,hsa:5162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6752,hsa:2770,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3309,hsa:9451,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:107,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:5155,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2932,hsa:3799,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5970,hsa:3383,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:107987479,hsa:4128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:4790,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23308,hsa:29851,PPrel,activation,path:hsa04672 Intestinal immune network for IgA production,1,0.8
hsa:2785,hsa:7046,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124583,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:581,hsa:54205,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:64902,hsa:4322,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00350,path:hsa00130,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:218,hsa:51380,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:54659,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:9261,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:108,cpd:C00575,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
cpd:C11695,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:10488,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:956,hsa:955,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2771,hsa:55970,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:2770,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2946,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4128,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2771,hsa:112,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:64902,path:hsa00640,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:408,hsa:6714,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:91860,hsa:5532,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:177,hsa:50507,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:8503,hsa:10000,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:83667,hsa:5571,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2932,hsa:200186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:1036,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:3552,hsa:5970,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1854,hsa:7084,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3665,hsa:3446,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:9475,hsa:56994,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:25828,no_relation,no_relation,no_relation,no_relation,0.0
hsa:63826,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1388,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5293,hsa:998,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:2771,hsa:115,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:65082,hsa:7879,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:5594,hsa:5741,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2950,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:7099,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5136,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5970,hsa:3661,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:331,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:797,hsa:10203,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:387,hsa:1050,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:6300,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:5745,hsa:2776,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:998,hsa:7454,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:218,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:54600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:654364,hsa:955,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10672,hsa:9826,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:1496,hsa:87,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:1543,hsa:2952,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:873,hsa:340061,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9586,hsa:1026,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:8471,hsa:5293,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:55970,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6009,hsa:2475,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8503,hsa:3674,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:10672,hsa:9826,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4831,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:8826,hsa:1499,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:23659,hsa:54434,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,hsa:221,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1565,hsa:391013,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23365,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8936,hsa:10097,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5601,hsa:5599,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
cpd:C00334,hsa:2565,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1491,hsa:2806,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,2,0.5
hsa:5091,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:2846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:1500,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:2778,hsa:109,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2775,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8681,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2322,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5610,hsa:1965,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:107987479,hsa:54575,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:85465,hsa:122618,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2773,hsa:8826,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2034,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:92483,hsa:5162,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3988,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:56302,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:8517,hsa:4792,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3845,hsa:673,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:23646,hsa:123745,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5568,hsa:1385,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1962,hsa:100526794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:596,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:5571,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:54331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:223,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:207,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5566,hsa:9586,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1558,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54947,hsa:7365,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:2949,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2949,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:54575,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5600,hsa:468,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:11200,hsa:7157,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:7365,hsa:5207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:108,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:5315,hsa:5161,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5663,hsa:3709,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:124583,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:9586,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:956,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:5566,hsa:84699,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5566,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:7367,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:83593,hsa:3356,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:4718,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7225,hsa:659,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2572,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
hsa:3290,hsa:54578,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:8936,hsa:10094,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:369,hsa:1610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7124,hsa:7132,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4214,hsa:5608,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2773,hsa:114,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:942,hsa:940,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
hsa:3643,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:114,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,cpd:C00027,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:7852,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:488,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5600,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:7367,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1385,hsa:596,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:5566,hsa:10488,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:207,hsa:2953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9583,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26275,hsa:1892,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:91860,hsa:816,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5970,hsa:7187,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5530,hsa:4772,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00038,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:815,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2950,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5605,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:387,hsa:9475,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:29922,hsa:955,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5663,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:1432,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:39,hsa:5019,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
cpd:C00639,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5604,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:5566,hsa:468,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:114,hsa:5566,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5594,hsa:5743,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:79671,hsa:4191,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:957,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5295,hsa:208,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5533,hsa:1906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:108,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:4790,hsa:3458,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:4128,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:2792,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:27121,hsa:598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:90993,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:955,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7278,hsa:30833,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:873,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:4357,hsa:3945,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2939,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:196883,cpd:C00575,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5568,hsa:84699,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:7367,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:815,hsa:2308,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:8639,hsa:217,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2771,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7479,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:189,hsa:6472,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:56924,hsa:3984,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
cpd:C00076,hsa:805,PCrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:10645,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4259,hsa:3290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,cpd:C01245,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:5900,hsa:5899,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:3265,hsa:5293,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3091,hsa:5155,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:3480,hsa:4893,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:84335,hsa:1978,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4830,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
cpd:C01245,path:hsa00650,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:8936,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:10720,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:873,hsa:54658,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6416,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:487,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:151056,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:7704,hsa:8900,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:9170,hsa:2768,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2947,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:10000,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:207,hsa:2475,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:59345,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5879,hsa:5058,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:5564,hsa:2309,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5465,hsa:6257,PPrel,binding/association,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:18,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:10449,hsa:5096,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1945,hsa:3984,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:111,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:94235,hsa:4907,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:11145,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2806,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:317,hsa:54205,PPrel,binding/association,path:hsa05161 Hepatitis B,1,0.5
hsa:4129,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:50487,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54578,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01673,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2308,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:953,hsa:54963,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:1020,hsa:2932,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:56924,hsa:3985,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:1399,hsa:1793,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:5604,hsa:5594,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:122618,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:6774,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:51135,hsa:7189,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:339896,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:3667,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:6772,hsa:8651,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5603,hsa:4258,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:28514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:114,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:3845,hsa:63826,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9138,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:9586,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:6774,hsa:1558,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,cpd:C00575,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:1564,hsa:7363,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2534,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1399,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:208,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5599,hsa:958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9446,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5533,hsa:4772,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5532,hsa:4773,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:489,hsa:815,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:4217,hsa:6416,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,2,0.8
hsa:5331,cpd:C01245,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:5295,cpd:C05981,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2932,hsa:3800,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:223,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:1029,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1843,hsa:6300,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:6773,hsa:27102,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
cpd:C00002,hsa:10161,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:593,hsa:259307,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:132158,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:815,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:399694,hsa:6655,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4830,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:9370,hsa:5053,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5322,hsa:10627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5562,hsa:2309,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:137362,path:hsa00130,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:369,hsa:1728,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5567,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5338,hsa:124583,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:51806,hsa:5532,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5609,hsa:1559,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:122618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:123745,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2773,hsa:51764,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:22808,hsa:6240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5609,hsa:5599,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2952,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5567,hsa:8398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83439,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:1890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23365,hsa:10627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:373156,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5571,hsa:32,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:6654,hsa:3265,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:332,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:207,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:137362,hsa:7475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:998,hsa:8976,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:1788,hsa:1847,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:10488,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4325,hsa:1839,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
path:hsa00250,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5880,hsa:8826,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:22800,hsa:85464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:208,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4313,hsa:1839,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5579,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1962,hsa:26275,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
cpd:C05981,hsa:208,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3845,hsa:5296,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3290,hsa:1548,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:275,hsa:1738,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5819,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:10488,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1557,hsa:6347,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5770,hsa:1499,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:2786,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5530,hsa:4775,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2099,hsa:10683,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:587,path:hsa00290,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",3,0.5
hsa:5579,hsa:778,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10390,hsa:6241,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4215,hsa:3158,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3135,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5091,hsa:92483,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5578,hsa:3265,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:22943,hsa:3554,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3709,hsa:163688,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:4893,hsa:5290,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:154,hsa:2770,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4690,hsa:106821730,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:5293,hsa:208,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:51764,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:54659,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6774,hsa:7422,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:2953,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1565,hsa:10720,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:113675,hsa:189,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:4628,hsa:60,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:10000,hsa:108,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:113675,path:hsa00290,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:54331,hsa:2950,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:1630,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:9365,hsa:3643,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2778,hsa:109,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3454,hsa:7297,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:7704,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1564,hsa:54657,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5595,path:hsa00130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:64764,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5295,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1385,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5567,hsa:56302,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5608,hsa:5600,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:27121,hsa:93034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00575,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:224,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:27306,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3725,hsa:5155,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:51806,hsa:4842,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5530,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1385,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:3449,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:7124,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5733,hsa:2793,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5606,hsa:6300,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:3717,hsa:8471,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:54657,hsa:56288,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:5562,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:8611,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:50487,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3717,path:hsa00250,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5600,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:4790,hsa:2330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:160287,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:1738,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:207,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:3725,hsa:7412,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:7365,hsa:5734,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11145,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2534,hsa:1500,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:107987478,hsa:115650,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:2885,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:4790,hsa:3440,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:7366,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2768,hsa:9138,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
cpd:C00038,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2641,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:5467,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:50507,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5734,hsa:2788,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8398,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:8503,hsa:5053,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:6347,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:107987478,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:6347,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:54961,hsa:1072,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5609,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:113,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:94235,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:217,hsa:126,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C05981,hsa:207,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5610,hsa:593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6237,hsa:5295,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5595,hsa:90993,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:4893,hsa:5296,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:93034,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:102723407,hsa:2205,PPrel,binding/association,path:hsa05310 Asthma,2,0.5
hsa:3665,hsa:998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2475,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3725,hsa:10720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4831,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:10488,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5568,hsa:64764,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1432,hsa:7157,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:2775,hsa:113,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:2791,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:5566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5894,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6774,hsa:5743,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:1385,hsa:1026,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:224,hsa:128,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3725,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,cpd:C00165,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:3265,hsa:1029,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3309,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10993,path:map00460,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:54490,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1646,hsa:7363,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2947,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:107987478,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:2778,hsa:112,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5290,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5601,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5914,hsa:5914,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:6885,hsa:3551,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5566,hsa:1499,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:221264,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5734,path:map00680,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5330,cpd:C00165,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:2793,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1511,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:1549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4776,hsa:3576,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5291,hsa:207,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:956,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6502,hsa:1027,PPrel,inhibition,path:hsa05222 Small cell lung cancer,1,0.8
hsa:7378,hsa:1806,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:3710,hsa:51806,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5566,hsa:9586,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2946,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:4893,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5567,hsa:84699,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:885,hsa:886,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4833,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2099,hsa:26281,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:5606,hsa:5603,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:10201,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:148327,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05161 Hepatitis B,2,0.8
hsa:1442,hsa:2690,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:654364,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:222,hsa:8639,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2034,hsa:7040,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:2785,hsa:1962,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5313,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1388,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5313,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1738,hsa:2950,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,cpd:C01245,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C16845,hsa:5590,PCrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:207,hsa:2932,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5608,hsa:5603,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1549,hsa:54578,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:2771,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2330,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:23236,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1854,hsa:10201,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
cpd:C01245,hsa:3710,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:808,hsa:1286,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3448,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:9586,hsa:8600,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:5290,cpd:C05981,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1388,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:6934,hsa:595,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:54205,hsa:587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8471,hsa:5290,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2100,hsa:10092,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:2353,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:7187,hsa:29110,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:7704,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3445,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:5594,hsa:2113,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
cpd:C00780,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:347733,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:587,hsa:2730,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:10383,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:36,hsa:1962,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5568,hsa:125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6237,hsa:5290,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:7365,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3716,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00260,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:817,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:999,hsa:5566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1543,hsa:5313,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:581,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:1029,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:85465,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7157,hsa:1026,GErel,expression,path:hsa04218 Cellular senescence,2,0.5
hsa:4832,hsa:124583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5567,hsa:5315,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5970,hsa:7124,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:3710,hsa:7417,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9826,hsa:387,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:51806,hsa:818,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5571,hsa:10203,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8772,hsa:7472,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5997,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:1258,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
hsa:5567,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8611,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:8503,hsa:22978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3725,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5295,hsa:208,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C00788,hsa:4940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:377841,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:51422,cpd:C00003,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3665,hsa:3441,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:30,hsa:5095,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2099,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8976,hsa:60,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:1558,hsa:2947,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5604,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:3709,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5567,hsa:5571,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5603,hsa:7157,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5605,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124583,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:4853,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:10720,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:197322,hsa:217,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5604,hsa:5595,PPrel,activation,path:hsa05161 Hepatitis B,2,0.8
hsa:501,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8936,hsa:57180,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:7364,hsa:4713,no_relation,no_relation,no_relation,no_relation,0.0
hsa:347733,hsa:2688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:7364,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2785,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1398,hsa:1793,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:115,hsa:5568,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:953,hsa:7083,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5571,hsa:30833,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2475,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1548,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30833,hsa:10449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6752,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6778,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5501,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5481,hsa:7417,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5295,hsa:10000,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:9054,hsa:5745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5535,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:217,hsa:3441,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1854,hsa:4833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:4790,hsa:3552,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:1491,path:hsa00640,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:7704,hsa:890,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:6885,hsa:8517,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:222,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1491,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:114,cpd:C00575,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1892,hsa:56994,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112398,hsa:2034,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:10645,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:2940,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5594,hsa:847,no_relation,no_relation,no_relation,no_relation,0.0
hsa:177,hsa:293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:54947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:27123,hsa:7474,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:1003,hsa:5609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9583,hsa:7371,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5608,hsa:6300,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:54576,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7084,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5747,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,path:map01056,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3265,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:6885,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:137362,hsa:2787,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1793,hsa:5058,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2330,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2534,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1385,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:6472,hsa:10993,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:1431,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:128,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1388,hsa:8600,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:4790,hsa:3486,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:4035,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2767,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:4846,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:953,hsa:93034,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:10392,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:5170,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:122618,hsa:54979,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2778,hsa:112,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:155,hsa:2771,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
path:hsa00640,hsa:501,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1558,hsa:2952,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:51764,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1499,hsa:1499,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5609,hsa:1432,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4214,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5331,cpd:C00165,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5603,hsa:5602,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:8471,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84532,hsa:501,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:956,hsa:93034,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:3290,hsa:10627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:9586,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5602,hsa:3725,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
cpd:C00002,hsa:2846,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4137,hsa:100532726,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5595,hsa:2353,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5140,cpd:C00575,PCrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:71,hsa:81,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:3551,hsa:8471,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2806,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4773,hsa:3091,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:6237,hsa:7424,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1431,hsa:38,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:2932,hsa:3831,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:64600,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:387,hsa:1072,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:3661,hsa:3451,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:59345,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5970,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5604,hsa:5594,PPrel,activation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:36,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22978,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5167,hsa:7084,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:586,path:hsa00290,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",3,0.5
hsa:5568,hsa:1386,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:79924,hsa:10203,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2778,hsa:111,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2770,hsa:2785,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
cpd:C00780,hsa:3356,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:7157,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2147,hsa:9170,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2353,hsa:1442,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:2147,hsa:2149,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2784,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
path:hsa00250,hsa:3948,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5567,hsa:84699,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C00547,hsa:154,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:369,hsa:5605,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:808,hsa:5534,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:4129,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1646,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:654364,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7378,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5578,hsa:775,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:25945,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5530,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5732,hsa:2792,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:5096,path:hsa00640,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:3845,hsa:5063,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:6352,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:4205,hsa:50964,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:143686,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:4775,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2052,hsa:1543,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6416,hsa:5602,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:1499,hsa:83439,PPrel,activation,path:hsa05210 Colorectal cancer,2,0.8
hsa:2785,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5296,hsa:208,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:10645,hsa:53632,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2770,hsa:5603,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:2792,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57180,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:5315,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:9252,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:367,hsa:2730,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51727,hsa:1633,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:143686,hsa:5562,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:64902,path:hsa00290,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:207,hsa:332,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:8976,hsa:10097,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:6416,hsa:6300,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:207,hsa:3551,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:3665,hsa:7471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10720,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2771,hsa:501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:4609,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:160287,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79888,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5609,hsa:5599,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:4087,hsa:84647,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7366,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:1388,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2791,hsa:7042,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00790,path:hsa00130,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:5894,hsa:5604,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:92483,hsa:353376,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,path:hsa00250,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
path:hsa00640,hsa:54579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:132158,hsa:441531,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:377841,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:3552,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:10390,hsa:64600,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:7186,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:7083,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10093,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:10092,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:808,hsa:815,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:2790,hsa:51727,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:9586,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3717,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10097,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:10109,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:9583,hsa:84618,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,2,0.8
hsa:222,hsa:54331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5731,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2688,hsa:2690,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3845,hsa:8503,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5567,hsa:64764,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3661,hsa:3441,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:957,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:586,hsa:594,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5566,hsa:2998,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5160,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1499,hsa:10383,no_relation,no_relation,no_relation,no_relation,0.0
hsa:197322,hsa:316,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:3135,hsa:567,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:23411,hsa:7157,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:5599,hsa:3725,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:810,hsa:5533,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
cpd:C00681,hsa:1902,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
cpd:C00076,hsa:1728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:84335,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1548,hsa:54659,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:2353,hsa:4318,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2773,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4088,hsa:4089,PPrel,binding/association,path:hsa05210 Colorectal cancer,1,0.5
hsa:55902,hsa:39,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:8976,hsa:10093,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:355,hsa:56953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:100137049,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4790,hsa:4318,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:55748,hsa:2330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:652,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:8517,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:3984,hsa:1073,PPrel,phosphorylation,path:hsa04360 Axon guidance,2,0.8
hsa:387,hsa:9475,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:6773,hsa:5610,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5606,hsa:5603,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
cpd:C00076,hsa:8503,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5594,hsa:2100,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2773,hsa:107,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4137,hsa:3948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6470,hsa:5162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:32,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5571,hsa:31,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2773,hsa:108,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:10365,hsa:7295,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5606,hsa:5603,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
cpd:C00076,hsa:810,PCrel,binding/association,path:hsa04740 Olfactory transduction,1,0.5
hsa:2475,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:4209,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:27121,hsa:7472,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:808,hsa:5530,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:8517,hsa:4792,PPrel,activation,path:hsa05161 Hepatitis B,2,0.8
hsa:5609,hsa:5599,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2731,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1854,hsa:4831,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5970,hsa:3576,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:1496,hsa:7414,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:5578,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4538,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5567,hsa:84699,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:107987479,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85464,hsa:1073,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:6237,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6237,hsa:5296,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:221357,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5500,hsa:5934,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4259,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10000,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:93034,hsa:56302,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:107987478,hsa:54600,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2784,hsa:10094,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4627,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:2784,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2793,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1432,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2768,hsa:23365,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:4215,hsa:5606,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5595,hsa:3725,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5291,cpd:C05981,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5293,cpd:C05981,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4087,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10094,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:83667,hsa:5565,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:6009,hsa:2944,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:208,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10672,hsa:23365,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:84618,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
cpd:C00704,hsa:5970,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:10568,hsa:9368,PPrel,binding/association,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:2778,hsa:2791,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:79784,hsa:71,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:1576,hsa:4129,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4191,path:hsa00020,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:1565,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:3551,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3445,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:22808,hsa:5295,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2771,hsa:31,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:2353,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:4137,hsa:883,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00250,hsa:5313,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5606,hsa:1432,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:4690,hsa:5058,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
cpd:C00334,hsa:31,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:2353,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:27123,hsa:51384,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:377841,hsa:5921,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8976,hsa:10552,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:9475,hsa:4636,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:5608,hsa:6300,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2953,hsa:2782,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:51727,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55823,hsa:338382,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:2771,hsa:5599,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5567,hsa:1386,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:972,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7372,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
cpd:C00076,hsa:5595,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5605,hsa:5600,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2885,hsa:6654,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:9446,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5594,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:111,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:7186,hsa:1029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:23236,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5291,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2952,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3442,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:102723407,hsa:1003,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1442,hsa:2690,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:163688,hsa:816,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:4790,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1373,hsa:3155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9451,hsa:1965,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:6885,hsa:6300,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
cpd:C00334,hsa:2563,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:85465,hsa:5322,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:23646,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:983,hsa:85417,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:59345,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1499,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6093,hsa:10627,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:1548,hsa:7364,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5609,hsa:5599,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:1491,path:hsa00260,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5290,hsa:5609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7471,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2329,hsa:10109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:54575,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:34,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1549,hsa:3290,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:59345,hsa:3445,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:2948,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2782,hsa:57571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55748,hsa:219,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5608,hsa:1870,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:84699,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5175,hsa:382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:196883,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2776,hsa:23236,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:223,hsa:54498,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:6237,hsa:1029,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4790,hsa:3576,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:5295,hsa:9138,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:654364,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5091,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C00410,hsa:799,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5106,hsa:5091,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4893,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3710,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:4780,hsa:4880,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:4690,hsa:10298,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:1738,hsa:6470,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:5567,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:54963,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:10746,hsa:332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:108,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5601,hsa:3725,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:84790,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5606,hsa:1432,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
path:hsa00270,path:hsa00640,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:873,hsa:5136,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5894,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:132158,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5320,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5590,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:7278,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1386,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5562,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1553,hsa:7366,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:208,hsa:3551,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:5241,hsa:4853,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:5732,hsa:2783,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:7099,hsa:5594,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:2932,hsa:369,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:18,hsa:219,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:30,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:54490,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:4893,hsa:5296,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5608,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:9586,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2322,hsa:6688,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5567,hsa:1386,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:222,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5609,hsa:5601,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3452,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11200,hsa:93,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2953,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:4790,hsa:1906,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:805,hsa:51727,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:2790,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:2773,hsa:291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4707,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:133,hsa:10203,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2689,hsa:2690,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2944,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2788,hsa:598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3553,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:3091,hsa:7422,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:3717,hsa:8660,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1432,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:183,hsa:185,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5579,hsa:151056,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:808,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:373156,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2771,hsa:5295,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:3716,hsa:6772,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:8936,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5603,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa05219 Bladder cancer,2,0.8
hsa:1460,hsa:1499,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:5568,hsa:1386,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10000,hsa:2475,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2099,hsa:6714,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:51764,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1557,hsa:2952,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1491,path:hsa00480,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:7157,hsa:4616,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1738,hsa:54961,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3709,hsa:801,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5878,hsa:55823,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:5568,hsa:64764,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
path:hsa00010,hsa:441531,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5880,hsa:57144,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:2939,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7124,hsa:7133,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:64170,hsa:3661,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5563,hsa:2775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5241,hsa:6776,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:107987479,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,path:hsa00620,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2949,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:22978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,2,0.8
hsa:5608,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1549,hsa:54658,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5019,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:4257,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
cpd:C00575,hsa:5568,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5443,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22808,hsa:5293,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3447,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01312,hsa:5739,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1548,hsa:54657,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:1944,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10810,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1576,hsa:2938,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:208,hsa:4846,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:10681,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:23411,hsa:2309,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:3158,path:hsa00910,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3030,hsa:35,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:5605,hsa:5595,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:23236,hsa:5578,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2793,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
cpd:C00788,hsa:155,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:64764,hsa:2740,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4697,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5610,hsa:3667,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1646,hsa:7366,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:7189,hsa:6300,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:4129,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100526794,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1431,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:84699,hsa:2353,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:5568,cpd:C16844,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9583,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6654,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5881,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:8517,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:26275,hsa:1962,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:501,hsa:128,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5604,path:hsa00250,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:779,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2771,hsa:122618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1386,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5330,cpd:C01245,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1021,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:53632,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2353,hsa:5155,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:23411,hsa:10891,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3458,hsa:5608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:4792,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,2,0.8
hsa:5322,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00681,hsa:1902,PCrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:122618,hsa:30814,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00584,hsa:10092,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57180,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:2805,hsa:92483,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:1576,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:5595,PPrel,activation,path:hsa05133 Pertussis,1,0.8
cpd:C00002,hsa:7423,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:3708,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:817,hsa:109,PPrel,phosphorylation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5331,cpd:C01245,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5606,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5734,hsa:94235,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:805,hsa:5063,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3440,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:387,hsa:71,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:2806,path:hsa00350,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:137362,hsa:7263,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2773,hsa:111,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:54576,hsa:4214,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:7378,no_relation,no_relation,no_relation,no_relation,0.0
hsa:18,hsa:217,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:3708,hsa:91860,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:126,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2775,hsa:182,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26279,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:151056,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5734,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7188,hsa:7879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:2099,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:84532,hsa:38,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:39,hsa:64064,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2885,hsa:6654,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:4907,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2572,hsa:10097,no_relation,no_relation,no_relation,no_relation,0.0
hsa:132158,path:hsa00010,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:3659,hsa:3593,GErel,expression,path:hsa05133 Pertussis,1,0.5
hsa:221264,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3984,hsa:1073,PPrel,inhibition,path:hsa04360 Axon guidance,2,0.8
hsa:5534,hsa:63826,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:207,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1491,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3157,hsa:790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1003,hsa:1499,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:5565,hsa:32,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:10645,hsa:5563,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5898,hsa:5879,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:3661,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:1026,GErel,expression,path:hsa04218 Cellular senescence,1,0.5
hsa:221357,hsa:7363,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1576,hsa:373156,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:10993,hsa:54658,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:2150,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1562,hsa:2939,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1549,hsa:54579,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5602,hsa:7417,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6198,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5595,hsa:148327,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:119391,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1559,hsa:2326,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5566,hsa:5819,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5594,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5568,hsa:9138,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:1137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:51380,hsa:4907,no_relation,no_relation,no_relation,no_relation,0.0
hsa:35,hsa:3030,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1559,hsa:5091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8471,hsa:5291,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4790,hsa:3448,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:805,hsa:63826,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3030,hsa:34,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",3,0.5
hsa:2771,hsa:196883,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:3717,hsa:25759,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:6655,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4088,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:653857,hsa:2783,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:2947,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:7084,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5601,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:124583,hsa:5095,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79799,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
path:hsa00640,path:hsa00290,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:355,hsa:8772,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5745,hsa:5925,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5900,hsa:5898,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:84532,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5578,hsa:3611,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:501,hsa:1029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221357,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5295,cpd:C05981,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:125061,path:hsa00620,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:218,hsa:54498,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,2,0.8
hsa:5595,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8605,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5595,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:208,hsa:1147,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5595,hsa:2353,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5566,hsa:2309,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:7852,hsa:94235,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5894,hsa:137362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:208,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:107987479,hsa:54579,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:4137,hsa:203068,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3939,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:84628,hsa:64101,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:5167,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:39,path:hsa00650,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4087,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:148327,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:7364,hsa:2746,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100137049,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:587,hsa:3155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:537,hsa:5582,PPrel,binding/association,path:hsa05161 Hepatitis B,1,0.5
path:hsa00250,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:818,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
cpd:C00025,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:64764,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:10000,hsa:2309,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:10097,path:hsa00430,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2099,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5568,hsa:4208,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1869,hsa:993,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:377841,hsa:22978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5533,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:1258,PCrel,activation,path:hsa04740 Olfactory transduction,2,0.8
hsa:6416,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:805,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:587,path:hsa00260,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2771,hsa:114,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:9586,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
cpd:C00788,hsa:152,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:51176,hsa:1499,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:4214,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:64764,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5604,hsa:5095,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:54434,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:2944,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6300,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1386,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1959,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00770,hsa:2806,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:873,hsa:7364,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2475,hsa:6199,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5566,hsa:1594,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:6654,hsa:3265,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2787,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:57571,hsa:219,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2771,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:4636,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:115,cpd:C00575,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:51806,hsa:163688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5567,hsa:468,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:6237,hsa:5291,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:7852,hsa:2782,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6300,hsa:2277,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:7248,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2906,PCrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:207,hsa:7248,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:23411,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:5921,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:10000,hsa:2100,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:6777,hsa:3486,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:2948,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5609,hsa:5602,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3661,hsa:3449,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:6093,hsa:103910,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:5595,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6472,hsa:5468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,cpd:C00575,PCrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:1459,hsa:1499,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5290,hsa:207,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:4893,hsa:4214,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:107987479,hsa:7367,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:1737,path:hsa00640,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3945,hsa:125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:9252,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:2950,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5605,hsa:5595,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:1511,hsa:2151,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:6300,hsa:3725,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:8660,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:207,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:115,hsa:2149,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5617,hsa:5618,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:673,hsa:5604,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
cpd:C00681,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00008,hsa:5029,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
cpd:C00076,hsa:2790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:8310,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1386,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5568,hsa:4792,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:207,hsa:3551,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:956,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:7189,hsa:5599,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:374875,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8471,hsa:5290,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5608,hsa:200186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:5336,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53632,hsa:57521,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:5604,hsa:5603,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5604,hsa:100137049,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54947,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:208,hsa:2309,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
cpd:C00681,hsa:2846,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3845,hsa:369,PPrel,activation,path:hsa05210 Colorectal cancer,2,0.8
hsa:10488,hsa:1026,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:5600,hsa:1386,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C01996,hsa:1128,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5579,hsa:776,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5608,hsa:5603,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5568,hsa:468,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1386,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5330,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
path:hsa00620,hsa:50484,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23586,hsa:57506,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5296,hsa:5894,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:374875,hsa:54490,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5332,cpd:C00165,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
cpd:C00925,hsa:6382,PCrel,binding/association,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:10094,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5296,hsa:6932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5293,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2475,hsa:6198,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:111,cpd:C00575,PCrel,activation,path:hsa04926 Relaxin signaling pathway,4,0.8
cpd:C00745,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3443,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2770,hsa:2793,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5468,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:998,hsa:56924,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:5290,hsa:2952,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26275,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5578,PCrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:1141,hsa:3717,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:10096,hsa:7363,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:197322,hsa:223,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2771,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00071,hsa:1431,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:4137,hsa:2790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3728,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25,hsa:55740,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
cpd:C00547,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:111,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2791,hsa:7367,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00010,hsa:5224,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:51380,hsa:64601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:7414,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2940,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5567,hsa:7082,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2940,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2099,hsa:2255,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:5564,hsa:32,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2788,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1559,hsa:2327,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6470,hsa:1610,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:2534,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51727,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6470,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:3479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10095,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:5606,hsa:5600,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:2775,hsa:956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:1258,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6774,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:65985,hsa:38,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1392,hsa:1869,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9583,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3290,hsa:54600,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6714,hsa:5881,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5970,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:9446,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5605,hsa:5602,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1557,hsa:119391,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3716,hsa:6772,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10552,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5338,hsa:26279,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5290,hsa:5170,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5595,hsa:3725,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:487,hsa:818,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:5567,hsa:468,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5604,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:2151,no_relation,no_relation,no_relation,no_relation,0.0
hsa:218,hsa:57506,no_relation,no_relation,no_relation,no_relation,0.0
hsa:177,hsa:221,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:5214,no_relation,no_relation,no_relation,no_relation,0.0
hsa:811,hsa:714,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:221,hsa:54498,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2769,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:972,hsa:3117,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:163688,hsa:5535,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:51764,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:8605,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2776,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:7297,hsa:6775,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2100,hsa:2252,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:1549,hsa:54657,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:8503,hsa:208,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:4893,hsa:673,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
cpd:C00575,hsa:956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4728,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5338,hsa:283748,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5291,hsa:586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5894,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5879,hsa:5599,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5609,hsa:5599,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:10488,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2769,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3845,hsa:5894,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
cpd:C00025,hsa:2903,PCrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:85465,hsa:100137049,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2778,hsa:113,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4833,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
cpd:C05981,hsa:207,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:314,hsa:224,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5175,hsa:5296,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:1910,hsa:2773,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5534,hsa:4776,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:84532,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1386,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:7124,hsa:7132,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5970,hsa:1958,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:818,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2778,hsa:113,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:207,hsa:2932,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:387,hsa:5562,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5899,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:4843,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5568,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,cpd:C05981,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:816,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5933,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:56994,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26275,hsa:3030,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1432,hsa:2353,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:6714,hsa:53358,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2785,hsa:1030,no_relation,no_relation,no_relation,no_relation,0.0
hsa:154,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5731,hsa:56924,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4258,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5568,hsa:64764,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5566,hsa:1388,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4609,hsa:1029,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5604,hsa:3945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4731,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5091,path:hsa00630,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5566,hsa:1386,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5603,hsa:5160,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:119391,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:1559,path:hsa00220,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1553,hsa:1646,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2767,hsa:5331,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:1793,hsa:5879,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:196883,hsa:5568,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:7454,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27306,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22978,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:978,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57617,hsa:338382,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:2770,hsa:108,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5970,hsa:2846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:5747,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:51727,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5533,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:10390,hsa:2785,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3157,hsa:64064,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:54600,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5868,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:54490,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:10093,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:355,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1491,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9370,hsa:637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:4893,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2775,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5534,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4357,hsa:8399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:1432,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:2353,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10095,hsa:5598,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2915,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:35,path:hsa00640,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:7189,hsa:5603,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:3665,hsa:3456,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:6300,hsa:9261,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:369,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7157,hsa:1026,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:5295,hsa:5162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55902,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5595,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2947,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5106,hsa:5313,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3718,hsa:6776,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5734,hsa:653857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5603,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:2308,hsa:4088,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:4907,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
path:map00950,path:hsa00130,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:2793,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:10365,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5878,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5579,hsa:9368,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:978,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:122618,hsa:3728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:6300,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:10810,hsa:57180,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:114,cpd:C00575,PCrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:6885,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:5019,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5169,hsa:4907,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5481,hsa:10105,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:6300,hsa:3725,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1956,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5599,hsa:3667,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3290,hsa:54575,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:208,hsa:3551,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:107987478,hsa:54658,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2776,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4907,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:207,hsa:7249,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:91860,hsa:5530,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2769,hsa:1610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10810,hsa:10094,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
cpd:C01245,hsa:3708,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:5105,hsa:5313,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C00780,hsa:3363,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1432,hsa:5602,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:4217,hsa:5609,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:468,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:7263,hsa:1491,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5605,hsa:5601,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:501,hsa:18,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5733,hsa:2786,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:207,hsa:1147,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:1907,hsa:51806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:2953,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:805,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:131,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1141,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2559,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5161,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2783,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:217,hsa:54498,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5567,hsa:468,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:1564,hsa:10941,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5535,hsa:2932,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5595,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:2353,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
cpd:C00025,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:155,hsa:2770,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5295,hsa:2308,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:367,hsa:10203,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:56953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1576,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5175,hsa:5175,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
cpd:C00212,hsa:140,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2885,hsa:399694,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5241,hsa:9314,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:5532,hsa:572,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:107,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83667,hsa:53632,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1548,hsa:30833,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:2770,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:2309,hsa:847,GErel,expression,path:hsa04211 Longevity regulating pathway,1,0.5
hsa:3665,path:hsa00600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5601,PPrel,activation,path:hsa05133 Pertussis,1,0.8
cpd:C01245,hsa:3708,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:1147,hsa:5970,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3449,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:113,hsa:5567,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:652,hsa:93,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:810,hsa:883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5320,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:177,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:54657,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3276,hsa:2308,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2941,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2767,hsa:6352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6469,hsa:948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:7417,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00240,hsa:338382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5604,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:374875,hsa:7366,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:4790,hsa:4790,PPrel,inhibition,path:hsa05161 Hepatitis B,1,0.8
hsa:3441,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:23646,hsa:50487,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:106821730,hsa:8440,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:10000,hsa:3551,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:30,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2932,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C05981,hsa:10000,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:10000,hsa:332,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:23236,hsa:54577,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9583,hsa:93034,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1564,hsa:574537,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:714,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56924,hsa:3984,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:4191,path:hsa00630,maplink,compound,path:hsa00620 Pyruvate metabolism,2,0.5
hsa:122618,hsa:5319,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:369,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4615,hsa:3654,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:537,hsa:5579,PPrel,binding/association,path:hsa05161 Hepatitis B,1,0.5
hsa:805,hsa:5534,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5530,hsa:221,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,hsa:83593,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:224,hsa:18,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:112,cpd:C00575,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:9181,hsa:200186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5568,hsa:1388,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3456,hsa:1906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:1388,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1565,hsa:6195,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:375,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5340,hsa:2151,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5330,hsa:5580,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5532,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:5293,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5600,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5105,hsa:5091,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:6093,hsa:4636,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:6093,hsa:7132,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7472,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5898,hsa:387,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2770,hsa:5160,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5568,hsa:64764,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1559,hsa:3948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100137049,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:224,hsa:130,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5156,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00122,hsa:112399,PCrel,inhibition,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:1386,hsa:2947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6198,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
cpd:C00002,hsa:5029,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2773,hsa:5600,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:6009,hsa:3685,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8471,hsa:5290,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
cpd:C00165,hsa:3984,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4690,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:5319,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7414,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:93034,hsa:4318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2571,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22926,hsa:1649,GErel,expression,path:hsa05014 Amyotrophic lateral sclerosis,1,0.5
hsa:8717,hsa:7186,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5567,hsa:10488,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2773,path:hsa00600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4773,hsa:405,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:53632,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:2151,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:1268,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:8651,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:114,hsa:7363,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8936,hsa:10093,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:2939,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1543,hsa:84532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:2949,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3569,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5582,hsa:673,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:55970,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:8503,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5533,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:51422,hsa:84335,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:953,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:4258,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221357,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:810,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:207,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:64764,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:10488,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:593,hsa:587,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:54947,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2783,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6300,hsa:3725,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10488,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:9514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6774,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:2771,hsa:2787,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:1806,hsa:1807,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5322,hsa:4711,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5567,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2787,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5599,hsa:2353,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5169,hsa:5925,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:10941,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5600,hsa:148327,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:53632,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987479,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3725,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:4233,hsa:2549,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
path:hsa00640,hsa:316,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:38,hsa:3155,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:377841,hsa:100526794,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:56953,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5594,hsa:406890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2271,hsa:4191,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:369,hsa:5604,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
cpd:C00025,hsa:2905,PCrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:5568,hsa:84699,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:137362,hsa:5153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:223,hsa:64805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:114,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:332,hsa:836,PPrel,inhibition,path:hsa05161 Hepatitis B,1,0.8
hsa:3845,hsa:5291,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
cpd:C00076,hsa:808,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:369,hsa:5605,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,2,0.8
hsa:5605,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3725,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
cpd:C11695,hsa:1268,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5535,hsa:4772,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:93034,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:1491,hsa:587,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5371,hsa:2793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:355,hsa:8772,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3725,hsa:4318,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:5595,hsa:3479,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5608,hsa:6300,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5568,hsa:1386,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4893,hsa:5894,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5567,hsa:113675,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:111,PPrel,activation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:5534,hsa:4776,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:4833,hsa:9583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:29922,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:2773,hsa:5602,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:114,cpd:C00575,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2271,path:hsa00630,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5315,hsa:160287,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2770,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:4988,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5105,path:hsa00630,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:10365,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5601,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:3600,hsa:56953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23586,hsa:3440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:4357,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4830,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:9368,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5609,hsa:5599,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:7099,hsa:2773,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:4690,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:4790,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:5532,hsa:54961,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:1553,hsa:275,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:3162,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:51806,hsa:7189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:2353,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5567,hsa:90993,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:3718,hsa:6778,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:107987478,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:54511,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6776,hsa:8651,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:2790,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2100,hsa:2248,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:131,hsa:54434,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:4318,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5332,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:217,no_relation,no_relation,no_relation,no_relation,0.0
hsa:406933,hsa:6776,PPrel,inhibition,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
cpd:C00334,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:4257,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3265,hsa:5594,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:113675,path:hsa00020,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:27123,hsa:7481,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:4137,hsa:10382,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2771,hsa:8503,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:32,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:9002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:10365,hsa:2944,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5604,hsa:54963,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:8517,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:207,hsa:3551,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:3551,hsa:5970,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5970,hsa:3456,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:594,hsa:1629,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",3,0.5
hsa:83667,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1549,hsa:2034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:3551,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:8660,hsa:5291,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:578,hsa:54205,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:59345,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3845,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:5743,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:5970,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3685,hsa:3690,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:1646,hsa:54579,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5295,hsa:10000,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:39,path:hsa00020,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
path:hsa00640,hsa:100137049,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:2309,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:8639,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:1443,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:810,hsa:5533,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4780,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7084,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3661,hsa:3442,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
cpd:C00575,hsa:3355,no_relation,no_relation,no_relation,no_relation,0.0
hsa:224,hsa:126,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5091,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5091,hsa:1910,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:284958,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:124583,hsa:84618,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:23411,hsa:5468,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4790,hsa:330,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:5566,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:5733,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00076,hsa:5578,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:7852,hsa:2792,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:814,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1386,hsa:81873,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:3726,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5337,hsa:9252,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:2550,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:369,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5295,hsa:3674,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2952,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10201,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5601,hsa:3725,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5567,hsa:84699,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:54490,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3985,hsa:1072,PPrel,inhibition,path:hsa04360 Axon guidance,1,0.8
cpd:C00076,hsa:5530,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:713,hsa:4035,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:3551,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:3685,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3032,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5731,hsa:2773,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:7098,cpd:C00027,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3448,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:4137,hsa:4713,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
path:hsa00900,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:63826,path:map00460,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:2940,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5610,hsa:8660,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:373156,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:2787,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100137049,hsa:637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2099,hsa:956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:54331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2185,hsa:6714,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1616,hsa:4217,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:3442,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5053,path:map00960,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:115,hsa:5568,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5335,cpd:C00165,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2793,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:30814,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C05981,hsa:4929,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:7084,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:54331,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:7189,hsa:5602,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:840,hsa:4137,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:9844,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7298,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5053,hsa:137362,ECrel,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",2,0.5
hsa:4217,hsa:2327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27244,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C02198,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:6774,hsa:10092,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2322,hsa:5138,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:18,hsa:223,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:29119,hsa:5096,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10720,hsa:7249,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5291,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5291,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:64064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5530,hsa:4773,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5594,path:hsa00630,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:5606,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:8936,hsa:1892,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5878,hsa:65082,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:91860,hsa:5153,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:3661,hsa:3446,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:217,hsa:186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:317,hsa:842,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:51727,hsa:83549,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
cpd:C01996,hsa:2768,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1399,hsa:1793,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:259307,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3709,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:3554,hsa:1738,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5880,hsa:5062,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:5970,hsa:1514,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:586,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2149,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:6197,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:377841,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3157,hsa:54511,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:7365,hsa:54575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10094,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
cpd:C00533,hsa:2982,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:54658,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3448,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5900,path:hsa00630,no_relation,no_relation,no_relation,no_relation,0.0
hsa:137362,path:map00960,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:2771,hsa:10095,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00665,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5601,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5167,hsa:100526794,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:54331,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
cpd:C00788,hsa:147,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4214,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:8681,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10941,hsa:382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:1432,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:109,hsa:5566,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:6885,hsa:1147,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5532,hsa:200186,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:10390,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:551,hsa:554,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:581,hsa:54205,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:7367,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10390,hsa:54979,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5568,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:7423,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5594,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:1969,hsa:25,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:3643,hsa:8660,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5578,hsa:5894,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:6416,hsa:5601,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1147,hsa:3667,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:1839,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5595,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:189,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:109,PPrel,phosphorylation,path:hsa04740 Olfactory transduction,1,0.8
hsa:189,hsa:6472,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
cpd:C00076,hsa:5594,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00533,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2773,hsa:373156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:2353,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:163688,hsa:5535,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5733,hsa:51806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4830,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:4129,hsa:316,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:596,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54963,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:10000,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2308,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:100137049,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:27244,hsa:259307,no_relation,no_relation,no_relation,no_relation,0.0
hsa:255189,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4215,hsa:5606,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5566,hsa:90993,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:23646,hsa:84647,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2953,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4357,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:102723407,hsa:5732,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2952,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:2788,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,cpd:C01245,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:91860,hsa:4842,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:4833,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:8936,hsa:653857,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:112817,path:hsa00260,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:2785,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:221357,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5731,hsa:51764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6714,hsa:3265,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1549,hsa:54600,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:374875,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:5136,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5564,hsa:57521,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5058,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5869,hsa:64601,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:2778,hsa:109,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4137,hsa:4722,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
cpd:C01996,hsa:338382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5880,hsa:5058,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:5465,hsa:6256,PPrel,binding/association,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:4893,hsa:5894,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:4832,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3939,hsa:10109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5295,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:4548,hsa:6898,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5603,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:219,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:27035,hsa:2792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,cpd:C00575,PCrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:23586,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:148327,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5535,hsa:54434,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2775,hsa:2782,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:4790,hsa:4313,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5970,hsa:5154,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5594,hsa:1958,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5321,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:808,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5564,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:3665,hsa:3452,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:2948,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2770,hsa:2782,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5599,hsa:93034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:5062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:2786,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:10109,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:26275,hsa:92,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:2947,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:842,hsa:836,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
path:hsa00240,hsa:316,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1576,hsa:92483,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:154,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2783,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5880,hsa:56924,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:2549,hsa:5293,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:5291,cpd:C05981,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2771,hsa:10681,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:10365,hsa:2946,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
cpd:C00165,hsa:221357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:653689,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5091,hsa:8835,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5533,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2932,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4775,hsa:5743,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:972,hsa:3118,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:6472,path:hsa00230,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5970,hsa:4790,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5571,hsa:5315,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:109,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
hsa:55626,hsa:8678,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:998,hsa:56924,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:5337,hsa:100137049,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4137,hsa:4701,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2941,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3030,hsa:8310,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5605,hsa:955,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,2,0.8
hsa:3725,hsa:81873,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:196883,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:4690,hsa:5063,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:5335,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4087,hsa:1030,GErel,expression,path:hsa04218 Cellular senescence,1,0.5
hsa:2534,hsa:998,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5567,hsa:1385,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2790,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:9138,hsa:998,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:223,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:718,hsa:719,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5599,hsa:3725,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:4214,hsa:6416,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2846,hsa:2768,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:10645,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4776,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2938,hsa:54498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4832,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79784,hsa:7472,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:391013,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:387,hsa:5338,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4137,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5566,hsa:468,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:7414,hsa:10580,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:4137,hsa:4706,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5566,hsa:468,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5566,hsa:468,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1555,hsa:1557,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5602,hsa:2353,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5535,hsa:4776,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:8503,cpd:C05981,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5320,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10941,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:151056,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:8517,hsa:8660,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1559,hsa:653689,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:8717,hsa:7187,PPrel,binding/association,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:54579,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4792,hsa:2939,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:3939,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:3091,hsa:7043,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:1564,hsa:54577,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:841,hsa:836,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:177,hsa:5582,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54657,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2773,hsa:5296,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:223,hsa:18,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:7132,hsa:8717,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:59345,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1577,hsa:1902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3554,hsa:8517,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:18,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1738,hsa:34,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:6714,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:2932,hsa:673,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:71,hsa:29119,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:3665,hsa:3443,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:2549,hsa:1398,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5734,hsa:2791,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:9583,hsa:56288,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:10681,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5568,hsa:3710,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:4627,hsa:60,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:5331,cpd:C01245,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:23646,hsa:54979,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5608,hsa:1557,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1869,hsa:7422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54658,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6714,hsa:27330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7098,hsa:148022,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
cpd:C00165,hsa:5582,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",2,0.8
hsa:487,hsa:2952,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:196883,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2628,hsa:3611,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00260,hsa:189,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:2944,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5567,hsa:2309,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
cpd:C00547,hsa:148,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:9451,hsa:54600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5169,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:6416,hsa:5599,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5606,hsa:6300,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:6885,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:2353,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5567,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3725,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5606,hsa:148,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:10627,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:1386,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:137362,path:map00950,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:5606,hsa:6300,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:6750,hsa:1072,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:3845,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:373156,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6416,hsa:6300,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:64902,path:hsa00630,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:1945,hsa:2534,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:1495,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:1594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1147,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3265,hsa:5295,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:107987478,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:817,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5601,hsa:51020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:572,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:30833,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:85465,hsa:8399,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:92483,hsa:5161,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5603,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3553,hsa:3554,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3716,hsa:6772,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,2,0.8
hsa:6608,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C06124,hsa:3552,no_relation,no_relation,no_relation,no_relation,0.0
hsa:224,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
cpd:C00575,hsa:5567,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5530,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1902,hsa:10672,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5894,hsa:5605,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10096,hsa:3441,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5734,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1908,hsa:1910,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4842,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:2554,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00038,hsa:2932,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5091,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27113,hsa:596,PPrel,inhibition,path:hsa05210 Colorectal cancer,1,0.8
hsa:107987478,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5582,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:84699,hsa:1839,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4780,hsa:445,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5291,hsa:6196,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:7852,hsa:2785,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2778,hsa:2783,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:2792,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1610,path:hsa00630,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:7366,hsa:189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2770,hsa:114,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:38,hsa:31,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5532,hsa:4776,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2534,hsa:387,PPrel,inhibition,path:hsa04360 Axon guidance,1,0.8
hsa:2773,hsa:2785,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:6093,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:586,hsa:593,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:3290,hsa:1553,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:572,hsa:3441,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5331,cpd:C00165,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:51380,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:3716,hsa:6773,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:4259,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3091,hsa:2056,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
cpd:C05981,hsa:207,PCrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2805,hsa:160287,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5169,hsa:100526794,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:998,hsa:5062,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:7298,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:151056,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:53358,hsa:6654,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5534,path:hsa00360,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,cpd:C00027,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
cpd:C00076,hsa:5291,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:8517,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22926,hsa:3695,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:8717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5534,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:801,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:3945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:54577,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2791,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5879,hsa:387,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2572,path:hsa00250,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5568,hsa:468,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5564,hsa:3553,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5770,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6470,path:hsa00230,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:10000,hsa:7423,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2950,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:468,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:107987479,hsa:7366,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5608,hsa:9475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:2113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:815,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5881,hsa:56924,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:5530,hsa:4772,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3375,hsa:799,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2773,hsa:5601,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5582,hsa:778,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4893,hsa:4907,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1386,hsa:2353,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:10645,hsa:5914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:6723,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3290,hsa:54579,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2597,hsa:7186,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5970,hsa:5155,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5533,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5293,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2952,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2783,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10062,hsa:246,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:3667,hsa:5291,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:373156,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1003,hsa:6775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124583,hsa:284958,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3708,hsa:883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6241,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5970,hsa:3458,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:978,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:4790,hsa:3592,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5291,hsa:208,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5295,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:373156,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5604,hsa:7366,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:2475,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1131,hsa:2776,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:10163,hsa:81873,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
cpd:C00584,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1021,hsa:896,PPrel,binding/association,path:hsa04218 Cellular senescence,3,0.5
hsa:6655,hsa:4893,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5602,hsa:8660,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5533,hsa:4776,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:38,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6773,hsa:84618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25945,hsa:5819,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:9564,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5530,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:132158,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:54947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5207,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:9138,hsa:387,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:972,hsa:3115,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:4214,hsa:4790,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:5970,hsa:596,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:6472,hsa:189,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:2783,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:6714,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:80326,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:207,hsa:3033,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54,hsa:5167,ECrel,compound,path:hsa00740 Riboflavin metabolism,1,0.5
hsa:3665,hsa:5023,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83549,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4690,hsa:147179,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:84532,hsa:223,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:208,hsa:1147,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1549,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:8681,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:221,hsa:51380,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2790,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3442,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5566,hsa:5564,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5595,hsa:1906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:131,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5566,hsa:84699,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:18,hsa:224,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5568,hsa:1386,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5595,hsa:90993,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2770,hsa:567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:10993,hsa:1848,no_relation,no_relation,no_relation,no_relation,0.0
hsa:653857,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:653689,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3665,hsa:3440,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:8936,hsa:10094,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:4790,hsa:3627,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:5933,hsa:1869,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:387,hsa:6093,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5899,hsa:5881,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5608,hsa:5598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5295,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1959,hsa:1387,PPrel,binding/association,path:hsa05161 Hepatitis B,1,0.5
hsa:10201,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:57521,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
path:hsa00230,path:hsa00260,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:6300,hsa:10488,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:673,hsa:10672,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10941,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5604,hsa:5595,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2791,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5534,hsa:4776,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3157,hsa:5019,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5331,cpd:C00165,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:57180,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:9583,hsa:284958,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
cpd:C00780,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10201,hsa:957,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3845,hsa:5894,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:8398,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3815,hsa:5295,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5595,hsa:487,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:5970,hsa:3576,GErel,expression,path:hsa05163 Human cytomegalovirus infection,2,0.5
hsa:3718,hsa:6774,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:148327,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:224,hsa:124,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2327,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:125,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1576,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,8,0.5
hsa:6776,hsa:9021,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:653857,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:1373,hsa:2746,ECrel,compound,path:hsa00910 Nitrogen metabolism,1,0.5
hsa:957,hsa:100526794,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2328,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4129,hsa:3690,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:83593,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1564,hsa:54658,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:6773,hsa:9451,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
cpd:C00575,hsa:56953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4191,hsa:3945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5322,cpd:C00533,no_relation,no_relation,no_relation,no_relation,0.0
path:map01056,cpd:C00076,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:2308,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5881,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1021,hsa:894,PPrel,binding/association,path:hsa04218 Cellular senescence,3,0.5
hsa:59345,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3451,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:983,hsa:9133,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:207,hsa:2308,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1942,hsa:2534,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5914,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:9368,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5331,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3725,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8936,hsa:51807,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8681,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:29119,hsa:7414,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:4137,hsa:1806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5878,hsa:57617,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:5291,hsa:3674,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:440275,hsa:5160,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2147,hsa:224,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55748,hsa:222,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:107987479,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1562,hsa:441925,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5899,hsa:6778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1965,hsa:468,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:6300,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:2782,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2782,hsa:26275,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:317,hsa:8398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:109,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:3032,hsa:79602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:18,hsa:51380,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1385,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:6093,hsa:10398,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:8503,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:26279,no_relation,no_relation,no_relation,no_relation,0.0
hsa:572,hsa:596,PPrel,inhibition,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:7852,hsa:2787,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5595,hsa:1051,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:5533,hsa:4257,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1495,hsa:122618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1549,hsa:374875,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6885,hsa:51701,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:5566,hsa:84699,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4594,hsa:197322,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:10941,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:25759,hsa:4257,no_relation,no_relation,no_relation,no_relation,0.0
hsa:578,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:8517,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
cpd:C01245,hsa:3710,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:6714,hsa:4893,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:6300,hsa:29851,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:5295,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:54331,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:818,hsa:1432,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:6416,hsa:5603,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10000,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:6794,hsa:5571,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:51176,hsa:4609,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:6300,hsa:3479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84532,hsa:224,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:551,hsa:553,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1500,hsa:998,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:7976,hsa:9474,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4548,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:222,hsa:314,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:10673,hsa:23495,PPrel,activation,path:hsa04672 Intestinal immune network for IgA production,3,0.8
hsa:55902,path:hsa00640,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5609,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54205,hsa:842,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:8517,hsa:4790,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6655,hsa:4893,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:56267,hsa:1491,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:3948,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:27306,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5970,hsa:3592,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5733,hsa:2770,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1491,hsa:1036,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:22978,hsa:1854,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:84532,hsa:39,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:5732,hsa:1385,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:18,hsa:501,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:111,hsa:5568,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:9583,hsa:4907,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5579,hsa:5894,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
cpd:C00076,hsa:10645,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3815,hsa:6777,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5533,hsa:4772,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5241,hsa:6777,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:113,hsa:5567,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:653689,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:57144,hsa:3985,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2932,hsa:147700,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:7852,hsa:54331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2792,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5296,hsa:208,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:6654,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:7124,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5313,hsa:5160,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:959,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5330,cpd:C01245,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:23236,cpd:C01245,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4907,hsa:1854,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
cpd:C00518,hsa:2817,PCrel,binding/association,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:377841,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1737,hsa:200186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:109,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:22943,hsa:80326,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2786,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:54979,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6093,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:999,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5925,hsa:1871,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:51135,hsa:7099,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2787,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1548,hsa:54578,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:387,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:1543,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:6775,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2330,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:3725,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5296,hsa:10000,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
cpd:C13856,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:207,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5567,hsa:84699,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1788,hsa:2113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:468,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:8740,hsa:8764,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:207,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2572,hsa:217,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:6898,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5566,hsa:1388,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:8976,hsa:10093,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:2790,hsa:2946,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:10382,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
path:map00940,path:map00950,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:22808,hsa:83593,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1491,hsa:2805,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,2,0.5
hsa:2353,hsa:7412,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
cpd:C00122,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:653689,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:57571,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:9021,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:7474,hsa:6259,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:57571,hsa:339896,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:644150,hsa:653857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5532,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5568,hsa:10488,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:122618,hsa:7879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10298,hsa:7363,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1854,hsa:7083,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2783,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:841,hsa:38,no_relation,no_relation,no_relation,no_relation,0.0
hsa:867,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:5745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81579,hsa:54963,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:1386,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2773,hsa:5293,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:23411,hsa:7157,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:369,hsa:2100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5914,hsa:8900,GErel,expression,path:hsa05221 Acute myeloid leukemia,2,0.5
hsa:5732,hsa:1029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29119,hsa:7474,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80824,hsa:1630,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:1387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:957,hsa:10331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2534,hsa:2786,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4724,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:1558,hsa:2949,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1559,hsa:221357,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:7454,hsa:71,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2034,hsa:7043,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:712,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:148,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4129,hsa:5467,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5925,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5096,hsa:84693,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:3716,hsa:6776,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:221,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3091,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:10645,hsa:124583,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:1072,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5578,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:30,hsa:669,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27306,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:953,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:817,hsa:6300,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:5567,hsa:2309,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2793,hsa:10095,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8639,hsa:224,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:6416,hsa:5599,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:8976,hsa:10095,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5894,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4792,hsa:1594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,cpd:C05981,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5600,hsa:5601,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:109,hsa:5567,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:3661,hsa:3441,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:586,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:119391,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3845,hsa:5894,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2775,hsa:112,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:55102,hsa:26100,PPrel,binding/association,path:hsa05010 Alzheimer disease,1,0.5
hsa:137362,hsa:1258,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:6347,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:4776,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7263,hsa:3948,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5160,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C00076,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:83549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54658,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,hsa:8613,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:1432,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:4832,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:387,hsa:6093,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:957,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:2950,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:1545,hsa:9446,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:1646,hsa:2752,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:2953,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:27306,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:71,hsa:7414,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:5604,hsa:5594,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:7189,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:6776,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:57154,hsa:387,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:2771,hsa:5600,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:2941,hsa:558,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2322,hsa:5295,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2770,hsa:6655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2308,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1491,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:2941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:1943,hsa:5921,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5567,hsa:1385,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8517,hsa:8471,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00575,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00480,hsa:137362,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:7046,hsa:4088,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1902,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:64764,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3107,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:10720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:134,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5609,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4833,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7157,hsa:83667,GErel,expression,path:hsa04211 Longevity regulating pathway,1,0.5
hsa:7297,hsa:4940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3442,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:85465,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:219,hsa:125,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:10390,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9564,hsa:4214,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:219,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
hsa:3309,hsa:2081,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:3665,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7371,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6655,hsa:4893,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1843,hsa:5600,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:18,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:111,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:5733,hsa:54331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:151531,hsa:2952,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5603,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4259,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10201,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:7046,hsa:4088,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1737,hsa:5161,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5534,hsa:3948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5894,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2329,hsa:653689,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:160287,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5605,hsa:5595,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:7363,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10018,hsa:596,PPrel,inhibition,path:hsa05210 Colorectal cancer,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5567,hsa:1594,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4790,hsa:5019,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10672,hsa:9138,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1545,hsa:51727,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:163688,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:2940,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5568,hsa:776,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2309,hsa:9474,GErel,expression,path:hsa04211 Longevity regulating pathway,1,0.5
hsa:83593,hsa:5499,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:7186,hsa:5501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:64764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5295,cpd:C05981,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1128,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:5603,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:2775,hsa:107,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:4088,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C04549,hsa:26100,PCrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:3725,hsa:3552,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:207,hsa:572,PPrel,inhibition,path:hsa05161 Hepatitis B,1,0.8
hsa:586,path:hsa00640,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5063,hsa:3984,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:1543,hsa:405,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7099,hsa:2771,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:6416,hsa:5599,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5534,hsa:2932,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4773,hsa:5743,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:71,hsa:4301,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:3665,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:6401,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5595,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:4258,hsa:8613,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:8878,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5315,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:1432,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:956,hsa:284958,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:6416,hsa:5601,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C00681,hsa:1514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:81027,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6300,hsa:2353,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5293,hsa:208,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:10201,hsa:2941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5096,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4907,hsa:54600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:35,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5604,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4790,hsa:598,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:391013,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5595,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5566,hsa:84699,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5599,hsa:4088,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1511,hsa:2150,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:107987479,hsa:54658,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5600,hsa:63826,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9054,hsa:7263,PPrel,activation,path:hsa04122 Sulfur relay system,1,0.8
hsa:132158,hsa:5223,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:10000,hsa:5140,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:23339,hsa:7879,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
cpd:C00076,hsa:808,PCrel,binding/association,path:hsa04740 Olfactory transduction,1,0.5
hsa:5295,hsa:207,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:4831,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:574537,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:6778,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:673,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:8681,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10365,hsa:221357,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:1432,hsa:3725,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2932,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:796,hsa:799,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2786,hsa:993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7298,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1576,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:8503,hsa:5563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7186,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:7366,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3725,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:54658,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:4719,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4087,hsa:4089,PPrel,binding/association,path:hsa05210 Colorectal cancer,1,0.5
hsa:259307,hsa:10552,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4776,hsa:3091,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
cpd:C00076,hsa:163688,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2791,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2770,hsa:2791,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5605,hsa:5594,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:208,hsa:7249,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:5732,hsa:2790,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:10365,hsa:2949,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:4137,hsa:9583,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:4907,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:3725,hsa:4318,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5568,hsa:468,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8517,hsa:4792,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:163688,hsa:5534,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:2776,hsa:23236,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:57571,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C06124,hsa:10094,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:10993,path:hsa00290,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5567,hsa:9586,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4137,hsa:4717,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2784,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4214,hsa:5603,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:2100,hsa:8822,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:5500,hsa:5933,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:10681,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:3460,hsa:3717,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:3158,path:hsa00020,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
cpd:C05981,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:5590,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:574537,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5606,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:501,hsa:126,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:6009,hsa:2475,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:84699,hsa:54947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:387,hsa:5602,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:163688,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:5894,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5058,hsa:3984,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:374875,hsa:54578,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:10390,hsa:122618,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5169,hsa:7083,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:796,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:29895,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5568,hsa:90993,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10201,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5566,hsa:84699,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5594,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5337,hsa:391013,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1443,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5313,path:hsa00010,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:64902,hsa:224,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5595,hsa:1386,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:6714,hsa:1630,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:5578,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:339896,hsa:501,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1956,hsa:2885,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4790,hsa:3552,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:10163,hsa:10092,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:4258,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4259,path:map00680,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51727,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4615,hsa:31,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2628,path:hsa00600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:2806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3717,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:4893,hsa:83593,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:218,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4357,hsa:3948,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:102723996,hsa:29851,PPrel,activation,path:hsa04672 Intestinal immune network for IgA production,1,0.8
hsa:2773,hsa:6300,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5293,hsa:10000,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5731,hsa:54331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5295,hsa:2947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:2941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:1386,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5169,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5320,hsa:54511,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8471,hsa:7422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2322,hsa:6777,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5880,hsa:5601,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:4205,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7366,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9583,hsa:30833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6772,hsa:4940,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:5599,hsa:2353,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
cpd:C00334,hsa:2555,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:137362,hsa:4190,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:3661,hsa:2904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3452,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5332,cpd:C00165,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:7083,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:2805,hsa:4357,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5293,hsa:10000,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3667,hsa:5296,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2771,hsa:2788,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:148327,hsa:4722,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:801,hsa:5535,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:9583,hsa:80326,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51727,hsa:56953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:959,hsa:958,PPrel,activation,path:hsa04672 Intestinal immune network for IgA production,1,0.8
hsa:6093,hsa:137362,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00008,hsa:5024,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4780,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2326,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:391013,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2770,hsa:3984,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:54575,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:501,hsa:125,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:189,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5818,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8976,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:3486,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:31,path:hsa00061,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:7263,hsa:160287,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2805,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,path:hsa00620,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51733,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:5601,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5290,hsa:208,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5970,hsa:4318,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:54490,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:207,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
cpd:C05981,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9054,hsa:4357,PPrel,activation,path:hsa04122 Sulfur relay system,1,0.8
hsa:5567,hsa:90993,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:846,hsa:2771,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1495,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:797,hsa:799,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3439,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:4907,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3106,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:7278,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5293,cpd:C05981,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2353,hsa:2688,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:221264,hsa:124583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:177,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5603,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
path:map01056,hsa:8826,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1857,hsa:2932,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:10000,hsa:84335,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:27121,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:4846,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1496,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:218,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,4,0.5
hsa:5568,hsa:2997,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
cpd:C00076,hsa:5290,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1147,hsa:8639,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:54576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7372,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:2776,hsa:5332,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5732,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:4594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57121,hsa:1514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5602,hsa:3725,PPrel,activation,path:hsa05161 Hepatitis B,2,0.8
hsa:3667,hsa:5741,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:8503,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:369,hsa:5604,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:7278,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:3265,hsa:5914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:2952,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:124583,hsa:4907,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5091,hsa:160287,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3948,hsa:5161,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5534,hsa:4775,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
cpd:C00212,hsa:135,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5295,hsa:55062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7371,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:23236,hsa:3708,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:4842,cpd:C00533,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:64135,hsa:57506,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2572,hsa:219,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:8605,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:59345,hsa:7040,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2100,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
cpd:C00212,hsa:136,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:84532,hsa:217,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5568,hsa:51422,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5880,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:8503,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:501,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
cpd:C00002,hsa:64805,PCrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
cpd:C01245,hsa:3685,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8612,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5167,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2783,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5605,hsa:2944,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:356,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2309,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4137,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5607,hsa:7364,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64600,hsa:160287,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:31,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:113,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5567,hsa:90993,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1431,hsa:39,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:5565,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:115,hsa:5566,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:8517,hsa:6401,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:3685,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:9475,hsa:10398,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:374875,hsa:7367,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6093,hsa:224,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:56302,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5337,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5371,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5603,hsa:5601,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:54658,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3661,hsa:3441,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:5087,hsa:3586,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:4833,hsa:4842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2147,hsa:2846,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:957,hsa:22978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5568,hsa:6898,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2939,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:155,hsa:10993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:3115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:4846,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2787,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7263,hsa:50487,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C06124,hsa:9294,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5606,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7157,hsa:1026,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:208,hsa:112,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4627,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:10488,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:6932,hsa:1499,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:3845,hsa:5290,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:57571,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
hsa:815,hsa:4329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54490,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3447,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5594,hsa:5207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5601,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:119391,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5571,hsa:32,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:6774,hsa:9641,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:5095,hsa:30833,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:7084,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5167,hsa:22978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5925,hsa:1869,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:5602,hsa:3667,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:29110,hsa:3661,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1543,hsa:8835,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:3690,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3106,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:6196,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:801,hsa:5532,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:10000,hsa:5091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:2309,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:55902,hsa:219,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:54578,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5167,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2932,hsa:998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6776,hsa:11040,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:1629,hsa:34,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:2782,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
cpd:C00076,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10673,hsa:2100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:32,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:9475,hsa:10627,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:55970,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5747,hsa:5296,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:2770,hsa:111,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:2771,hsa:1962,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2769,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3709,hsa:91860,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:8398,hsa:2952,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3845,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:51727,hsa:30833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:953,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6655,hsa:3945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:4128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3569,GErel,expression,path:hsa05163 Human cytomegalovirus infection,2,0.5
hsa:3630,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27244,hsa:5562,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2773,hsa:108,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
path:hsa00290,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:816,hsa:5600,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:369,hsa:5605,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:83549,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5566,hsa:2997,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:22926,hsa:6240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:151056,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:84618,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1385,hsa:7040,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:5605,hsa:5595,PPrel,activation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:10365,hsa:5970,PPrel,binding/association,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5564,hsa:31,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
path:hsa00250,hsa:3456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5533,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5290,hsa:6714,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3667,hsa:6383,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64135,hsa:57506,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:10092,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:125,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5731,hsa:2783,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8503,hsa:207,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:84532,hsa:219,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2784,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4137,hsa:6775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:154,hsa:2778,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:1892,hsa:3033,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2778,hsa:115,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:6416,hsa:5600,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10720,hsa:100526794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:3440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4216,hsa:10672,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8639,hsa:6608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81873,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:5293,hsa:208,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:218,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2770,hsa:59345,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:10645,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:51806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5599,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:6009,hsa:57521,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
cpd:C03758,hsa:6241,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:81579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:2770,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6773,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:3709,hsa:7188,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:119391,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5605,hsa:27306,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:123745,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5608,hsa:5600,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:283106,hsa:29851,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3265,hsa:5296,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3661,hsa:3447,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:5290,cpd:C05981,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,6,0.8
hsa:5566,hsa:4205,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3442,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:3984,hsa:2953,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00250,hsa:3939,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:8517,hsa:4790,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5610,hsa:8471,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5914,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,hsa:957,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:207,hsa:1147,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1565,hsa:4128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:6370,hsa:10803,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
path:hsa00240,hsa:223,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:137362,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00640,path:map01056,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5601,hsa:2353,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:8517,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5293,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5566,hsa:64764,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:221,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:1907,hsa:1910,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:818,hsa:39,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54577,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3106,hsa:567,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:953,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5731,hsa:2791,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2326,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23130,hsa:26100,PPrel,binding/association,path:hsa05014 Amyotrophic lateral sclerosis,1,0.5
hsa:57180,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:51806,hsa:5535,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5290,hsa:355,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5534,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:54205,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00951,hsa:2100,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:4357,hsa:4259,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6655,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:222,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:54979,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10449,path:hsa00020,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:84618,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:5594,hsa:7419,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5594,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:54600,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2977,cpd:C00942,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:85465,hsa:23646,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5566,path:hsa00760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8772,hsa:841,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5565,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:8772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54979,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5600,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:1147,hsa:4792,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1549,hsa:10720,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:2805,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:8310,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:54361,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6237,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:160287,path:hsa00630,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51135,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284958,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:953,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2099,hsa:2253,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:2773,hsa:196883,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:10201,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:653689,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4780,hsa:4257,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:1564,hsa:7366,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:3845,hsa:5293,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:1003,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:2185,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3945,hsa:5161,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4893,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2767,hsa:5331,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2776,hsa:5332,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2885,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:2353,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:3709,hsa:1902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:85464,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
cpd:C00076,hsa:4846,PCrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:8976,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:4790,hsa:3593,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
cpd:C00780,hsa:3350,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:10094,hsa:1141,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:5291,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
path:hsa00900,hsa:3158,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:8936,hsa:57180,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:2806,path:hsa00360,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
cpd:C00410,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,cpd:C05981,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,6,0.8
hsa:501,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
hsa:2786,hsa:1514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:5925,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1562,hsa:4259,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:148327,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:8681,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2944,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:1956,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:8605,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:8503,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:1978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:6300,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:1558,hsa:27306,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:369,hsa:54658,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:5582,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3032,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5290,hsa:208,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:79888,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1558,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:9475,hsa:10627,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:2773,hsa:1432,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:23339,hsa:338382,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:1565,hsa:7365,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5970,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:2885,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1576,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987479,hsa:7363,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:1385,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5568,hsa:1388,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C05981,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4831,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:6777,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5530,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:8503,hsa:6195,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:10673,hsa:1854,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:123745,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5970,hsa:3593,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5293,hsa:208,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2806,hsa:1036,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:572,hsa:596,PPrel,inhibition,path:hsa05210 Colorectal cancer,1,0.8
hsa:2549,hsa:8503,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:957,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:3725,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4259,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2767,hsa:23236,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:154,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:957,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3661,hsa:1500,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9446,hsa:7082,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1962,hsa:36,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5881,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10097,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5568,hsa:64764,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:339896,hsa:217,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5599,hsa:8660,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00025,hsa:2904,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
cpd:C00575,hsa:5568,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:10000,hsa:842,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5338,hsa:11145,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:64902,hsa:316,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5605,hsa:5594,PPrel,activation,path:hsa05161 Hepatitis B,2,0.8
hsa:6196,hsa:2100,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:197322,hsa:219,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1432,hsa:187,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:3553,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:7186,hsa:4217,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5604,hsa:83549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:114,hsa:5566,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:5337,hsa:5320,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:51727,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5601,hsa:55062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3710,hsa:100526794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7042,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:5601,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5534,hsa:4772,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:108,cpd:C00575,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5594,hsa:1385,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10201,hsa:10552,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,cpd:C05981,PCrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:7367,hsa:406933,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:2791,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6470,hsa:189,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:4780,hsa:5160,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:3725,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:1386,hsa:7414,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6608,hsa:2534,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:208,hsa:7494,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:5140,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5293,cpd:C05981,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:472,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:2628,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9267,hsa:382,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:207,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
hsa:151056,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:391013,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00008,hsa:5023,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3725,hsa:4313,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2773,hsa:5595,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:4780,hsa:2941,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5296,cpd:C05981,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
cpd:C05981,hsa:10000,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3845,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00002,hsa:22953,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1571,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1385,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:223,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1549,hsa:7364,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:6470,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5063,hsa:8440,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:5880,hsa:5599,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:818,hsa:5600,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:953,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:3716,hsa:2948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:4633,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
path:hsa00350,hsa:1545,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:468,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:8517,hsa:3667,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5296,cpd:C05981,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:873,hsa:54659,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5293,hsa:10000,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3553,hsa:3554,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:1491,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1892,hsa:35,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:3948,hsa:5162,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:83439,hsa:1499,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
path:map01056,hsa:4191,no_relation,no_relation,no_relation,no_relation,0.0
path:map01056,hsa:54511,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:972,hsa:3111,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5366,hsa:596,PPrel,inhibition,path:hsa05210 Colorectal cancer,1,0.8
hsa:1544,hsa:10,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,4,0.5
hsa:5566,hsa:1388,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:4087,hsa:5732,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2770,hsa:5137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:7249,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:1646,hsa:1548,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:3107,hsa:567,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5567,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00270,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:8851,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1557,hsa:3030,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:2782,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5293,hsa:2308,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:3716,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5315,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1901,hsa:5136,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4190,path:hsa00020,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:53632,hsa:31,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1386,hsa:596,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:1139,hsa:409,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4893,hsa:5290,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:26279,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:22943,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:54575,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2950,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:107,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:6416,hsa:5601,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5595,hsa:5600,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4087,hsa:1287,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5606,hsa:4329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:846,hsa:5567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5731,hsa:94235,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2946,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:94235,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:51806,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5605,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:126,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6885,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:7852,hsa:5609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:957,hsa:84618,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:27244,hsa:5571,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1557,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:805,hsa:817,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:27128,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1386,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:55902,hsa:55902,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C00076,hsa:5579,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2788,hsa:4907,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4215,hsa:5608,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5602,hsa:6714,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1432,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5169,hsa:54434,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:4190,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:53358,hsa:2885,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10097,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:7480,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:8503,hsa:6714,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:23646,hsa:100137049,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5970,hsa:3445,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:2783,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:5608,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:163688,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:1545,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3688,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:7365,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1385,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:51806,hsa:5532,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1553,hsa:873,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2805,hsa:3948,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:3265,hsa:5290,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4087,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1555,hsa:1548,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7367,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7364,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5331,cpd:C01245,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:65082,hsa:338382,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:4790,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57571,hsa:224,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5731,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:10000,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2770,hsa:5600,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:3309,hsa:22926,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:27123,hsa:7473,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:85465,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2768,hsa:9138,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1978,hsa:9470,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
cpd:C00584,hsa:5731,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5733,hsa:2252,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1854,hsa:654364,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5594,hsa:2002,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5291,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1738,hsa:6472,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:2771,hsa:111,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:5565,hsa:2309,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:10552,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4215,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:109,PPrel,activation,path:hsa04740 Olfactory transduction,2,0.8
hsa:5731,hsa:2549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:127,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5606,hsa:5601,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10163,hsa:81873,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5320,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5731,path:hsa00130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:3984,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:6347,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:54579,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5296,hsa:3456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2034,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7298,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3985,hsa:1073,PPrel,inhibition,path:hsa04360 Axon guidance,1,0.8
hsa:3709,hsa:2113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3032,hsa:1962,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:9586,hsa:3948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1843,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3158,hsa:3155,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:4775,hsa:2917,no_relation,no_relation,no_relation,no_relation,0.0
hsa:637,hsa:578,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:673,hsa:5605,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:6772,hsa:2534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:1499,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:2775,hsa:8772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:948,hsa:5605,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:22800,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54578,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:54106,hsa:4615,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5568,hsa:2998,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5156,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2747,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,path:hsa00230,no_relation,no_relation,no_relation,no_relation,0.0
hsa:128,hsa:7423,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5105,hsa:4191,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:222,hsa:2572,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5091,hsa:5161,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2787,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:10681,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5053,hsa:259307,ECrel,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:208,hsa:114,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:1843,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:29851,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:1958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3091,hsa:7040,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:1646,hsa:54659,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5582,hsa:5608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:387,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:1548,hsa:7367,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5880,hsa:106821730,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:2782,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1559,hsa:56302,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:3155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:64764,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2793,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5532,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2915,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:6240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2329,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3445,hsa:57144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1591,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:84699,hsa:4190,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:5564,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3439,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:718,hsa:727,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:4830,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6300,hsa:64764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:377841,hsa:7083,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:8471,hsa:8503,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:468,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:2771,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:54576,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3716,hsa:6773,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
cpd:C00745,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,path:hsa00910,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4773,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64601,hsa:7879,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:5567,hsa:84699,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:51733,hsa:958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:196883,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:83593,hsa:5500,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:468,hsa:2353,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:27121,hsa:7482,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5731,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:4259,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5595,hsa:2113,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:27121,hsa:124583,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:572,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4893,hsa:5894,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2773,hsa:107,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:36,hsa:3449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:9368,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:85465,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:407024,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27102,hsa:1965,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:8772,hsa:10681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:468,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:808,hsa:815,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2946,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4773,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:7157,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5566,hsa:1385,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5603,hsa:5599,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5053,hsa:406887,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56267,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:207,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:4214,hsa:5608,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5604,hsa:93034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2939,hsa:57506,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5535,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:57154,hsa:117,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4705,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3030,hsa:26275,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5295,hsa:10000,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
cpd:C11695,hsa:7442,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:6654,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1388,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:956,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3845,hsa:5295,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:1388,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
cpd:C00076,hsa:2185,PCrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:808,hsa:817,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5319,hsa:4258,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2100,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:6009,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:119391,hsa:2791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:3685,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3135,hsa:3805,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:2099,hsa:1950,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
cpd:C06124,hsa:1901,PCrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:6655,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:8471,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:30833,hsa:1854,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2778,hsa:63826,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3445,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00410,hsa:7040,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:1435,no_relation,no_relation,no_relation,no_relation,0.0
hsa:127,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3717,hsa:6776,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10000,hsa:63916,no_relation,no_relation,no_relation,no_relation,0.0
hsa:125,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:596,hsa:581,PPrel,inhibition,path:hsa05161 Hepatitis B,1,0.8
hsa:4833,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1549,hsa:79799,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5337,hsa:11145,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1559,hsa:1548,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1558,hsa:6752,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1576,hsa:2950,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1807,hsa:51733,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:10681,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:54963,hsa:3155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:31,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:55970,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:4548,hsa:56267,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
cpd:C00547,hsa:155,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:10000,hsa:1147,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2791,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1576,hsa:1557,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:4790,hsa:7189,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5296,hsa:2308,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:6608,hsa:155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10093,hsa:2949,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8471,hsa:5295,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5605,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:1386,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00076,hsa:91860,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2099,hsa:2277,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5169,hsa:84618,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5566,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:7249,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:100526794,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5594,hsa:2099,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2952,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5599,hsa:8471,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
path:hsa00770,hsa:137362,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:6714,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9844,hsa:1962,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5331,cpd:C00165,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:581,hsa:596,PPrel,inhibition,path:hsa05210 Colorectal cancer,1,0.8
hsa:5530,hsa:2932,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2788,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:10000,hsa:2475,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
cpd:C05981,hsa:5213,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:7412,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:8611,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:3845,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5602,hsa:3725,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5606,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:196883,hsa:5566,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:2549,hsa:5291,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:4301,hsa:5819,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:4357,hsa:160287,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:126,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:207,hsa:112,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5970,hsa:2571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2949,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:283748,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2783,path:hsa00030,no_relation,no_relation,no_relation,no_relation,0.0
hsa:578,hsa:54205,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5603,hsa:3725,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:3665,hsa:3451,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:10000,hsa:115,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:883,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54657,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2773,hsa:55811,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:6654,hsa:3265,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2787,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6195,hsa:2100,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:10449,hsa:1962,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5532,hsa:4773,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
cpd:C00076,hsa:51806,PCrel,binding/association,path:hsa04740 Olfactory transduction,1,0.5
hsa:114,cpd:C00575,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:124,hsa:318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:2782,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:224,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4690,hsa:5062,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:6654,hsa:318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:3725,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:100506742,hsa:836,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5063,hsa:3985,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:1543,hsa:9446,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5594,hsa:596,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:221357,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1111,hsa:993,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:2778,hsa:115,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3661,hsa:3440,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:2938,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:8503,hsa:207,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:4833,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1906,hsa:1910,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5567,hsa:56302,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:2773,hsa:2788,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
cpd:C00025,hsa:2918,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5868,hsa:64601,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:1553,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:7099,hsa:5594,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:6794,hsa:5571,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:115,cpd:C00575,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:59345,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:22943,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3290,hsa:54576,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1543,hsa:2953,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:7100,hsa:4615,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:4087,hsa:1284,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2784,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6850,hsa:64170,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2475,hsa:1978,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5330,cpd:C00165,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:130,hsa:22978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7099,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:790,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:1258,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
hsa:377841,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:2778,hsa:113,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3480,hsa:3845,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:57506,hsa:7187,PPrel,binding/association,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:6608,hsa:2534,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:6300,hsa:5136,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:373156,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5331,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10746,hsa:5608,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:207,hsa:2309,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:207,hsa:2475,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5603,hsa:79799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6752,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10163,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:2212,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5564,hsa:2100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79784,hsa:60,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:2778,hsa:114,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5590,hsa:7363,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:653689,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5567,hsa:57617,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:55970,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5601,hsa:2353,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1386,path:hsa00760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1591,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:196883,cpd:C00575,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:587,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:815,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5603,hsa:3725,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:10488,hsa:2353,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:3551,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:7297,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:51020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:10000,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:861,hsa:6688,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:4258,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:673,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:113,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:217,hsa:5567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1385,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:10488,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:654364,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5567,hsa:9586,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2767,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6470,hsa:113675,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:6472,hsa:1500,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1789,hsa:2939,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:31,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2790,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:208,hsa:57521,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:57144,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1549,hsa:27330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:6196,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5567,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
path:map00940,path:hsa00130,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:2940,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7084,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:4772,hsa:405,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:4780,hsa:1843,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5599,hsa:10095,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:79799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283748,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5567,hsa:90993,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:9475,hsa:10627,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:883,hsa:1491,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5595,hsa:1958,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5566,hsa:1386,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5594,hsa:100526794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30833,hsa:1029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:10488,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:100137049,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:369,hsa:5605,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5603,hsa:468,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:537,hsa:5578,PPrel,binding/association,path:hsa05161 Hepatitis B,1,0.5
hsa:2475,hsa:1978,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:3678,hsa:3611,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:108,hsa:256435,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2747,path:hsa00250,maplink,compound,path:hsa00910 Nitrogen metabolism,1,0.5
hsa:2946,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2572,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:10163,hsa:10096,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5566,hsa:1385,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5566,hsa:468,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2770,hsa:115,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5567,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,path:hsa00240,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
cpd:C00788,hsa:644150,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2768,hsa:9826,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:55748,hsa:4716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:2185,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4831,hsa:955,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:91860,hsa:817,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:27306,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5567,hsa:9368,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:339896,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:93034,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:8399,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2784,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5338,hsa:3948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:778,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2773,hsa:54331,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5295,hsa:208,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2885,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:637,hsa:581,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:85465,hsa:30814,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5167,hsa:84618,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:6196,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:1432,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5568,hsa:10488,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:124583,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10673,hsa:608,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
path:hsa00640,hsa:1892,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5731,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:4790,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:2938,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:8612,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:221357,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3815,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:108,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:8878,hsa:2626,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:5567,hsa:64764,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5594,hsa:1432,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:5594,hsa:836,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4258,hsa:955,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:54576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5321,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2475,hsa:6198,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:54511,hsa:30,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:9446,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:160287,hsa:7186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2572,hsa:501,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:57506,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2322,hsa:5290,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:8936,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83593,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:102723996,hsa:29851,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
hsa:3984,hsa:4217,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3709,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5595,hsa:468,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:259307,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:207,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:2782,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:107987478,hsa:54577,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:4790,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:4313,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2785,hsa:54579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:26279,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2932,hsa:3800,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:489,hsa:818,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:8503,hsa:207,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5594,hsa:4702,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81579,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1576,hsa:1558,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:8936,hsa:653857,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5595,hsa:3725,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:107987479,hsa:54600,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5604,hsa:1591,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2033,hsa:2034,PPrel,binding/association,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:84532,hsa:38,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5567,hsa:90993,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4833,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:2775,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2932,hsa:64837,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:122618,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1629,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:5603,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5608,hsa:5600,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:29119,hsa:7082,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:27306,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:998,hsa:57144,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:84699,hsa:7082,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3444,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:8660,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5137,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5605,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3444,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:85465,hsa:123745,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00547,hsa:146,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2782,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2939,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:57144,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:10000,hsa:572,PPrel,inhibition,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1388,hsa:2791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10201,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:4214,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:1871,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5600,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5608,hsa:1432,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5562,hsa:57521,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1646,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2326,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5091,hsa:87,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00639,hsa:5737,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:91860,hsa:815,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:3458,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,hsa:5568,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:10941,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2932,hsa:64837,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3030,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5153,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5567,hsa:468,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:56953,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2475,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:953,hsa:54490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:2151,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4257,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6774,hsa:3726,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5095,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4792,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83667,hsa:5563,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2773,hsa:112,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:79888,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:79861,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83549,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10758,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:7253,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:275,path:hsa00250,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:3552,hsa:4843,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5530,hsa:200186,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5532,hsa:6778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1843,hsa:1432,PPrel,inhibition,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5602,hsa:2353,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2572,hsa:223,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2147,hsa:841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:2791,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:163688,hsa:4842,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:3456,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5608,hsa:5600,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:501,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:7364,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5169,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:5290,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2805,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:8605,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:55970,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5530,hsa:4776,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3708,hsa:808,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:2782,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:2771,hsa:2977,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:815,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5731,hsa:2792,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5567,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:957,hsa:284958,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:673,hsa:5605,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:387,hsa:5337,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5663,hsa:9451,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:53632,hsa:32,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:7124,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:957,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10018,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5291,cpd:C05981,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,6,0.8
hsa:5594,hsa:2353,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:2100,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7704,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:972,hsa:3109,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:6714,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:2250,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:10000,hsa:7248,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:5295,hsa:207,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:1943,hsa:5095,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54577,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
cpd:C00038,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3439,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5603,hsa:9586,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5881,hsa:8826,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:6772,hsa:9021,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5169,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:208,hsa:8517,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:4190,path:hsa00020,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:10000,hsa:572,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
cpd:C01996,hsa:1139,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:956,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3710,hsa:163688,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:26279,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:836,hsa:5162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:10941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:9475,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1564,hsa:54490,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:9586,hsa:4357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,hsa:4128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8936,hsa:10095,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5319,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5567,hsa:468,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2571,hsa:2950,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:1548,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
cpd:C00925,hsa:2817,PCrel,binding/association,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:1956,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1128,path:map00960,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53358,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54961,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:9586,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5595,hsa:148327,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:805,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27306,path:map00680,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:2939,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1545,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54578,hsa:29895,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:3551,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:5594,hsa:1549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:100137049,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:801,hsa:815,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5337,hsa:64600,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3661,hsa:3448,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:4594,hsa:7365,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:596,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:5568,hsa:468,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:122618,hsa:5320,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6416,hsa:5599,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:115,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:133,hsa:7367,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:10094,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2534,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8976,hsa:653857,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:2328,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:22978,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:4216,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:5609,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:1945,hsa:1969,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
cpd:C00745,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5532,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:8639,hsa:4214,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7132,hsa:6885,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:6300,hsa:2353,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5106,hsa:54579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3106,hsa:3805,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:57521,hsa:6198,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2982,cpd:C00942,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:51806,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5894,hsa:1890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5610,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:6300,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:5095,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5899,hsa:2939,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:5154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:2885,hsa:6655,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5594,hsa:4313,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2791,hsa:56994,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:5338,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2770,hsa:5603,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5606,hsa:5600,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5600,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:3446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23417,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:6195,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:53358,hsa:6655,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2953,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:1814,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2475,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:816,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:221264,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:3551,hsa:8660,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5970,hsa:3451,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:873,hsa:54575,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2099,hsa:27006,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:339896,hsa:407026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:3845,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:6773,hsa:4940,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:2940,hsa:5154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5293,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:151531,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1965,hsa:468,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5608,hsa:54498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:54659,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2778,hsa:2787,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
cpd:C00076,hsa:5579,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:7220,hsa:659,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:81027,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5534,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:3845,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:64600,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5566,hsa:1385,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6655,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:196883,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4357,hsa:316,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:6932,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:7422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1495,hsa:4301,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:4775,hsa:3091,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:3665,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:501,hsa:131,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:953,hsa:957,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:8976,hsa:57180,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:3551,hsa:5970,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8471,hsa:5295,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5747,hsa:5293,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:5566,hsa:90993,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:57144,hsa:3984,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:4137,hsa:1029,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5582,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00076,hsa:5535,PCrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:5161,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:314,hsa:217,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5568,hsa:1385,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2773,hsa:2100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1901,hsa:4776,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:2773,hsa:2568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2147,hsa:6470,no_relation,no_relation,no_relation,no_relation,0.0
hsa:978,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1890,hsa:1806,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5594,hsa:3479,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:4846,hsa:221357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5534,path:hsa00350,no_relation,no_relation,no_relation,no_relation,0.0
hsa:790,path:hsa00220,maplink,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:10681,hsa:3162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:50484,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:2938,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:1545,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:808,hsa:4842,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:4214,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2944,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4548,hsa:53632,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:2944,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6482,hsa:10331,ECrel,compound,path:hsa00512 Mucin type O-glycan biosynthesis,1,0.5
hsa:54331,hsa:10097,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3674,hsa:6714,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:64902,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84693,hsa:2786,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2328,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3717,hsa:6772,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:51380,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
hsa:8503,hsa:208,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
path:hsa00290,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:217,hsa:124,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4137,hsa:5610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7454,hsa:60,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
cpd:C00076,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54577,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2052,hsa:1545,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5019,hsa:51020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:51422,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:283748,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:6416,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00250,hsa:36,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:208,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:23646,hsa:26279,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5734,hsa:2770,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2099,hsa:2248,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:55748,hsa:217,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:10000,hsa:2099,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2572,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:4790,hsa:7124,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:10392,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:2950,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2784,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
cpd:C02198,hsa:6915,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5566,hsa:2277,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1910,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3290,path:hsa00620,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7277,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5604,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:4846,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
cpd:C06124,hsa:3358,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5167,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5610,hsa:1965,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
cpd:C00665,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5315,path:hsa00010,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1388,hsa:4720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:4633,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:2770,hsa:2784,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:29922,hsa:124583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:7097,hsa:4615,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:108,hsa:5566,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:1545,hsa:6822,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6416,hsa:5602,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:6470,path:map00460,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:57521,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:653689,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5605,hsa:5594,PPrel,activation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:10163,hsa:10094,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:54963,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2773,hsa:5603,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:51727,hsa:93034,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:51727,hsa:10720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11145,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:38,no_relation,no_relation,no_relation,no_relation,0.0
hsa:355,hsa:8772,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2771,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:3661,no_relation,no_relation,no_relation,no_relation,0.0
hsa:407025,hsa:9314,PPrel,inhibition,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:85465,hsa:5337,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4830,hsa:957,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:218,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7852,hsa:2788,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:107,cpd:C00575,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5914,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:468,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5535,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:259307,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:109,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:942,hsa:940,PPrel,activation,path:hsa04672 Intestinal immune network for IgA production,1,0.8
hsa:30,hsa:1395,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2308,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:805,hsa:5533,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1549,hsa:54575,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:57144,hsa:3985,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:6472,path:map00680,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:51806,hsa:5530,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:6472,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:27330,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:8503,hsa:8440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:30833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:2791,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6772,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:107987479,hsa:10720,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2786,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:91860,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3290,hsa:1549,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:5499,hsa:2690,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4720,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:27123,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:6776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:148327,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6472,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7363,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:27121,hsa:80326,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5371,hsa:6688,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:6352,hsa:1234,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:177,hsa:27035,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:355,hsa:8772,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:208,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10673,hsa:115650,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
hsa:6352,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:5319,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
path:hsa00480,hsa:56267,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2793,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:221,hsa:2572,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:27121,hsa:2939,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1147,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2771,hsa:2793,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:8936,hsa:10109,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:5608,hsa:51727,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4258,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:275,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64064,hsa:54511,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5566,hsa:10488,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:119391,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5291,hsa:207,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:4129,hsa:1557,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3091,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:593,hsa:1738,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:10673,hsa:608,PPrel,activation,path:hsa04672 Intestinal immune network for IgA production,1,0.8
path:hsa00250,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3627,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:27123,hsa:7475,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5601,hsa:2353,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:283748,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:472,hsa:11200,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:1496,hsa:6401,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4833,hsa:2937,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:3479,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5568,hsa:4792,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:284958,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:387,hsa:60,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:10109,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:817,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:6774,hsa:595,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:83549,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:2770,hsa:107,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:29922,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1386,hsa:2805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:8503,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5534,hsa:4772,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6654,hsa:4893,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5568,hsa:9586,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5295,hsa:1737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30833,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2571,path:hsa00250,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5604,hsa:5600,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5600,hsa:64764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:861,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:8660,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:9586,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:91860,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:2534,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:84335,hsa:6198,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4129,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5894,hsa:5604,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:10941,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:84618,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5604,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,cpd:C00165,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5290,hsa:124583,no_relation,no_relation,no_relation,no_relation,0.0
path:map01056,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9446,hsa:57506,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5894,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5606,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1553,hsa:10720,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5594,hsa:1386,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:224,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5167,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:3845,hsa:5296,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
cpd:C00334,hsa:2557,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3665,hsa:3448,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:4193,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3988,hsa:5468,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:55902,hsa:1431,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:3551,hsa:8471,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:8660,hsa:4706,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1847,hsa:5595,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:810,hsa:8835,no_relation,no_relation,no_relation,no_relation,0.0
hsa:587,hsa:594,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5819,hsa:5819,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:6416,hsa:1258,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3107,hsa:3805,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:56267,hsa:2806,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2771,hsa:108,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:5568,hsa:1594,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:10163,hsa:10094,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:155,hsa:2778,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:586,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5869,hsa:57617,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:4087,hsa:2950,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00640,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54963,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57521,hsa:1978,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2770,hsa:5601,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:7132,hsa:8772,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4629,hsa:71,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:1432,hsa:10488,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:32,hsa:487,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7099,hsa:2773,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:207,hsa:113,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3458,hsa:3459,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:6300,hsa:3725,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5062,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6654,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:7852,hsa:2784,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2946,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53632,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:115,hsa:883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5371,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5595,hsa:10488,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10645,hsa:51422,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5095,hsa:29119,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:51422,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:8503,hsa:208,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10365,hsa:3162,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5566,hsa:148327,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5533,hsa:4773,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5371,hsa:8900,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:2952,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2549,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22978,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
cpd:C00338,hsa:7474,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:1906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:6300,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:6885,hsa:5605,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:801,hsa:5535,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4790,hsa:4843,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:7976,hsa:5296,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2952,hsa:4723,no_relation,no_relation,no_relation,no_relation,0.0
hsa:218,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7371,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5881,hsa:5921,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:2689,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:113675,path:map00460,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:6714,hsa:1956,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:36,hsa:4217,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:2308,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:7298,hsa:4209,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:7366,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:7706,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:957,hsa:54963,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10018,hsa:4329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:998,hsa:5058,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:5734,hsa:27330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:338382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:196883,cpd:C00575,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5565,path:map00940,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:208,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:2778,hsa:108,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:207,hsa:221,no_relation,no_relation,no_relation,no_relation,0.0
hsa:955,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:955,hsa:30833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2785,hsa:9583,no_relation,no_relation,no_relation,no_relation,0.0
hsa:219,hsa:5162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:537,hsa:1050,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:7477,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:4790,hsa:7124,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:11145,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5534,hsa:5175,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5534,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:123745,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5562,hsa:2475,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:8936,hsa:10096,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5601,hsa:3725,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
cpd:C00547,hsa:147,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5609,hsa:10803,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:115,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:111,cpd:C00575,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:122618,hsa:8399,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5568,hsa:10488,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1557,hsa:2953,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5970,hsa:3441,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:5295,hsa:6195,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:55902,hsa:501,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:7189,hsa:1432,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:81873,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2913,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:6776,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1431,hsa:4191,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:6885,hsa:5970,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:84693,hsa:4594,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:2778,hsa:196883,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5970,hsa:3439,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:8660,hsa:5291,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:8976,hsa:57180,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:3661,hsa:3446,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:2147,hsa:2151,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3725,hsa:2782,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10672,hsa:2776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4830,hsa:7476,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3158,hsa:64064,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:4357,hsa:883,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:83549,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:64764,hsa:8600,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:873,hsa:50964,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:2773,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6472,hsa:1610,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:10645,hsa:5562,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:10645,hsa:5565,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:23411,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5321,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5296,hsa:8900,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1385,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2353,hsa:3569,GErel,expression,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:1111,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6472,path:hsa00600,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:377841,hsa:955,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:23646,hsa:11145,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00334,hsa:2558,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:6776,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:3690,hsa:5747,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:5608,hsa:6776,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3611,hsa:5829,PPrel,phosphorylation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:163688,hsa:3945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:58498,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:6885,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51727,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6416,hsa:7046,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:150,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8862,hsa:187,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3265,hsa:4214,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1545,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:1562,hsa:119391,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:54577,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5091,hsa:3939,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4208,hsa:10365,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5599,hsa:8471,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5568,hsa:148327,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:10449,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,path:hsa00061,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00388,hsa:3269,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:6714,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6416,hsa:5600,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:387,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:339896,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
hsa:374875,hsa:1549,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:2771,hsa:2783,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:4257,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5733,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:151531,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:51764,hsa:109,PPrel,activation,path:hsa04740 Olfactory transduction,2,0.8
hsa:5734,hsa:2771,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3665,hsa:3446,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:2731,hsa:1610,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:84335,hsa:6199,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4259,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4257,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1564,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4087,hsa:3445,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:387,hsa:57506,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1737,hsa:1738,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:369,hsa:5605,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:2790,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:54578,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
cpd:C00025,hsa:116443,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3718,hsa:6774,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:148327,hsa:8600,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:4137,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:221357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:81029,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6655,hsa:4893,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:4137,hsa:51807,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:369,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:8772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:2782,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:2944,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2788,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:90,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3135,hsa:567,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
cpd:C00547,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5105,hsa:1258,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81029,hsa:7976,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:10390,hsa:8612,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4257,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5595,hsa:2113,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1962,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7057,hsa:948,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:5608,hsa:653689,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:4205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:5566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2769,hsa:10161,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1131,hsa:7423,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:4313,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:27123,hsa:81029,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3845,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3447,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:1387,hsa:3091,PPrel,binding/association,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:1629,hsa:221,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:55823,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10810,hsa:10109,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2778,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5313,hsa:5162,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5594,hsa:2113,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:2778,hsa:109,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:2784,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5291,hsa:5894,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:124583,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2950,hsa:355,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:873,hsa:54490,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:10095,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:6343,hsa:6344,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:6794,hsa:5024,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:6093,hsa:10627,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:10365,hsa:119391,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:7083,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3798,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2946,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2776,hsa:5332,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:7298,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:4258,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3443,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5160,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5295,hsa:3685,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:51807,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:51727,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:55902,hsa:4842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3667,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6469,hsa:91653,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5594,hsa:5600,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:8976,hsa:10092,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:115,hsa:5567,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5568,hsa:5571,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2947,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3551,hsa:4792,PPrel,activation,path:hsa05161 Hepatitis B,2,0.8
hsa:5296,hsa:2952,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5878,hsa:3552,no_relation,no_relation,no_relation,no_relation,0.0
hsa:955,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:808,hsa:816,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:7187,hsa:10010,PPrel,binding/association,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:373156,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:387,hsa:2938,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:2353,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:3447,hsa:4301,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,hsa:5568,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:54579,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:38,path:hsa00640,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3661,hsa:31,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:6197,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:808,hsa:5532,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:57121,hsa:10672,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5609,hsa:5601,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:107987479,hsa:574537,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:409,hsa:673,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:147,hsa:2776,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:2778,hsa:2786,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:284958,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5894,hsa:5605,PPrel,activation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:1946,path:hsa00600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5332,cpd:C01245,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:23365,hsa:7422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:9586,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:355,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
path:map01056,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:255189,hsa:2941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:7367,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:8660,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1969,hsa:5921,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5567,hsa:9368,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2885,hsa:6654,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:221264,hsa:9583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:873,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:2792,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5605,hsa:5322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:5599,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:2792,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:84628,hsa:27244,no_relation,no_relation,no_relation,no_relation,0.0
hsa:137362,hsa:4357,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:54578,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10993,hsa:63826,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:22800,hsa:6009,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:4088,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:4646,hsa:501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3725,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1843,hsa:5603,PPrel,inhibition,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2949,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2770,hsa:113,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:1564,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:572,PPrel,inhibition,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:501,hsa:124,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1491,hsa:56267,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,2,0.5
hsa:54490,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5595,hsa:2353,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:8517,hsa:1136,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:6885,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:2776,hsa:5330,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5663,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6569,hsa:9368,PPrel,binding/association,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:2771,hsa:2792,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:6714,hsa:5894,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:5175,hsa:5291,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:148327,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1388,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5568,hsa:468,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4646,hsa:60,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:27306,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3667,hsa:5290,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2791,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1432,hsa:1385,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5062,hsa:3984,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:4690,hsa:7456,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:218,hsa:2572,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:4832,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
path:hsa00270,hsa:10993,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:85465,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5578,hsa:4792,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5734,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1869,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:39,hsa:3032,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:4137,hsa:4704,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2328,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:817,hsa:2308,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:805,hsa:54963,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:399694,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2775,hsa:55970,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:1562,hsa:1374,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:9314,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:4846,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,3,0.5
hsa:5601,hsa:3725,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5604,hsa:6300,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:64601,hsa:338382,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:5745,hsa:409,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5568,hsa:7083,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29110,hsa:10580,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:64764,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00681,hsa:2149,PCrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:8976,hsa:10109,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:3725,hsa:6347,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:4137,hsa:637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10163,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5734,hsa:5598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:998,hsa:5058,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:654364,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:637,hsa:581,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5096,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5606,hsa:25945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4842,cpd:C00533,PCrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:10672,hsa:9138,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:27123,hsa:7483,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:4087,hsa:1282,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:1565,hsa:54490,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:10096,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:132158,hsa:5224,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
cpd:C00780,hsa:3352,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:84617,hsa:2948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3443,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:7363,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
path:hsa00230,hsa:2731,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:107987479,hsa:54657,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5894,hsa:5604,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5568,hsa:468,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C00780,hsa:3362,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1565,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:7976,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:347688,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2771,hsa:5925,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2938,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10365,hsa:2034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:2255,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:262,hsa:9844,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1128,hsa:2776,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2806,hsa:4190,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:1553,hsa:79799,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
cpd:C00122,hsa:54583,PCrel,inhibition,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:5603,hsa:2353,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:7298,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:998,path:hsa00600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57144,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2917,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1564,hsa:79799,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:6714,hsa:2885,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:6776,hsa:8835,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:2778,hsa:113,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:22800,hsa:5290,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5600,hsa:1029,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:65985,hsa:3155,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:3480,hsa:10993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:54331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,hsa:955,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3439,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:2770,hsa:4325,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2775,hsa:59345,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:2593,hsa:2628,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5579,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:10941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:637,hsa:7367,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00745,hsa:154,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5322,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:122618,hsa:100137049,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3725,hsa:1906,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:217,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5566,hsa:1385,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:10681,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5894,hsa:597,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:54577,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:4907,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:2731,hsa:6472,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:4191,path:hsa00020,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2770,hsa:5154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:100137049,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3939,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:374875,hsa:79799,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5600,hsa:5599,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:7157,hsa:355,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:2932,hsa:1499,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:107987479,cpd:C00533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:1398,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:2328,hsa:224,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:11040,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:5295,cpd:C05981,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,6,0.8
hsa:48,hsa:1431,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
cpd:C00575,hsa:5566,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5595,hsa:596,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:113457,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:468,hsa:2792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:54576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8826,hsa:60,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:1431,hsa:4190,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:4259,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3441,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:5881,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1562,hsa:4258,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:52,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:2948,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:27123,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:5319,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4233,hsa:1499,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:10390,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:7263,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:93034,hsa:2904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:51764,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:93034,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:6773,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:2952,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5295,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4780,hsa:7295,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5530,hsa:1591,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:106821730,no_relation,no_relation,no_relation,no_relation,0.0
hsa:653857,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:808,hsa:818,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5603,hsa:3725,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00780,hsa:3358,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5296,hsa:5500,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53632,cpd:C00003,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2790,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:113,hsa:5568,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:9446,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3000,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987479,hsa:1557,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5868,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:842,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:3717,hsa:6774,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5295,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5315,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2778,hsa:114,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5313,hsa:5161,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5606,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:2113,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:6472,hsa:953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1849,hsa:5595,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:5567,hsa:1386,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3718,hsa:6777,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2770,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5535,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2771,hsa:5155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:219,hsa:10327,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:60,hsa:7082,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:1565,hsa:1978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:6197,no_relation,no_relation,no_relation,no_relation,0.0
hsa:130,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3845,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:55811,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10810,hsa:10092,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:810,hsa:816,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
cpd:C00788,hsa:154,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:501,hsa:54498,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:85465,hsa:8681,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:805,hsa:5532,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:107987478,hsa:7366,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:1786,hsa:262,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:56953,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
cpd:C00745,hsa:2033,no_relation,no_relation,no_relation,no_relation,0.0
hsa:119391,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1843,hsa:1432,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2785,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:94235,hsa:9583,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:369,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:7371,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:3845,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:2353,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:816,hsa:2308,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
cpd:C00008,hsa:5028,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:9586,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:3265,hsa:5290,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5534,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:4775,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:208,hsa:2309,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:54578,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5894,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:83667,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5899,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84335,hsa:6198,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5734,hsa:2790,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2100,hsa:6714,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4775,hsa:5741,no_relation,no_relation,no_relation,no_relation,0.0
hsa:683,cpd:C13050,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:2938,hsa:810,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54659,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1738,hsa:5161,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1017,hsa:9134,PPrel,binding/association,path:hsa04218 Cellular senescence,3,0.5
hsa:5595,hsa:1958,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5567,hsa:1386,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:6470,hsa:29851,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5534,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:221264,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:23236,hsa:219,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:815,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5291,hsa:207,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2784,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:27330,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1431,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3091,hsa:4907,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3827,hsa:624,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2778,hsa:114,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:51764,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:5320,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5295,hsa:208,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2776,hsa:5330,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:3717,hsa:6773,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:3661,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:223,hsa:2559,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1388,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1559,hsa:4258,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3091,hsa:262,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2747,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:275,hsa:6470,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:6654,hsa:3265,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:107987478,hsa:54578,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:3265,cpd:C16844,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5733,hsa:4780,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:137362,hsa:4191,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2773,hsa:5295,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
cpd:C00788,hsa:150,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4214,hsa:5606,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:6416,hsa:5601,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
cpd:C00165,hsa:9170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:89780,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5169,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5733,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:1147,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5733,hsa:2790,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:387,hsa:9475,PPrel,activation,path:hsa04360 Axon guidance,3,0.8
hsa:3032,hsa:5095,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:6416,hsa:5602,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5568,hsa:84618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:6416,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4217,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:2941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3091,hsa:5136,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,cpd:C01245,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:9170,hsa:10672,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:7364,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5331,cpd:C00165,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:106821730,hsa:57180,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:207,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:1562,hsa:2953,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:30833,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:846,path:hsa00630,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57180,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:4259,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6237,hsa:5293,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5734,path:hsa00130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84647,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5091,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4846,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:9568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2941,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2787,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3551,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
path:map00710,path:hsa00030,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:4790,hsa:3553,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:5609,hsa:5602,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:38,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3685,hsa:5970,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2778,hsa:112,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:219,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5747,hsa:1630,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:5567,hsa:148327,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5053,hsa:1871,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5295,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1147,hsa:4792,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:5290,hsa:207,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:501,hsa:5610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:673,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5747,hsa:1398,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4831,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:7263,hsa:883,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2786,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4790,hsa:596,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:5731,hsa:2790,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:84699,hsa:8600,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:10000,hsa:1147,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:177,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:5295,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1901,hsa:4772,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:1029,hsa:4193,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:5601,hsa:5563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4833,hsa:1909,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284958,hsa:1854,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:208,hsa:1147,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5568,hsa:64764,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2778,hsa:112,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6464,hsa:2885,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C00076,hsa:810,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
path:hsa00250,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3717,hsa:6774,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:801,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:1553,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:545,hsa:8878,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:221357,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1496,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57571,hsa:501,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:137362,path:map00940,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",2,0.5
hsa:5595,hsa:3725,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:369,hsa:5605,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2773,hsa:111,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:8398,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1147,hsa:4792,PPrel,activation,path:hsa05161 Hepatitis B,2,0.8
hsa:683,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:1147,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:2944,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
path:hsa00640,hsa:217,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2949,hsa:2782,no_relation,no_relation,no_relation,no_relation,0.0
hsa:151056,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5137,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:84647,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:25759,hsa:6655,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1849,hsa:5594,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:10201,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:972,hsa:3112,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:2770,hsa:114,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:85464,hsa:5579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5881,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:6775,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5568,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3661,hsa:3445,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:5608,hsa:5603,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:2770,hsa:5599,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:2778,hsa:2788,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:5925,hsa:7422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2729,hsa:5567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4217,hsa:5606,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:1557,hsa:27306,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
cpd:C00745,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5579,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:387,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2940,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5331,hsa:3709,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:1788,hsa:58498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4831,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:54658,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5594,hsa:2353,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2773,hsa:109,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5595,hsa:488,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
cpd:C00076,hsa:163688,PCrel,activation,path:hsa04740 Olfactory transduction,1,0.8
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:5566,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:160287,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:2941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:10488,hsa:6654,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:4893,hsa:5295,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:2778,cpd:C00003,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:27102,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:842,hsa:836,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:51135,hsa:53632,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5594,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5732,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2099,hsa:8817,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:7043,hsa:7046,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5595,hsa:9252,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:5600,hsa:10488,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5601,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5605,hsa:5594,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5604,hsa:284958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,path:hsa00600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2939,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4594,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:2949,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:339896,hsa:8772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:79444,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:998,hsa:57144,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:5914,hsa:6688,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2353,hsa:2113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:2793,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:340061,hsa:57506,PPrel,binding/association,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:4893,hsa:673,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5600,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:387,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5602,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2475,hsa:6199,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2786,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:399694,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:84647,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5533,hsa:4775,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:207,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:100506742,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
cpd:C01245,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:54576,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:29110,hsa:3661,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5609,hsa:5599,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10163,hsa:10095,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:4627,hsa:71,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:27330,hsa:2099,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:654364,hsa:1902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5319,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:5140,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:148022,hsa:7187,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2771,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:3710,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5743,cpd:C00584,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5319,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5499,hsa:56302,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:90993,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5595,hsa:2353,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5290,hsa:6195,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:6776,hsa:5292,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:1869,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4831,hsa:124583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2784,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5894,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51380,hsa:217,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5600,hsa:9586,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5330,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:2353,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3728,hsa:5467,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:10000,hsa:3551,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:8936,hsa:10552,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5338,hsa:8399,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:108,cpd:C00575,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:6416,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6774,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2100,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:153,hsa:2773,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
cpd:C01996,hsa:8973,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
cpd:C00076,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8936,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122618,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:2353,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:85464,hsa:1072,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:189,path:map00460,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:6885,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4217,hsa:5609,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:873,hsa:1553,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:1892,hsa:36,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5293,hsa:208,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:7042,hsa:7048,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3939,hsa:1843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9365,hsa:8660,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1147,hsa:4792,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5609,hsa:2100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5565,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:957,hsa:93034,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:653689,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2776,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:208,hsa:7248,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:801,hsa:5533,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
cpd:C00025,hsa:2906,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:208,hsa:3551,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:834,hsa:3606,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:6472,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:208,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:3106,hsa:567,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:4893,cpd:C00027,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1553,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3449,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:5604,hsa:83447,no_relation,no_relation,no_relation,no_relation,0.0
hsa:143686,hsa:8797,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5731,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:9586,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00788,hsa:6655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5023,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:8398,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:808,hsa:5532,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5970,hsa:3569,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:4137,hsa:4709,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:673,hsa:5604,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:4137,hsa:9314,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3309,hsa:4831,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00430,hsa:2100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3157,hsa:3451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:9586,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:27072,hsa:338382,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:207,hsa:2309,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4830,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5337,hsa:1594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5153,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:2944,hsa:3953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2947,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:27121,hsa:2997,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4907,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:38,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4258,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4832,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5566,hsa:84699,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:218,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:57571,hsa:55748,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
hsa:5603,hsa:2353,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5295,hsa:6196,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:6774,hsa:56994,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3725,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5295,hsa:83593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:54963,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5594,hsa:262,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:10298,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:4893,hsa:7363,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:5290,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5571,hsa:84335,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1558,hsa:2941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:7189,hsa:5599,PPrel,activation,path:hsa05133 Pertussis,1,0.8
cpd:C00165,hsa:5582,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:369,hsa:5605,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5338,hsa:9564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5600,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3440,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:100506742,hsa:836,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2773,hsa:2787,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:2778,hsa:107,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5053,hsa:2805,ECrel,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",2,0.5
hsa:113,cpd:C00575,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:5568,hsa:10488,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4790,hsa:4313,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2785,hsa:54578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2309,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:54490,hsa:23495,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:468,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5567,hsa:64764,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:3661,hsa:3447,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:3985,hsa:9446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2571,hsa:217,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1017,hsa:8900,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:714,hsa:4035,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:2771,hsa:54331,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:1956,hsa:1499,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:10645,hsa:814,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:10365,hsa:653689,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:111,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:4233,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:84699,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5566,hsa:2308,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1564,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:1432,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5594,hsa:26275,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84693,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5734,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:3725,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5606,hsa:6300,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5868,hsa:55823,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:873,hsa:54579,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5295,hsa:207,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2885,hsa:6464,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3445,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:221,path:hsa00600,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:200959,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1021,hsa:595,PPrel,binding/association,path:hsa04218 Cellular senescence,3,0.5
hsa:5595,hsa:10488,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5606,hsa:6300,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:4790,hsa:1435,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:85465,hsa:112399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:654364,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:10390,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:85465,hsa:283748,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5601,hsa:3725,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:91860,hsa:5534,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:6472,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:4259,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:10000,hsa:3551,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2784,hsa:501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:3553,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6300,hsa:1385,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2475,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8471,hsa:5293,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1559,hsa:5467,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8639,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5601,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:38,path:hsa00650,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5337,hsa:5319,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:30,hsa:3033,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2776,hsa:5332,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:113,cpd:C00575,PCrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:22943,hsa:7474,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:38,hsa:54511,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
cpd:C03758,hsa:224,no_relation,no_relation,no_relation,no_relation,0.0
hsa:972,hsa:3127,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:90993,hsa:840,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5336,cpd:C01245,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5829,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5970,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:7084,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2778,hsa:94235,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:10390,hsa:7366,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:3973,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:999,hsa:999,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:5567,hsa:1388,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5337,hsa:8399,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5291,cpd:C05981,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4832,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:5321,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2475,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3447,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:5296,hsa:207,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5731,hsa:2770,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2775,hsa:107,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:10681,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3265,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9451,hsa:1965,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:815,hsa:5600,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:55970,cpd:C00533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1806,path:hsa00240,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:10201,hsa:2100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3569,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:9826,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7366,hsa:4301,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4548,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:119391,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1499,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,path:hsa00770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6343,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:5925,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:10390,hsa:5320,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5608,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:83593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2271,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:653689,hsa:4329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:10000,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5167,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5605,hsa:5599,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:85465,hsa:7039,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100526794,hsa:4720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1029,hsa:4193,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5568,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:5594,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:208,hsa:2475,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:7189,hsa:5162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:3725,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:4548,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107,cpd:C00575,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:112,cpd:C00575,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:8936,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3553,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:2775,hsa:2784,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:59345,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1962,hsa:35,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:5602,hsa:4089,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:7297,hsa:4907,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9844,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3449,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:22808,hsa:5290,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5606,hsa:5600,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:23236,cpd:C01245,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:132158,hsa:669,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:10109,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:7188,hsa:8517,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:64902,hsa:6470,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
cpd:C00165,hsa:5579,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5880,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:5603,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5606,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:148327,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4214,hsa:5601,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:2475,hsa:1978,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
cpd:C00076,hsa:91860,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:842,hsa:836,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5777,hsa:1500,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:115,hsa:5566,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:1549,hsa:873,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5564,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5315,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1557,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2271,hsa:4190,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:51764,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
cpd:C00575,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1562,hsa:373156,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5564,hsa:84335,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2571,hsa:224,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2768,hsa:23365,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:7263,hsa:56267,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:27306,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:409,hsa:5894,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4790,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:489,hsa:816,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:5609,hsa:5599,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2773,hsa:108,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
cpd:C00533,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8772,hsa:841,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2776,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,2,0.8
hsa:2778,hsa:2792,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:5091,hsa:3945,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:63916,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:54961,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:339896,hsa:3948,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00533,hsa:2983,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:2778,hsa:112,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:957,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2775,hsa:109,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:6794,hsa:5562,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:6655,hsa:3845,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:998,hsa:106821730,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:4830,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10993,path:hsa00600,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:177,hsa:1536,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2788,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:369,hsa:7478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:587,path:hsa00640,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:8764,hsa:7188,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2770,hsa:107,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:369,hsa:5604,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1543,hsa:27306,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:956,hsa:31,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2034,hsa:7422,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:6472,hsa:2731,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:7189,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,hsa:5579,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5568,hsa:9021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:132158,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5331,hsa:355,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:5562,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5315,hsa:5162,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:7297,hsa:6776,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5567,hsa:9586,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5602,hsa:2353,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:2475,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,path:hsa00430,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,2,0.5
hsa:5578,hsa:673,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:7084,hsa:7298,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:382,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:54490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:6667,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5601,hsa:3725,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:52,hsa:57144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2309,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:259307,path:map00960,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:23646,hsa:81579,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:54434,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5291,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:7363,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:83593,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:108,hsa:5568,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:5290,hsa:8399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:391013,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:373156,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6472,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5595,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:23236,hsa:2946,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:5603,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:3718,hsa:998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5169,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:143686,hsa:5564,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:81873,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:8660,hsa:5296,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5605,hsa:5594,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3709,hsa:808,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:9586,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2786,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:221357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:4880,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5595,hsa:2002,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2785,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:22808,hsa:1029,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2326,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
cpd:C00584,hsa:5731,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5594,hsa:9252,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:3661,hsa:3442,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:6464,hsa:6655,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:196883,hsa:8795,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3309,hsa:7363,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:54579,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:818,hsa:3690,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,hsa:5568,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5568,hsa:3708,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:4129,path:hsa00620,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:2771,hsa:2277,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8471,hsa:5291,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:6352,hsa:7084,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,cpd:C05981,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:51733,hsa:58498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:1432,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:8503,hsa:7479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1793,hsa:5879,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:956,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3552,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:10488,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:10094,no_relation,no_relation,no_relation,no_relation,0.0
hsa:405,hsa:2034,PPrel,binding/association,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:217,hsa:10327,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5338,hsa:8398,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5568,hsa:1385,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:377841,hsa:623,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5599,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2773,hsa:115,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:10000,hsa:1147,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:22808,hsa:8503,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:148327,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:6778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:4792,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:840,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:1147,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:3948,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:654364,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:54579,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4907,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:4128,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5818,hsa:1610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:4609,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2793,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2889,hsa:5908,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:1545,hsa:221357,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5609,hsa:5602,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:6300,hsa:468,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3710,hsa:805,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:4318,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:387,hsa:71,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:9826,hsa:387,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:60,hsa:81,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
path:map00460,path:hsa00250,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:7367,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5970,hsa:85464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:6300,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:4832,hsa:957,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:846,hsa:2770,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:572,hsa:598,PPrel,inhibition,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:3661,hsa:3445,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5566,hsa:1386,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:6608,cpd:C00076,PCrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5567,hsa:64764,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2549,hsa:5921,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:259307,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54659,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:815,hsa:109,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
hsa:208,hsa:2475,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:5568,hsa:10488,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:815,hsa:2308,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:4830,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1950,hsa:2064,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
cpd:C00025,hsa:2905,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:369,hsa:4191,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100526794,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:4792,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23365,hsa:387,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:10552,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:131,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2790,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1543,hsa:5095,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3708,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:8503,hsa:5894,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5530,hsa:4775,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:65018,hsa:5071,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:10000,hsa:1147,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5337,hsa:123745,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1945,hsa:5921,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
cpd:C00076,hsa:824,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5608,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:126328,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3309,hsa:9451,PPrel,inhibition,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:57121,hsa:587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2952,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2790,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3290,hsa:54659,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:51806,hsa:5136,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:3000,cpd:C00942,PCrel,activation,path:hsa04740 Olfactory transduction,2,0.8
hsa:5970,hsa:653689,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4772,hsa:7124,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:4907,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:501,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1432,hsa:1388,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:673,hsa:5604,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:27123,hsa:7482,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:440275,hsa:1965,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:1017,hsa:898,PPrel,binding/association,path:hsa04218 Cellular senescence,3,0.5
hsa:6898,hsa:56267,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:3447,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:9586,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5337,hsa:5321,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:7043,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,hsa:8503,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
cpd:C00584,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84532,hsa:9,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3443,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:107,hsa:83549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:1906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57617,hsa:7879,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:2885,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:3728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:468,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5162,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5337,hsa:26279,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:808,path:hsa00600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:218,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6777,hsa:5292,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:208,hsa:4846,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1147,hsa:4792,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,2,0.8
hsa:5663,hsa:6263,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:7297,hsa:6778,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:8503,cpd:C05981,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3452,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:27244,hsa:53632,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:163688,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7042,hsa:7046,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1562,hsa:653689,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1564,hsa:54659,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2773,hsa:5601,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:2783,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:1843,hsa:5599,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5295,hsa:10000,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:57571,hsa:51380,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:38,hsa:39,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:4790,hsa:7186,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:3728,hsa:6934,PPrel,binding/association,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:10645,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:805,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:578,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:1553,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:3845,hsa:5293,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:1557,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:955,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2475,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5595,hsa:4842,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:54331,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
path:hsa00900,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:2149,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5734,hsa:59345,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5603,hsa:1029,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:51727,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:7364,hsa:10010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7189,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:2785,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5663,hsa:3710,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:222,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1910,hsa:2770,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:38,hsa:3157,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:5530,hsa:4842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3452,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:1559,hsa:27306,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:92483,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2773,hsa:7419,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3030,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8976,hsa:1854,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:4792,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:83667,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2938,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3290,hsa:10941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:64902,hsa:2729,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:3551,hsa:5734,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:4636,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:369,hsa:2534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:1385,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5567,hsa:106821730,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9586,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,cpd:C00575,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5296,hsa:10000,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5564,path:map00940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:10398,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:955,hsa:22978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:347688,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:51727,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:1051,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:4128,hsa:316,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:5747,hsa:956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3728,hsa:4609,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:25945,hsa:25945,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:955,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:54578,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:64135,hsa:57506,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:3952,hsa:94235,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:5136,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6482,hsa:27090,ECrel,compound,path:hsa00512 Mucin type O-glycan biosynthesis,1,0.5
hsa:5578,hsa:779,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:7367,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:221357,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3265,hsa:673,PPrel,activation,path:hsa05219 Bladder cancer,2,0.8
hsa:5319,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5899,hsa:4329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:222,hsa:10092,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3444,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00240,hsa:501,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
cpd:C00122,hsa:112398,PCrel,inhibition,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:377841,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:5610,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5797,hsa:1499,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:1431,path:hsa00020,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:653689,hsa:5567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:8503,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:6416,hsa:5599,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:10365,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:114,cpd:C00575,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:5293,cpd:C05981,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:369,cpd:C00076,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:2941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5565,hsa:31,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:9266,hsa:382,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:123745,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2778,hsa:107,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
cpd:C00788,hsa:146,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:208,hsa:2782,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8613,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5594,hsa:9586,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1491,hsa:586,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:4357,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5818,hsa:5818,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:4831,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:10000,hsa:8517,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2932,hsa:5894,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5568,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:55811,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1942,hsa:151531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:3725,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
cpd:C00533,hsa:5155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1562,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:109,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:25945,hsa:56288,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:224,hsa:54498,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5568,hsa:90993,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:9138,hsa:4257,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:8074,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5734,hsa:2787,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2776,hsa:5331,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5745,hsa:2771,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1017,hsa:890,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:842,hsa:3674,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,path:map00940,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",2,0.5
hsa:2099,hsa:8823,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:1392,hsa:1394,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
path:map01056,hsa:3032,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:115,cpd:C00575,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5562,hsa:31,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:23646,hsa:5320,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:7099,hsa:2771,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:3815,hsa:5290,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5535,hsa:4775,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2787,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:653689,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1432,hsa:5063,no_relation,no_relation,no_relation,no_relation,0.0
hsa:581,hsa:5153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55748,hsa:3115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29110,hsa:3665,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:8936,hsa:10092,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:2783,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4216,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122618,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3447,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5568,hsa:100137049,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:9446,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5594,hsa:3725,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5747,hsa:10000,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5606,hsa:1432,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5608,hsa:1432,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:224,hsa:125,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2770,hsa:111,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5970,hsa:6347,GErel,expression,path:hsa05163 Human cytomegalovirus infection,2,0.5
hsa:4907,hsa:1978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5105,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:57571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:314,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2787,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:3667,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2938,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1738,hsa:1629,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",3,0.5
hsa:387,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5371,hsa:3728,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:5594,hsa:150,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:53632,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:5336,cpd:C00165,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3480,hsa:1499,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:5291,hsa:7371,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3133,hsa:567,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:1576,hsa:9446,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5564,hsa:32,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:208,hsa:2203,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3091,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3091,hsa:338382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8613,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:6898,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56953,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5970,hsa:574537,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:941,hsa:940,PPrel,activation,path:hsa04672 Intestinal immune network for IgA production,1,0.8
hsa:5443,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2327,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:8471,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:84699,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:57144,hsa:26100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:2950,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
path:hsa00250,hsa:92483,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:6376,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:4089,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1562,hsa:2952,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:132158,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124583,hsa:83549,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:22800,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:83549,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:4780,hsa:9446,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2953,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5607,hsa:5598,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:581,hsa:54205,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:224,hsa:127,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2915,hsa:2776,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5734,hsa:2785,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:54106,hsa:7043,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5881,hsa:57144,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:111,cpd:C00575,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
cpd:C05981,hsa:208,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,6,0.8
hsa:27121,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2890,PCrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:1738,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:983,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:207,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5291,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:673,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:2322,hsa:1849,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3444,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:1545,hsa:2940,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5330,hsa:1491,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9365,hsa:8471,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1738,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1854,hsa:29922,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5530,hsa:4773,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2778,hsa:115,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1432,hsa:3725,PPrel,activation,path:hsa05133 Pertussis,1,0.8
cpd:C00076,hsa:5296,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:107,cpd:C00575,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
cpd:C00745,hsa:1374,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56994,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00575,hsa:1036,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3440,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:998,hsa:106821730,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:51764,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3105,hsa:567,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5290,hsa:207,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
cpd:C00025,hsa:2916,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5731,hsa:55970,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5594,hsa:2100,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:23308,hsa:10449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5734,hsa:1385,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:10810,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7298,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:377841,hsa:84618,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5602,hsa:3725,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5970,hsa:3440,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:2767,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1564,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:374291,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6776,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:217,hsa:441531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:102723407,hsa:2206,PPrel,binding/association,path:hsa05310 Asthma,2,0.5
hsa:55902,hsa:224,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5608,hsa:5600,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5562,cpd:C00003,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5606,hsa:5603,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2767,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:593,hsa:1629,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",3,0.5
cpd:C00025,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284958,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5337,hsa:5161,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2947,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57571,hsa:223,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:10673,hsa:115650,PPrel,activation,path:hsa04672 Intestinal immune network for IgA production,1,0.8
hsa:94235,hsa:1869,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:1029,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00480,hsa:2805,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:7298,hsa:7083,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:8717,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51176,hsa:85464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5332,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:2322,hsa:6774,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:7371,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:1562,hsa:125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7430,hsa:387,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:6794,hsa:5563,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:23586,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:581,hsa:54961,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,path:map00950,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:2771,hsa:5296,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
path:hsa00770,hsa:883,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:4831,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:55970,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8936,hsa:10095,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:6774,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:3452,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:4843,cpd:C00533,PCrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,2,0.8
hsa:2771,hsa:113,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:10000,hsa:109,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:217,hsa:18,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5019,hsa:284958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9915,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3725,hsa:151531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2941,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1844,hsa:9252,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1111,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:3725,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5606,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:197322,hsa:501,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:4190,hsa:3269,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6482,hsa:256435,ECrel,compound,path:hsa00512 Mucin type O-glycan biosynthesis,1,0.5
hsa:10093,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:1545,hsa:2944,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:6416,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:6472,hsa:55748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:727,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5319,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:9844,hsa:1793,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:653857,hsa:54567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3106,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00900,hsa:3157,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2778,hsa:196883,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2773,hsa:4128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2099,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:5327,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:998,hsa:8826,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:5241,hsa:8600,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:948,hsa:5604,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:5336,cpd:C00076,PCrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:217,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
hsa:5330,hsa:5578,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:1432,hsa:4540,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7298,hsa:22978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5337,hsa:8398,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:113,hsa:5568,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:2790,hsa:3155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3446,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:3630,hsa:3643,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:846,hsa:2767,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5599,hsa:2353,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:91860,hsa:5530,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:10000,hsa:2309,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2770,hsa:112,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:55748,hsa:223,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2950,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7188,hsa:1147,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:107987479,hsa:54577,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5602,hsa:4088,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5598,hsa:4780,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:4790,hsa:330,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5578,hsa:10095,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2947,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:2950,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:10758,hsa:5315,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11145,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6654,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:7124,GErel,expression,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
cpd:C05981,hsa:207,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:51764,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:3984,hsa:10912,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:64902,hsa:3479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6773,hsa:440275,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:1553,hsa:54658,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:10000,hsa:4880,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5534,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:4790,hsa:329,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:654364,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5595,hsa:2353,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:4780,hsa:5609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3448,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5599,hsa:3725,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:3290,hsa:7365,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3134,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,cpd:C05981,PCrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:7280,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:133,hsa:799,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5609,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:4615,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5331,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3717,hsa:6772,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2947,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5535,hsa:4776,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5568,hsa:9368,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2770,hsa:84532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:2949,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:7298,hsa:7084,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5105,path:hsa00010,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5582,hsa:56302,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:224,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5053,hsa:2806,ECrel,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",2,0.5
hsa:8660,hsa:5293,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5606,hsa:5599,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:207,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:224,hsa:10327,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:9586,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:7042,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3449,hsa:55062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4216,hsa:5606,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:1553,hsa:54579,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:2782,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00665,hsa:2203,PCrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
cpd:C00008,hsa:2846,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:84335,hsa:6199,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2787,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:587,hsa:2729,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:801,hsa:817,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:94235,hsa:146,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:373156,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1373,hsa:2752,ECrel,compound,path:hsa00910 Nitrogen metabolism,1,0.5
hsa:6654,hsa:4893,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:3032,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1737,hsa:5160,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5566,hsa:9586,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:10390,hsa:30814,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5566,hsa:3708,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:163688,hsa:5533,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3265,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2997,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:873,hsa:54577,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6608,hsa:1978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10096,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:4329,hsa:3456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:1432,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:5568,hsa:2997,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2944,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6714,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2947,hsa:2806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,cpd:C05981,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1548,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5291,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1577,hsa:1555,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:208,hsa:108,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:10163,hsa:653857,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:7364,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5608,hsa:4907,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:1958,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
cpd:C00518,hsa:6383,PCrel,binding/association,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:8399,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:284958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:5600,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:3716,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:36,hsa:5562,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7188,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:10365,hsa:1548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8471,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3799,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:208,hsa:2100,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2593,hsa:2034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:2784,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:10488,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:64600,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3710,hsa:91860,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:81579,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2100,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9446,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7852,hsa:59345,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5594,hsa:1386,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5608,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:1386,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:8976,hsa:71,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:35,hsa:1892,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
cpd:C00334,hsa:2570,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
cpd:C04549,hsa:55062,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5609,hsa:5603,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:127,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00745,hsa:155,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:7248,hsa:6009,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:5567,hsa:1906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:8517,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:339896,hsa:224,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:4790,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:89780,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1738,hsa:5160,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5602,hsa:8660,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2788,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8976,hsa:10096,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:163688,hsa:4313,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:572,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5567,hsa:5564,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1956,hsa:5296,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:10201,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5819,hsa:56288,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:85465,hsa:8611,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:8399,hsa:57144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:107,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1543,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10810,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,cpd:C00165,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3716,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:109,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
hsa:1499,hsa:595,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:54659,hsa:7263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,hsa:186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2147,hsa:7039,no_relation,no_relation,no_relation,no_relation,0.0
hsa:38,hsa:5019,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:10000,hsa:8517,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:654364,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:846,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:10000,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:8936,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,hsa:5582,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:6258,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:10000,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:1555,hsa:1978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2688,hsa:2690,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3661,hsa:3451,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:137362,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:998,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5818,hsa:5819,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:57571,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:810,hsa:5533,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5340,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2902,PCrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:1956,hsa:8503,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:8681,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:148022,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:5571,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2767,hsa:5330,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:6714,hsa:8717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:54539,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2771,hsa:1395,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1495,hsa:81,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:8503,cpd:C05981,PCrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2767,hsa:23236,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
cpd:C00780,hsa:3357,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5578,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:207,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5595,hsa:64764,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:6774,hsa:595,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:107987478,hsa:10720,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5970,hsa:3449,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:23646,hsa:283748,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10096,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:1565,hsa:54600,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:4790,hsa:7187,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5595,hsa:2100,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:207,hsa:4846,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3661,hsa:3452,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
cpd:C21013,hsa:177,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3030,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:54576,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5600,hsa:1388,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3709,hsa:805,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:2534,hsa:3695,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:54331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:223,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:10390,hsa:5741,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4088,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9586,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:653857,hsa:54576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1017,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56267,path:hsa00260,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:8503,hsa:5170,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:22854,hsa:57689,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:3443,hsa:151531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22978,hsa:331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2099,hsa:30833,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:3479,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
cpd:C00584,hsa:5732,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5053,path:hsa00350,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:59345,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:124583,hsa:54963,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5566,hsa:1385,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3845,hsa:5291,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:163688,hsa:5533,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2322,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2768,hsa:9826,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:221357,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,hsa:3708,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5566,hsa:148327,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:27121,hsa:7480,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5571,hsa:10941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6240,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:2790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:9261,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
path:hsa00250,hsa:6470,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:3355,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5567,hsa:4929,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:369,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5602,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:107,hsa:5568,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:2770,hsa:107,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1956,hsa:5291,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:3659,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:23236,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:6714,hsa:5879,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00002,hsa:5023,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:8936,hsa:7185,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79799,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2932,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5296,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5921,hsa:4893,PPrel,inhibition,path:hsa04360 Axon guidance,1,0.8
hsa:1545,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5530,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1558,hsa:2939,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:955,hsa:84618,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:143686,hsa:5563,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3845,cpd:C00027,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:90993,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:7185,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:111,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5602,hsa:5602,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1548,hsa:79799,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5894,hsa:5604,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6885,hsa:5606,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:79924,hsa:799,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5595,hsa:84699,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1558,hsa:2950,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2773,hsa:8503,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:391,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:60,hsa:5024,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54205,hsa:842,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:8471,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:1432,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:3845,hsa:5900,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5058,hsa:3985,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:143686,hsa:5571,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5970,hsa:5970,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:1843,hsa:5601,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
cpd:C00780,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:2771,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5819,hsa:3447,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2328,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1956,hsa:2885,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2775,hsa:108,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:314,path:hsa00620,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5732,hsa:4322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:9586,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1548,hsa:3290,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2775,hsa:653689,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10018,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:7481,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1960,hsa:2033,PPrel,binding/association,path:hsa05161 Hepatitis B,1,0.5
hsa:5566,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:3551,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:84618,hsa:1854,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:148327,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:1543,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2944,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:85465,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:1549,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:197322,hsa:84693,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2940,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5970,hsa:3569,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:23365,hsa:387,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:4329,hsa:18,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2773,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:2932,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5579,hsa:775,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:9586,hsa:9002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:8503,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:54579,hsa:2782,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3155,path:hsa00020,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5568,hsa:5562,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5566,hsa:1386,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
cpd:C00584,hsa:2948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4716,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:815,hsa:567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:84699,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:8503,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:5600,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:55902,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83667,hsa:5562,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:6237,hsa:387,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:8936,hsa:84693,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6777,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5602,hsa:8471,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:673,hsa:5604,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:79799,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4233,hsa:2549,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:3661,hsa:3439,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:841,hsa:637,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5594,hsa:3725,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:468,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2941,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1577,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83549,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5732,hsa:59345,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2790,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5600,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:955,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2771,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3553,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:6352,hsa:10096,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:23130,hsa:55062,PPrel,binding/association,path:hsa05014 Amyotrophic lateral sclerosis,1,0.5
hsa:5604,hsa:5594,PPrel,activation,path:hsa05161 Hepatitis B,2,0.8
hsa:5296,hsa:207,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:399694,hsa:2885,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:3725,hsa:3569,GErel,expression,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:224,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
cpd:C00584,hsa:5734,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4129,hsa:81,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23586,hsa:57506,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5295,cpd:C05981,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5879,hsa:5601,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5599,hsa:5601,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10365,hsa:143686,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2099,hsa:8822,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:972,hsa:3123,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:4833,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:2885,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
cpd:C00533,hsa:4322,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5566,hsa:10488,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5934,hsa:1871,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:4233,hsa:2885,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:1562,hsa:27306,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
path:map01056,hsa:3155,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:10000,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:3725,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:2773,hsa:111,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:5106,path:hsa00630,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5601,hsa:4088,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2788,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:545,hsa:1111,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3845,hsa:673,PPrel,activation,path:hsa05210 Colorectal cancer,2,0.8
hsa:4775,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:103910,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:6885,hsa:26100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:4773,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5313,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:2785,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1738,hsa:593,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:377841,hsa:93,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:2353,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:56994,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6772,hsa:155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:4893,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:222,hsa:51380,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:113675,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:119391,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2775,hsa:111,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,4,0.8
hsa:5592,hsa:952,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:102723407,hsa:5063,no_relation,no_relation,no_relation,no_relation,0.0
hsa:137362,path:hsa00430,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,2,0.5
hsa:4831,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:369,hsa:5605,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:3309,hsa:2081,PPrel,inhibition,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:5745,hsa:2767,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:71,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:217,hsa:6885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,cpd:C00575,PCrel,activation,path:hsa04740 Olfactory transduction,2,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:137362,path:hsa00360,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:8399,hsa:6776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1051,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:3685,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5296,hsa:10000,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:207,hsa:2099,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:221357,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:1559,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:5338,hsa:8737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:4191,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5594,hsa:2353,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:23646,hsa:5319,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5566,hsa:778,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C00076,hsa:5534,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2778,hsa:111,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
cpd:C00003,hsa:23411,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:137362,hsa:3948,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5608,hsa:8639,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27244,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:54576,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:2787,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:1557,hsa:221357,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1388,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:4790,hsa:7185,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5600,hsa:2353,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:207,hsa:9,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8851,hsa:4137,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:8717,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:10398,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5167,hsa:4907,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5563,cpd:C00003,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2783,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5291,hsa:10000,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:27330,hsa:2100,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:208,hsa:57521,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5291,hsa:2308,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:4214,hsa:5137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5532,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4843,cpd:C00533,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1557,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1139,hsa:3717,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5578,hsa:5609,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:898,hsa:57144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54583,hsa:3091,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:6416,hsa:5603,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5565,cpd:C00003,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1545,hsa:2946,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:959,hsa:958,PPrel,activation,path:hsa05310 Asthma,1,0.8
hsa:5296,hsa:10000,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:92483,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:30,hsa:1962,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2770,hsa:2790,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:1549,cpd:C00076,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2953,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5578,hsa:9021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:217,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5156,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5565,hsa:2308,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:54331,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4609,hsa:53632,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00338,hsa:2253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:817,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:7364,hsa:799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1629,hsa:36,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2328,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:197322,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:4209,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55811,cpd:C00575,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
path:map00940,path:hsa00350,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:2771,hsa:114,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5320,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1386,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:4357,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:103910,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:107987478,hsa:79799,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:7297,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:1147,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5564,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:10398,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:2747,hsa:2752,ECrel,compound,path:hsa00910 Nitrogen metabolism,1,0.5
hsa:5605,hsa:5594,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
cpd:C00165,hsa:5579,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
cpd:C00076,hsa:801,PCrel,binding/association,path:hsa04740 Olfactory transduction,1,0.5
hsa:3984,hsa:1072,PPrel,inhibition,path:hsa04360 Axon guidance,2,0.8
hsa:119391,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5167,hsa:93034,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5970,hsa:3592,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:7186,hsa:2941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2534,hsa:5879,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5332,hsa:3709,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:801,hsa:5532,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
path:hsa00770,hsa:56267,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:1956,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2767,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:885,hsa:887,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:6774,hsa:2569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7456,hsa:8976,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:6655,hsa:3845,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:51764,hsa:6352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:3667,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:653689,hsa:38,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5610,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10094,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:2773,hsa:113,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5568,hsa:56302,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5608,hsa:6300,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
cpd:C00575,hsa:146,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6237,hsa:3456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4258,hsa:9583,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10201,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5605,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5605,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:5290,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:2784,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:207,hsa:2475,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5567,hsa:1386,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1386,hsa:8600,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:30,path:hsa00640,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:223,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3710,hsa:801,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:1558,hsa:4258,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5568,hsa:5058,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:8611,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:2793,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3158,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10201,hsa:955,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:60,hsa:87,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
cpd:C00076,hsa:5578,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:29922,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
cpd:C00002,hsa:5030,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:805,hsa:815,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:2628,hsa:1610,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5970,hsa:8772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3725,hsa:7124,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:22943,hsa:7477,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5747,hsa:208,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3725,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:124583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3265,hsa:1514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:283748,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3717,hsa:6778,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2787,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:654364,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7367,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00071,hsa:38,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
cpd:C00122,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3725,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:2793,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1386,hsa:4719,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:4790,PPrel,activation,path:hsa05133 Pertussis,1,0.8
cpd:C00008,hsa:22953,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3455,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:7367,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22978,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:51764,path:hsa00760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:5970,hsa:3446,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:2100,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51733,hsa:27035,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:5933,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:7298,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2775,hsa:2787,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:6654,hsa:3265,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:3845,hsa:5290,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:2952,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:106821730,hsa:3984,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:7083,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1553,hsa:54576,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:53632,hsa:84335,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
path:map01056,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00480,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1553,hsa:10941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
cpd:C00165,hsa:5582,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2069,hsa:30814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:10941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:842,hsa:836,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2771,hsa:54947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:7248,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:1545,hsa:2947,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5568,hsa:779,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10488,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5579,hsa:81579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7263,hsa:3939,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:959,hsa:958,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
hsa:2773,hsa:196883,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2768,hsa:9826,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2773,hsa:54567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2327,hsa:5562,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9446,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:4318,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:218,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:84628,hsa:567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83593,hsa:5501,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4833,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:51733,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:405,hsa:27102,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22978,hsa:406888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:10298,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:7365,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:51,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:54577,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:3440,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:8440,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:8651,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57180,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4708,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6300,hsa:3725,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
path:hsa00350,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:83593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:57571,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C20640,hsa:340061,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:60,hsa:29119,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:1559,hsa:2953,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:810,hsa:7424,no_relation,no_relation,no_relation,no_relation,0.0
hsa:846,hsa:2776,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4780,hsa:4258,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5106,hsa:4191,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2771,hsa:5602,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5731,hsa:2775,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1564,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:91860,hsa:5137,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:3661,hsa:8851,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00620,path:hsa00020,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:3665,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:5879,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5290,hsa:10000,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:5568,hsa:2308,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:841,hsa:840,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa05161 Hepatitis B,2,0.8
hsa:10000,hsa:8517,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:5970,hsa:4318,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:1549,hsa:7365,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:91860,hsa:5535,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5747,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
path:map01056,hsa:3440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:38,path:hsa00020,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
path:map01056,hsa:10449,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:956,hsa:100526794,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:2475,hsa:50484,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1131,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:219,hsa:126,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:6885,hsa:5609,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:222,hsa:54498,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5566,hsa:1386,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1854,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5366,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10392,hsa:3553,PPrel,activation,path:hsa05133 Pertussis,1,0.8
cpd:C00788,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00122,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29119,hsa:4301,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:815,hsa:5603,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:2788,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:387,hsa:6093,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:2034,hsa:5155,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:3134,hsa:567,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5567,hsa:468,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:581,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:8660,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2689,hsa:2690,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:6416,hsa:1432,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:6794,hsa:5564,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:54600,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
cpd:C01996,hsa:5019,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3725,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:3448,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5331,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:4790,hsa:3449,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:5568,hsa:4929,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:2782,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6885,hsa:1432,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:9370,hsa:4842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:9021,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:84647,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:177,hsa:3845,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4087,hsa:10095,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:112,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:29922,hsa:10627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:6240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:488,hsa:816,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:5315,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6773,hsa:10096,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4615,hsa:51135,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:221264,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987479,hsa:7364,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:1962,hsa:8310,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:6009,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1385,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:55823,hsa:7879,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
cpd:C00334,hsa:2566,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5605,hsa:6300,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:4772,hsa:3091,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:5337,hsa:2805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:94235,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:2775,hsa:2790,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:408,hsa:673,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2771,hsa:2791,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:1559,hsa:7263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1633,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6794,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:255189,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1788,hsa:1850,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:5175,hsa:5295,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:801,hsa:818,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5291,hsa:207,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:6482,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:653689,hsa:406882,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:208,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
cpd:C00925,hsa:6385,PCrel,binding/association,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5566,hsa:2149,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:2353,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
cpd:C00334,hsa:2560,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
path:hsa00071,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1133,hsa:2776,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00076,hsa:805,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5606,hsa:1432,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:8717,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6777,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:10993,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3553,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5734,hsa:53632,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2322,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:406881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:1147,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:8936,hsa:81873,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2770,hsa:5290,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:10000,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1386,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3290,hsa:574537,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5337,hsa:81579,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2099,hsa:2250,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:207,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6773,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2788,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:7297,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:6300,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:815,hsa:109,PPrel,phosphorylation,path:hsa04740 Olfactory transduction,1,0.8
hsa:51727,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:137362,hsa:3447,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2767,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:54947,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:4893,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2099,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:7423,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3688,hsa:3611,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
cpd:C00076,hsa:5530,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:51733,hsa:1807,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5566,hsa:468,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2953,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1854,hsa:4329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:3710,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5535,hsa:4773,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:163688,hsa:5532,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2948,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3643,hsa:8660,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5603,hsa:125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:468,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1901,hsa:4775,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:22800,hsa:219,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:54577,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
cpd:C01996,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:7378,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:317,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:2353,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:1557,hsa:2941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:111,hsa:5566,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:23236,cpd:C01245,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:2938,hsa:1073,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2949,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7456,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:7480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7098,hsa:148022,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10376,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2052,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:407024,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:5296,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:373156,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3718,hsa:6773,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10163,hsa:10092,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:5899,hsa:79799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5136,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:10365,hsa:1036,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5295,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5340,hsa:9002,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5605,hsa:5603,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:91860,hsa:5534,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5868,hsa:65082,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:94235,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5594,hsa:10488,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:32,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5594,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5290,hsa:2309,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:5175,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:3486,no_relation,no_relation,no_relation,no_relation,0.0
hsa:115,hsa:5567,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:2785,hsa:1616,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5315,hsa:6654,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:63826,no_relation,no_relation,no_relation,no_relation,0.0
hsa:137362,hsa:92483,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5340,hsa:56288,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:6259,cpd:C00076,PCrel,activation,path:hsa04360 Axon guidance,1,0.8
path:hsa00240,hsa:224,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:6416,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:22978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3309,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1847,hsa:5594,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:2775,hsa:2791,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:10000,hsa:2100,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:10095,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:4776,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5594,hsa:2002,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5568,hsa:148327,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1543,hsa:2946,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:3459,hsa:3717,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:6773,hsa:56994,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:108,cpd:C00575,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5530,hsa:2185,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:10488,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5532,hsa:4775,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2932,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:468,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5332,cpd:C01245,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
path:hsa00260,hsa:10993,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:10000,hsa:64101,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2572,hsa:2784,no_relation,no_relation,no_relation,no_relation,0.0
hsa:224,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112398,hsa:3091,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:3728,hsa:595,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:10645,hsa:5571,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1549,hsa:54576,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:7188,hsa:3551,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:4629,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:5894,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:956,hsa:597,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22808,hsa:4832,no_relation,no_relation,no_relation,no_relation,0.0
hsa:654364,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:10390,hsa:5338,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10000,hsa:4846,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00575,hsa:90,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7367,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:5921,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987479,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5565,hsa:32,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1576,hsa:998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23417,path:hsa00061,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2792,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:54331,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2329,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:203068,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:594,hsa:586,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:1559,hsa:567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:1793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1562,hsa:2941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5733,hsa:54361,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6608,hsa:5578,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5295,cpd:C05981,PCrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5600,hsa:7157,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:94235,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5567,hsa:4209,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3708,hsa:51806,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:10365,hsa:25828,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2778,hsa:115,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5290,hsa:3685,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2773,hsa:338382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5563,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:94235,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:2100,hsa:2249,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:3725,hsa:2793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:5335,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4214,hsa:6416,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2212,hsa:5879,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:6714,hsa:5747,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:4548,hsa:883,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5105,hsa:3032,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2939,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:56302,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3716,hsa:6776,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
cpd:C00025,hsa:2903,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:83549,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
path:hsa00640,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:85464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:673,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:8503,hsa:10000,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:8660,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:103910,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:10093,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5566,hsa:9368,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:3717,hsa:501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:207,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5733,hsa:2792,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6300,hsa:5062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:2353,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5315,hsa:5091,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5595,hsa:2353,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:4258,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:55748,hsa:218,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:7297,hsa:6772,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:64600,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:92483,hsa:1491,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1850,hsa:5595,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:2327,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5053,path:hsa00360,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:6237,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:115,cpd:C00575,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:5567,hsa:64764,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:8517,hsa:5970,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:51806,hsa:817,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:7852,hsa:2773,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:1962,hsa:34,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",3,0.5
hsa:6655,hsa:1978,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C06124,hsa:1903,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2785,hsa:5062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:1544,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2932,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:5602,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10390,hsa:23646,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:7414,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:10201,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:23646,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:7709,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6464,hsa:6654,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:8976,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,hsa:4214,no_relation,no_relation,no_relation,no_relation,0.0
hsa:885,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2932,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:90993,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:673,hsa:5605,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:30814,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5604,hsa:5594,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5925,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5481,hsa:7416,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5313,hsa:3948,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2770,hsa:7422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1978,hsa:253314,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:810,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4711,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:2783,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2770,hsa:115,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:7709,hsa:1030,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5568,hsa:3708,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1548,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:3576,GErel,expression,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:4773,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9586,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25759,hsa:200186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2946,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:59345,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:3717,hsa:6773,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:64764,hsa:4696,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:84790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:9446,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1956,hsa:5295,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:369,hsa:1073,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:816,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:114,hsa:2817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:6714,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2785,hsa:10672,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:673,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10390,hsa:256435,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:57689,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:5743,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:2327,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:4790,hsa:4843,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:64902,hsa:2730,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:56924,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:1388,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:64764,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:8503,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5295,hsa:208,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5566,hsa:84699,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5970,hsa:4843,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:71,hsa:87,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:222,hsa:7416,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:54331,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:5608,hsa:440275,no_relation,no_relation,no_relation,no_relation,0.0
hsa:972,hsa:3119,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:1564,hsa:4536,no_relation,no_relation,no_relation,no_relation,0.0
path:map01056,hsa:5608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:50487,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C05981,path:hsa00250,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7132,hsa:8717,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:9475,hsa:4636,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:3710,hsa:1143,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:440275,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:84735,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:91860,hsa:818,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:317,hsa:4357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6775,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2767,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:163688,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2952,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3661,hsa:1890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1562,hsa:2940,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6470,path:hsa00600,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:221,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:4609,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5566,hsa:84699,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1511,hsa:9002,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:64064,hsa:3155,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1432,hsa:3725,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3661,hsa:3444,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:2771,hsa:5595,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5566,hsa:90993,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2786,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2770,hsa:109,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:6470,hsa:10993,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:5879,hsa:57144,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
path:hsa00640,hsa:54963,no_relation,no_relation,no_relation,no_relation,0.0
hsa:653857,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:7371,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5567,hsa:2998,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:10000,hsa:8517,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2081,hsa:7494,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:4790,hsa:7422,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2770,hsa:5295,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:55970,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
cpd:C01996,hsa:1129,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:6352,hsa:1230,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:7378,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84532,hsa:84532,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3449,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:339896,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4357,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:8835,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:107987478,hsa:1958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:2792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7483,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5465,hsa:6258,PPrel,binding/association,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:5533,hsa:4776,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:223,hsa:127,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5731,hsa:2785,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5567,hsa:1388,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10163,hsa:57180,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:5595,hsa:468,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
cpd:C04549,hsa:26100,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4137,hsa:84617,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2572,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:38,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:5894,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:6093,hsa:4636,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:2767,hsa:5331,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4646,hsa:6195,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:810,hsa:5535,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:283106,hsa:1499,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:22943,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:50487,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:805,hsa:5533,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:51727,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3725,hsa:1514,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2773,hsa:114,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:1499,hsa:6932,PPrel,activation,path:hsa05210 Colorectal cancer,2,0.8
hsa:3667,hsa:5296,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00076,hsa:801,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:2353,hsa:1906,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5733,hsa:2787,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4088,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,path:hsa00620,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:7048,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2938,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:27121,hsa:51384,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:316,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:8976,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22926,hsa:1649,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:2782,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5175,hsa:5290,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:1491,path:hsa00770,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:54979,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:27306,hsa:55748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:52,hsa:5169,ECrel,compound,path:hsa00740 Riboflavin metabolism,1,0.5
hsa:796,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1562,hsa:39,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79671,hsa:57506,PPrel,inhibition,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:4831,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5663,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:5594,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5879,hsa:106821730,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:5566,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:4312,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:6714,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:128,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3448,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2788,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
path:hsa00480,hsa:1036,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5566,hsa:64764,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:64902,hsa:2731,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:2784,hsa:57180,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3451,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:6416,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5566,hsa:1386,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00745,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10097,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:796,hsa:10203,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:83667,hsa:51422,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5567,hsa:53632,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5747,hsa:9181,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5568,hsa:1386,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1902,hsa:2768,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:23339,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:54576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
cpd:C01245,cpd:C00076,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:8517,hsa:8660,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6932,hsa:332,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:5293,hsa:6195,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:405,hsa:2056,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:998,hsa:8976,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:7084,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5332,hsa:8976,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4537,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2805,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4832,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5970,hsa:6352,GErel,expression,path:hsa05163 Human cytomegalovirus infection,2,0.5
hsa:4790,hsa:7483,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:10488,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:10163,hsa:10109,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:399694,hsa:1111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5578,hsa:776,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4773,hsa:10683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:1432,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5880,hsa:5602,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
cpd:C00076,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5869,hsa:2033,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:2308,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:1565,hsa:54657,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2776,hsa:5331,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:810,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3688,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8976,hsa:10095,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:196883,hsa:330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4257,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:223,hsa:131,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:94235,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3708,hsa:810,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:9451,hsa:54577,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5095,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2571,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:373156,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5604,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:151056,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5566,hsa:1385,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
cpd:C00076,hsa:801,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6093,hsa:29895,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:3133,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:109,PPrel,phosphorylation,path:hsa04740 Olfactory transduction,1,0.8
hsa:8936,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:8398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:35,hsa:1962,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5595,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,cpd:C00165,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6093,hsa:25759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5330,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2790,hsa:6240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3158,hsa:30,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2771,hsa:6300,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:127,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2785,hsa:623,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:775,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:6773,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
cpd:C00076,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:3361,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:223,hsa:10327,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5741,hsa:5745,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:51422,hsa:31,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:3661,hsa:3452,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:1131,hsa:2776,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5053,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:10449,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5605,hsa:3606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:4842,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:374875,hsa:1548,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:5337,hsa:84647,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5568,hsa:1385,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5610,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2330,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3134,hsa:567,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5970,hsa:3442,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:2034,hsa:7039,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:64902,path:hsa00230,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:54577,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83439,hsa:4609,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:6774,hsa:3486,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5609,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:1901,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6387,hsa:7852,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2549,hsa:197322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3725,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5601,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:208,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:84618,hsa:7039,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4714,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5532,hsa:54434,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:1548,hsa:54658,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:6416,hsa:5601,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5567,hsa:1029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1906,hsa:1910,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:673,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:10720,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5106,hsa:54511,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:51727,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8440,hsa:644150,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:5925,hsa:1870,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:6772,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:8936,hsa:224,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4301,hsa:25945,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:1386,hsa:7478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:1499,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:5533,hsa:85464,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:107,cpd:C00575,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5290,hsa:207,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
path:map01056,hsa:3158,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:391,hsa:9844,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:4137,hsa:4535,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:4780,hsa:221357,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5295,hsa:5894,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:59345,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:4216,hsa:7366,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3452,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:1564,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:574537,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5534,hsa:4773,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:6714,hsa:5747,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:217,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7043,hsa:3111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10163,hsa:10096,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:2792,hsa:2327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5330,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:2729,hsa:2937,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:8613,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:27128,hsa:382,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:9583,hsa:54963,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:217,hsa:25828,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00230,hsa:189,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:2770,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:39,hsa:30,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:6093,hsa:10398,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5599,hsa:2353,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:10298,hsa:3985,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:10681,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2806,hsa:92483,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:54575,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:84699,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10093,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:5295,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:2773,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4830,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:221357,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:84532,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5530,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:11145,hsa:10672,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2564,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
cpd:C00165,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:6241,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:10488,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2773,hsa:59345,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:154,hsa:2778,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4318,hsa:1906,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:6774,hsa:9021,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:114,hsa:5568,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:10365,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,cpd:C05981,PCrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:163688,hsa:5530,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:125,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:377841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
path:hsa00250,hsa:5315,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2790,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:54331,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2329,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10163,hsa:10097,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:2946,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1646,hsa:54657,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:10000,hsa:7249,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:85465,hsa:54979,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:30,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5465,hsa:3486,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:673,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:998,hsa:5063,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:6774,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5481,hsa:291,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:7297,hsa:6773,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1562,hsa:2938,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:814,hsa:10891,GErel,expression,path:hsa04211 Longevity regulating pathway,1,0.5
hsa:53632,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:8471,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3643,hsa:8471,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5606,hsa:5600,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5894,hsa:2947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:3265,hsa:369,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:53632,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5894,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:63826,path:hsa00470,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5535,hsa:4776,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3716,hsa:6777,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5605,hsa:6300,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:10365,hsa:2939,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2778,hsa:51764,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:1576,hsa:1555,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:805,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55902,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:119391,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3265,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9583,hsa:1793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:1978,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:23646,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:2939,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5599,hsa:2353,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:10000,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:64764,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4780,hsa:2572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:93408,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:8398,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2771,hsa:113,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:130,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:805,hsa:26100,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,cpd:C01245,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:23646,hsa:391013,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:7846,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:84699,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:64764,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1562,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:4907,hsa:2731,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81873,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30814,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4217,hsa:5609,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:369,hsa:7423,no_relation,no_relation,no_relation,no_relation,0.0
hsa:652,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:3725,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5530,hsa:54947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:6300,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:2069,hsa:1956,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:1036,hsa:883,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:207,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4217,hsa:5609,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2147,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:329,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:3106,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:208,PCrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5296,hsa:207,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:7297,hsa:6772,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:846,hsa:25945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:84699,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:38,hsa:3032,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:50487,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10449,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:4846,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
cpd:C00008,hsa:5027,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5330,cpd:C00165,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1457,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:93034,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1373,hsa:2747,ECrel,compound,path:hsa00910 Nitrogen metabolism,1,0.5
hsa:4137,hsa:10376,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2534,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5925,hsa:51727,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100526794,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:873,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:50487,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:999,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57521,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1549,hsa:1646,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5606,hsa:1432,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:5315,hsa:10645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:54331,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00010,hsa:669,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:3945,hsa:5162,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:8976,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:3945,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:112,hsa:5567,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5829,hsa:9261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3441,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:8660,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7365,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:23411,hsa:2309,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1956,hsa:8503,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:38,hsa:32,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:369,hsa:5604,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3455,hsa:3716,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:51727,hsa:284958,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:377841,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:109,cpd:C00575,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:5567,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8605,hsa:3157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,path:hsa00130,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:5606,hsa:5603,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:1386,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:3725,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:3444,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:189,hsa:2731,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:5600,hsa:7157,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5063,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:5293,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:50507,cpd:C00704,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00076,hsa:823,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3717,hsa:5595,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:818,hsa:3122,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6776,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:6714,hsa:5880,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:10163,hsa:10552,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:339896,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:60,hsa:4301,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:25759,hsa:6654,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2081,hsa:7186,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:85465,hsa:27330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2948,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:8074,hsa:2260,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:956,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5970,hsa:7422,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:1576,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:57521,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:6776,hsa:3726,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5881,hsa:5599,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
cpd:C13050,hsa:6263,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:10746,hsa:5608,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:18,hsa:2571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1553,hsa:3111,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:6776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:30833,no_relation,no_relation,no_relation,no_relation,0.0
path:map01056,hsa:2805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:54331,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:10201,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:2782,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5879,hsa:56924,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:4258,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:102723407,hsa:2207,PPrel,binding/association,path:hsa05310 Asthma,2,0.5
hsa:91653,hsa:6608,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:64764,hsa:596,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:6300,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4259,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5533,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:2938,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:59345,cpd:C13050,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5880,hsa:387,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6885,hsa:6416,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:8717,hsa:8772,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:10092,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8399,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:217,hsa:128,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:382,hsa:375,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:8660,hsa:5290,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:84699,hsa:1026,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:2776,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:54361,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5731,hsa:2793,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:124583,hsa:4205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3725,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:4137,hsa:4718,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2773,hsa:107,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:22943,hsa:89780,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00076,hsa:816,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
path:hsa00770,hsa:1491,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5293,cpd:C05981,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,6,0.8
cpd:C01996,hsa:39,no_relation,no_relation,no_relation,no_relation,0.0
hsa:18,hsa:339896,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2778,hsa:111,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:953,hsa:2784,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5734,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:2941,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:4209,hsa:50964,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:1432,hsa:468,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:9915,hsa:2034,PPrel,binding/association,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:5566,hsa:3709,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:7263,path:hsa00260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1036,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2947,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:35,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5603,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2771,hsa:107,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5535,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00942,hsa:5592,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:123745,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3717,hsa:6777,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:3690,hsa:4790,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:654364,hsa:957,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:196883,hsa:2768,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54578,hsa:56924,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51380,path:map00460,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1543,hsa:10092,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,hsa:5291,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:222,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,4,0.5
hsa:810,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5291,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:5443,hsa:4985,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1491,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:391013,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2790,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100526794,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6416,hsa:1284,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4190,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5562,hsa:32,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:7298,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:1072,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:2308,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5091,hsa:5160,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:30,hsa:5096,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2322,hsa:5293,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:4258,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4790,hsa:57180,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107,hsa:5568,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:5331,hsa:3708,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:4780,hsa:1728,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5169,hsa:22978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
path:map01056,hsa:39,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5599,hsa:4088,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5608,hsa:5153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65985,hsa:3157,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5604,hsa:5594,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:163688,hsa:6655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:107,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5747,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3570,hsa:3716,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5337,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1385,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:23308,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:283748,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3643,hsa:8471,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:51764,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:2768,hsa:10010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:5290,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:10390,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51727,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9583,hsa:100526794,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1843,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:5970,PPrel,inhibition,path:hsa05161 Hepatitis B,1,0.8
hsa:4128,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5732,hsa:1728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:221357,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:114,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:217,hsa:130,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3446,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1562,hsa:2950,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:9365,hsa:3667,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1432,hsa:148327,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1029,hsa:3032,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:4929,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:218,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10993,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:39,hsa:32,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:55902,hsa:32,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5894,hsa:93034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,hsa:5580,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:3569,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54979,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2147,hsa:51806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:5563,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5291,hsa:6195,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5604,hsa:1978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:596,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:163688,hsa:815,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:219,hsa:128,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:64902,hsa:2628,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:55811,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4776,hsa:5743,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:1147,hsa:4792,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
cpd:C00002,hsa:5028,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3643,hsa:8471,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
path:map00710,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:3155,hsa:10449,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:50487,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5568,hsa:468,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:55626,hsa:441925,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2475,hsa:3690,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00942,hsa:5593,PCrel,activation,path:hsa04740 Olfactory transduction,2,0.8
hsa:3551,hsa:4792,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:94235,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5105,hsa:5315,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:10580,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:10627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:1432,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:4357,hsa:56267,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:10000,hsa:4846,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10062,hsa:644150,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2948,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1147,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:106821730,hsa:3985,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
cpd:C00076,hsa:3440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:208,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1385,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:59345,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:3032,hsa:29851,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:7417,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2948,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5568,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5091,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:30814,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:59345,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5156,hsa:2885,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00025,hsa:2912,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1020,hsa:4137,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,2,0.8
hsa:8503,hsa:207,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1545,hsa:3451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55902,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:8600,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:6654,hsa:3845,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:54511,path:hsa00020,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1839,hsa:1956,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:808,hsa:5530,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3665,hsa:3456,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:1496,hsa:1499,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:2806,path:map00960,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:3157,hsa:955,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00640,hsa:113675,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:57121,hsa:2768,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
cpd:C01245,hsa:3709,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5535,hsa:54961,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5747,hsa:5295,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:1457,hsa:5582,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:4893,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:56924,hsa:8440,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:810,hsa:5137,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:2947,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:81579,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:90993,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4793,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:3708,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2885,hsa:53358,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:259307,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2953,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:713,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84532,hsa:3456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:3117,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5894,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:5731,hsa:2786,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1962,hsa:1962,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:7366,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5566,hsa:56302,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:8976,hsa:653857,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
cpd:C00076,hsa:801,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:29110,hsa:54498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,cpd:C05981,PCrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5747,hsa:1399,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:956,hsa:56901,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5534,hsa:200186,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1385,hsa:2353,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:2791,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:122618,hsa:8605,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4780,hsa:2948,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:54578,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:317,hsa:842,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:64764,hsa:1026,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:999,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:816,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:6237,hsa:5894,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:374875,hsa:5091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1565,hsa:54659,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:54578,hsa:4214,no_relation,no_relation,no_relation,no_relation,0.0
hsa:39,hsa:10449,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2782,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4137,hsa:9475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:818,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:1577,hsa:1559,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:332,hsa:842,PPrel,inhibition,path:hsa05161 Hepatitis B,1,0.8
hsa:5293,hsa:208,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:10095,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5894,hsa:5605,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5879,hsa:6259,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:115650,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3448,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:4217,hsa:5608,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:7297,hsa:6773,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5731,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:998,hsa:125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5970,hsa:9618,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5290,hsa:10000,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5315,hsa:3158,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:6772,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5330,cpd:C01245,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:11145,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:8835,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:1432,hsa:3725,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5605,hsa:5599,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:107987479,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:56994,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:221,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2690,hsa:3717,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:84735,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:91860,hsa:5534,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:107987478,hsa:1557,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:953,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1432,hsa:3725,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:122618,hsa:11145,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5567,hsa:3708,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2771,hsa:2785,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5156,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5566,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:4704,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:2353,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4128,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:7422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4357,hsa:92483,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:10746,hsa:5606,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2571,hsa:54659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5330,hsa:5137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:5894,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:208,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:3361,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:1978,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5970,hsa:4843,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:2791,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2309,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4208,hsa:50964,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:5599,hsa:2353,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:488,hsa:815,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:2790,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:11200,hsa:7157,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:2768,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:1956,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:2786,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:2002,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:107,hsa:4318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:369,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:5568,hsa:64764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:208,hsa:3551,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:316,hsa:953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:5319,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5602,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5894,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5293,hsa:3674,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:53632,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23365,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:5602,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:8471,hsa:5291,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:9586,hsa:83593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6472,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:574537,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,cpd:C00003,no_relation,no_relation,no_relation,no_relation,0.0
hsa:39,hsa:31,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5291,hsa:377841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1565,hsa:54658,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5296,hsa:10000,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4790,hsa:595,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:8639,hsa:1234,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:2997,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00002,hsa:5027,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5296,hsa:10000,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:221,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:56267,hsa:2805,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
cpd:C00533,hsa:4313,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
path:hsa00010,hsa:5223,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:56477,hsa:2826,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
hsa:3030,hsa:2941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,2,0.8
cpd:C01996,hsa:1133,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5881,hsa:8826,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:998,hsa:5063,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:6714,hsa:2768,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5734,hsa:2792,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5606,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:489,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:841,hsa:637,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
cpd:C00334,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00518,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6198,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:1558,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:222,hsa:51422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81029,hsa:6259,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5747,hsa:7846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5241,hsa:7471,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:208,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2330,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1906,hsa:1909,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
cpd:C00076,hsa:5534,PCrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:2773,hsa:196883,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:2335,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:4893,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5296,cpd:C05981,PCrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:27072,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1565,hsa:2033,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1386,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4258,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5582,hsa:54575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5293,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3059,hsa:1545,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:64600,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:91860,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6655,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:218,hsa:151,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4233,hsa:1500,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:6195,hsa:2099,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2771,hsa:7082,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:196883,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2786,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2773,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
path:map01056,hsa:5096,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:59345,hsa:2785,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:1548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5293,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4907,hsa:54579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1553,hsa:7364,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:7186,hsa:8737,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5880,hsa:5567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,hsa:2953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:196883,hsa:5567,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
cpd:C00025,hsa:54578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5296,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2790,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:217,hsa:125,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:18,hsa:55748,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:7157,hsa:1647,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1131,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10000,hsa:54578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3030,hsa:1962,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5879,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3988,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:6776,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:4790,hsa:3441,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:1854,hsa:122618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:93034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:115,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3984,hsa:1072,PPrel,phosphorylation,path:hsa04360 Axon guidance,2,0.8
hsa:5608,hsa:5601,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:9475,hsa:957,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:6777,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5105,hsa:4190,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4128,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5322,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5566,hsa:148327,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5337,hsa:608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,path:hsa00430,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,2,0.5
hsa:2783,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5880,hsa:135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:468,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5593,hsa:683,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:1854,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00533,cpd:C16845,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:8471,hsa:5296,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C00745,hsa:153,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5608,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84735,hsa:55748,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2939,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6772,hsa:8835,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5567,hsa:574537,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:8660,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5534,hsa:54961,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:6300,hsa:5602,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5568,hsa:148327,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5331,hsa:9252,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4233,hsa:1500,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:5745,hsa:2773,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:7099,hsa:5595,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5568,hsa:84699,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4775,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1388,hsa:1026,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:811,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:56302,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:54576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:581,hsa:54205,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
cpd:C00076,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:84618,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:4190,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:54657,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2329,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
cpd:C00076,hsa:51806,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:71,hsa:567,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:54579,no_relation,no_relation,no_relation,no_relation,0.0
path:map01056,hsa:5095,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5731,hsa:59345,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5608,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6723,hsa:144811,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
cpd:C00780,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2952,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1869,hsa:332,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:5608,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1843,hsa:5602,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:957,hsa:4907,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:4137,hsa:113457,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:64764,hsa:79861,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:3643,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:8174,hsa:3695,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
cpd:C01996,hsa:54498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5600,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5137,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:8605,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5594,hsa:3725,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:207,hsa:4790,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5565,hsa:84335,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2770,hsa:5602,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:6387,hsa:7852,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:5337,hsa:55748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:5291,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1844,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:207,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:4907,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1856,hsa:2932,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5600,hsa:4191,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5881,hsa:5602,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:406933,hsa:6777,PPrel,inhibition,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5606,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6776,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:3690,hsa:6714,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5609,hsa:883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:998,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:2475,hsa:2767,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2938,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1962,hsa:11040,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3445,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:314,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
cpd:C00681,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:114,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1956,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1020,hsa:4697,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:387,hsa:5894,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:6300,hsa:2353,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:501,hsa:10327,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3718,hsa:6775,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2100,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:673,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:112399,hsa:3091,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:91860,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:223,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5532,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
cpd:C00665,hsa:5213,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5315,hsa:3945,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5313,hsa:3945,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:131,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4830,hsa:124583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2776,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:113675,path:map00680,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:51422,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:151056,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5535,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1956,hsa:2885,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:3661,hsa:3447,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:810,hsa:5136,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:55902,hsa:217,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:953,hsa:9583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5566,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2889,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6241,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:6773,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2770,hsa:5291,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5568,hsa:84699,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3107,hsa:567,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:10681,hsa:7188,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:5601,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:54361,hsa:7976,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:10365,hsa:4258,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:314,hsa:501,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1147,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:3725,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:3030,hsa:3033,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:6416,hsa:5603,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3717,hsa:5747,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:80824,hsa:5595,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:5568,hsa:468,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
cpd:C00076,hsa:3845,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5608,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:3667,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:387,hsa:5608,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:107987478,hsa:7365,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2773,hsa:54498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:177,hsa:5879,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:2778,hsa:2782,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:8976,hsa:441531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:7263,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:4893,hsa:5894,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2771,hsa:115,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2775,hsa:10681,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:2731,path:hsa00250,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:5732,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:64764,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:4193,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6199,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6774,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:255189,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6093,hsa:58498,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:223,hsa:126,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1576,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30,hsa:3459,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:9020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2950,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:999,hsa:1499,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
cpd:C00025,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:3725,PPrel,activation,path:hsa05161 Hepatitis B,2,0.8
hsa:5337,hsa:221,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:27330,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5330,hsa:5579,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:2791,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:7365,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5733,hsa:2788,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5593,hsa:952,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5604,hsa:1432,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:124,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4775,hsa:3576,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5568,hsa:1388,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2788,hsa:5592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,hsa:7364,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4842,cpd:C00533,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:94235,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2885,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:128,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:8503,hsa:6197,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:811,hsa:712,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:5566,hsa:64764,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1559,hsa:2948,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:207,hsa:842,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2771,hsa:7365,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8851,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7124,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:163688,hsa:5530,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:2786,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6655,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5567,hsa:1385,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:114,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2948,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1499,hsa:51176,PPrel,activation,path:hsa05210 Colorectal cancer,2,0.8
hsa:3554,hsa:6885,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:953,hsa:56953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:222,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5881,hsa:106821730,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:5565,hsa:81579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:114,hsa:5567,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:3716,hsa:6778,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:207,hsa:115,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:6416,hsa:31,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:112,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:2260,hsa:2941,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:6513,no_relation,no_relation,no_relation,no_relation,0.0
hsa:113,hsa:65082,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:1029,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:468,hsa:1649,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:3290,hsa:10720,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5053,hsa:54963,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:2792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:208,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:2953,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2790,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5603,hsa:2353,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5291,cpd:C05981,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5567,hsa:3710,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
cpd:C01996,hsa:1131,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5173,hsa:4985,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:107987479,hsa:79799,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
cpd:C00076,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:177,hsa:3265,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:10379,hsa:6772,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5567,hsa:81579,no_relation,no_relation,no_relation,no_relation,0.0
path:map00710,path:hsa00030,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:8976,hsa:30,no_relation,no_relation,no_relation,no_relation,0.0
hsa:39,path:hsa00640,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:55902,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:8826,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7298,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:3674,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2057,hsa:3717,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:2786,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6654,hsa:3265,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:107987478,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:468,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:7368,hsa:2788,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4259,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4833,hsa:1435,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1839,hsa:1956,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5338,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7083,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2099,hsa:28514,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:468,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2950,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,cpd:C00165,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
path:hsa00620,path:hsa00910,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:4893,hsa:5894,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,2,0.8
hsa:862,hsa:6688,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:998,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:151056,hsa:54659,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01673,hsa:7421,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:22943,hsa:7478,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5606,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00942,hsa:5138,PCrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:818,hsa:1906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:314,hsa:5335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1788,hsa:1844,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:6655,hsa:3845,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:2335,hsa:3688,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:4087,hsa:1277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:4832,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1564,hsa:54579,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:8611,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3551,hsa:3667,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6774,hsa:11040,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:3032,hsa:2946,no_relation,no_relation,no_relation,no_relation,0.0
hsa:36,hsa:1892,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1553,hsa:54577,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:369,hsa:5604,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:219,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5295,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:84532,path:hsa00640,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:64600,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2775,hsa:115,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:30833,hsa:148,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51727,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1942,hsa:1969,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:83439,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7478,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3661,hsa:3456,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:9475,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8741,hsa:23495,PPrel,activation,path:hsa04672 Intestinal immune network for IgA production,3,0.8
hsa:208,hsa:841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1901,hsa:4773,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:22808,cpd:C16844,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5594,hsa:6300,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:10365,hsa:604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:130,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6772,hsa:2938,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:2944,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:8741,hsa:23495,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,3,0.5
hsa:4087,hsa:1285,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5533,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:652,hsa:90,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:27244,hsa:5563,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:373156,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6776,hsa:3486,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:472,hsa:8878,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:1558,hsa:9446,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5734,hsa:219,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:4258,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3710,hsa:808,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5610,hsa:8660,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5567,hsa:148327,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:6300,hsa:1029,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:587,path:hsa00290,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5371,hsa:7704,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:221,hsa:2571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1854,hsa:4830,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2782,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:59345,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:50487,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:8399,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5609,hsa:6300,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:107987479,hsa:10941,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:219,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5053,hsa:30833,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:1816,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1956,hsa:5293,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:356,hsa:355,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:94235,cpd:C00027,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5599,hsa:8660,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:377841,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2774,hsa:109,PPrel,activation,path:hsa04740 Olfactory transduction,2,0.8
hsa:208,hsa:3551,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:10062,hsa:19,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:5335,cpd:C00076,PCrel,activation,path:hsa04360 Axon guidance,1,0.8
cpd:C00533,hsa:2977,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5296,hsa:54498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:7371,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:2353,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5566,hsa:5322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3158,hsa:54511,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:4651,hsa:71,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:7852,hsa:2791,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00334,hsa:2562,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5571,hsa:3716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:119391,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5608,hsa:1432,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:367,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122618,hsa:5322,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4833,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:3439,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1850,hsa:5594,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:29922,hsa:1500,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:8399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7424,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,hsa:5578,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:259307,path:hsa00290,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5594,hsa:5019,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:2775,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2939,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5568,hsa:148327,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:9365,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:712,hsa:4035,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:127,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5534,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5337,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1399,hsa:2889,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:112,hsa:5566,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5296,hsa:208,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:7048,hsa:4088,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5296,hsa:3690,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3667,hsa:8503,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:221357,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2791,hsa:10094,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
cpd:C00076,hsa:816,PCrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2770,hsa:2788,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:207,hsa:572,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:91860,hsa:5533,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5568,hsa:90993,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:22943,hsa:7484,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:4790,hsa:3442,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:85464,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:148327,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:22978,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:2948,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:112,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:5595,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:10163,hsa:10109,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:1558,hsa:2946,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:54575,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4790,hsa:3452,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:1944,hsa:1969,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:1565,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:89953,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4893,hsa:8503,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:203068,hsa:5322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7046,hsa:4087,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:27035,cpd:C00704,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3945,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4137,hsa:4726,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3290,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:54659,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:146,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:54575,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1843,hsa:5599,PPrel,inhibition,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:54577,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:339896,hsa:55748,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1855,hsa:7480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:160287,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3948,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2946,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7083,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10390,hsa:5321,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3725,hsa:3553,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2147,hsa:2150,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5608,hsa:1432,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8851,hsa:4137,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1147,hsa:4792,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,2,0.8
cpd:C00076,hsa:808,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:10201,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5533,hsa:200186,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1020,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:1956,hsa:5594,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2940,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:8503,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:10390,hsa:38,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:103910,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:284958,hsa:1630,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7132,hsa:8717,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5091,hsa:54361,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5173,hsa:4988,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:124583,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56953,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:27121,hsa:7477,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:1051,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3290,hsa:7366,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:163688,hsa:5532,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5566,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:2793,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:4780,hsa:653689,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
cpd:C00547,hsa:155,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1399,hsa:4214,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2100,hsa:2251,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:5568,hsa:1386,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:207,hsa:1147,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
path:hsa00270,path:hsa00290,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:2775,hsa:109,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:4790,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5331,hsa:3710,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:2149,hsa:10672,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2805,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:317,hsa:842,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:9475,hsa:103910,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:5566,hsa:5207,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:10568,hsa:217,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:7157,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:29119,hsa:81,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:5291,hsa:27330,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:10993,path:map00680,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:5566,hsa:9586,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:6416,hsa:1432,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3661,hsa:3449,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:51422,hsa:32,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:4833,hsa:955,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6714,hsa:4893,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2792,hsa:1793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:25759,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:22943,hsa:9583,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:406890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,cpd:C05981,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:122618,hsa:283748,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3717,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2322,hsa:6776,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:3105,hsa:84693,no_relation,no_relation,no_relation,no_relation,0.0
hsa:356,hsa:355,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2326,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:7157,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
cpd:C00681,hsa:57121,PCrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:84647,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00745,hsa:1141,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:1398,hsa:4214,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2776,hsa:5332,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5879,hsa:19,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:6655,hsa:4893,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2773,hsa:2783,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5566,hsa:468,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:53632,hsa:31,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:6376,hsa:1524,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
cpd:C00076,hsa:91860,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5568,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4719,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:7298,hsa:284958,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:9365,hsa:955,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5313,hsa:3939,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5566,hsa:9586,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:9475,hsa:29895,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:6714,hsa:6850,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:377841,hsa:7371,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5733,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:5296,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:10000,hsa:112,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:54657,hsa:54498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:815,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5914,hsa:4609,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:5606,hsa:1432,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
cpd:C00533,hsa:4318,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2770,hsa:2786,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:208,hsa:5970,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:873,path:hsa00250,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7046,hsa:4088,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5568,hsa:10488,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5567,hsa:1386,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:6885,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54657,hsa:85464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:6655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100526794,hsa:1854,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:54961,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10201,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:22943,hsa:7475,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:64750,hsa:387,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:27121,hsa:54576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5156,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1910,hsa:2775,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:207,hsa:114,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2771,hsa:115,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:2773,hsa:10163,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:8651,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
cpd:C00076,hsa:818,PCrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:221264,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:6416,hsa:5600,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4780,hsa:2946,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:208,hsa:406890,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:3265,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:26279,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:51380,hsa:223,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:10365,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56953,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:805,hsa:3155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:4318,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:5732,hsa:5063,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:7277,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:7043,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:9368,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3945,hsa:5160,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5338,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:3815,path:hsa00130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3030,hsa:5161,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:2944,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4846,cpd:C00533,PCrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,2,0.8
hsa:5567,hsa:90993,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
cpd:C00025,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1565,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:6300,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:2946,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:107,hsa:8440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:6241,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4830,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1147,hsa:8471,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:7186,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:7056,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5970,hsa:3552,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:1543,hsa:2939,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5566,hsa:5565,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2785,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5599,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:10109,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:208,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:122618,hsa:8681,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6300,hsa:55902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:9586,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:107,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C02165,hsa:10094,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:3109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:3458,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
path:map01056,path:hsa00061,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C00076,hsa:91860,PCrel,binding/association,path:hsa04740 Olfactory transduction,1,0.5
hsa:596,hsa:221,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00665,hsa:5211,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:808,hsa:816,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5566,hsa:90993,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
cpd:C00575,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:10000,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:4833,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:9586,hsa:596,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:23646,hsa:8681,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2786,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
path:hsa00240,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:54579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7368,path:hsa00220,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5313,hsa:5091,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1854,hsa:4832,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:85465,hsa:3805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:2254,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:3643,hsa:3667,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2805,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:3845,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1576,hsa:27306,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:111,hsa:1871,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:314,hsa:3155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6009,hsa:2475,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5605,hsa:1030,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:54659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:1906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:18,hsa:54963,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4190,hsa:5579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57144,hsa:3984,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:10365,hsa:4257,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:112817,hsa:1496,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5161,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2308,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:654364,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:9636,hsa:23586,PPrel,binding/association,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:1646,hsa:54576,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3845,hsa:1029,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:208,hsa:4790,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2793,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2771,hsa:5594,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:3451,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:112,hsa:117,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:5563,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5340,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:3449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27072,hsa:7879,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:10580,hsa:4301,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:108,hsa:5567,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5567,hsa:84699,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:221264,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:79888,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:53632,hsa:2944,no_relation,no_relation,no_relation,no_relation,0.0
hsa:125,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10000,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:106821730,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:5296,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:374875,hsa:7365,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:56267,hsa:116443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:468,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5566,hsa:4208,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1565,hsa:54578,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5533,hsa:4773,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3845,hsa:5296,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:2353,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:574537,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2778,hsa:111,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4088,hsa:4609,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:4833,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:873,hsa:6240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:4257,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:208,hsa:113,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2775,hsa:196883,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
cpd:C01245,hsa:4035,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:1977,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:54361,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:148327,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:3827,hsa:623,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1577,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2771,hsa:6300,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5293,hsa:5894,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1562,hsa:6655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:5295,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5608,hsa:1432,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:9475,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:558,hsa:4615,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55748,hsa:221,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:7706,hsa:23586,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:5747,hsa:5291,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:2944,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2947,hsa:26100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5571,hsa:57521,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:30833,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:2475,hsa:3726,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:207,hsa:4313,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3452,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:6654,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5595,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7043,hsa:6240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:5603,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5608,hsa:1432,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:7132,hsa:338382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6472,hsa:113675,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:5533,hsa:373156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:2952,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:3667,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5564,cpd:C00003,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2940,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:953,hsa:1030,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5534,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5604,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55902,hsa:2947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4651,hsa:4158,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4128,hsa:3446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:25759,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4790,hsa:7124,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:10645,hsa:5565,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5091,hsa:5162,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2534,hsa:5881,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:3661,hsa:3443,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:8503,hsa:3155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6483,hsa:27090,ECrel,compound,path:hsa00512 Mucin type O-glycan biosynthesis,1,0.5
cpd:C00076,hsa:4907,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:7046,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3709,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5175,hsa:84618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148,hsa:2776,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:207,hsa:3551,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1788,hsa:80824,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:59345,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5566,hsa:148327,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:208,hsa:332,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5568,hsa:3710,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2952,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5563,hsa:2309,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3661,hsa:2914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:2308,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1557,hsa:2944,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5578,hsa:3611,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:6470,hsa:63826,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:1432,hsa:90993,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6776,hsa:79799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2572,hsa:55748,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5609,hsa:2113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:219,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8174,hsa:3676,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
hsa:5605,hsa:5595,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2787,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
cpd:C00584,hsa:5734,PCrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:5167,hsa:56953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5914,hsa:3728,GErel,expression,path:hsa05221 Acute myeloid leukemia,2,0.5
hsa:1495,hsa:7414,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:10390,hsa:5337,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
path:hsa00290,hsa:5571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:6300,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8517,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5137,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:6472,hsa:189,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5608,hsa:6300,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5481,hsa:292,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5610,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5535,hsa:4772,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4690,hsa:56924,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
path:hsa00071,hsa:39,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:1854,hsa:221264,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5053,hsa:6898,ECrel,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:3265,hsa:2938,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,hsa:5567,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:90993,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:10390,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:1395,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:115,cpd:C00575,PCrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:861,hsa:3728,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:2771,hsa:94235,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:8764,hsa:7186,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2353,hsa:3030,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:1147,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:51764,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:10383,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2770,hsa:94235,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
cpd:C00951,hsa:2099,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:208,hsa:1147,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:208,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55902,hsa:1737,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3845,hsa:369,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:978,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00533,hsa:4312,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:3845,hsa:5894,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:153,hsa:2778,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5532,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3091,hsa:6513,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:5532,hsa:6794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1020,hsa:4137,PPrel,activation,path:hsa05010 Alzheimer disease,2,0.8
hsa:808,hsa:1978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:4792,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2775,hsa:112,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:3665,hsa:3444,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:2572,path:map00460,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:862,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:38,hsa:10449,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5607,hsa:5598,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:55970,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3448,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2113,hsa:1029,GErel,expression,path:hsa04218 Cellular senescence,1,0.5
hsa:2475,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1540,hsa:23586,PPrel,inhibition,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:6093,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:113,hsa:7423,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26279,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00076,hsa:221264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:2353,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:22943,hsa:7481,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2773,hsa:2793,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:956,hsa:9583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:27121,hsa:10720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5468,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:5563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:7363,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5568,hsa:778,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C00165,hsa:4325,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:9583,hsa:56953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6470,hsa:332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:2916,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:1892,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4087,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6469,hsa:5727,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5747,hsa:1029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3451,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:3134,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:1499,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:56267,hsa:5571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8741,hsa:608,PPrel,activation,path:hsa04672 Intestinal immune network for IgA production,1,0.8
hsa:1571,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5530,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:90993,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1558,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5933,hsa:2948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:2950,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:9826,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:79799,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
path:hsa00480,hsa:2806,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
path:hsa00640,hsa:219,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5608,hsa:5600,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:137362,path:hsa00350,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:283748,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5609,path:map00940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2100,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1543,hsa:2940,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:8517,hsa:4792,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,2,0.8
hsa:5293,hsa:2002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:387,hsa:60,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:59345,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5371,hsa:4609,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:5530,hsa:572,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1549,hsa:54577,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5568,hsa:5563,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2099,hsa:5137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:8517,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1500,hsa:2915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:10488,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:131,hsa:1553,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5595,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:2475,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:5970,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3716,hsa:6775,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:83667,hsa:5564,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:387,hsa:2081,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:208,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:3551,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124583,hsa:7371,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1553,hsa:54575,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:23308,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3728,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5914,hsa:7704,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
cpd:C16844,hsa:5030,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:1491,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8936,hsa:81873,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:10365,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:10941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2791,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:284958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80824,hsa:5594,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:2773,hsa:115,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2932,hsa:5604,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1499,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5602,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:4129,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:999,hsa:1548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:127,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:90993,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5562,hsa:31,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
path:map00710,path:hsa00010,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:54947,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5605,hsa:5600,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1557,hsa:2946,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
path:hsa00640,path:hsa00260,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2534,hsa:84618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:5565,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1398,hsa:1793,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:5338,hsa:30814,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2805,path:hsa00360,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:3030,hsa:51,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:3032,path:hsa00640,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5894,hsa:5747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10941,hsa:3945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:2768,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26007,hsa:64135,PPrel,inhibition,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:2778,hsa:196883,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:9586,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:3030,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3133,hsa:3805,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:51727,hsa:84618,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:54331,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:57571,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:2784,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:2793,hsa:3945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:834,hsa:637,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:1496,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5340,hsa:2149,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5568,hsa:1385,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1562,hsa:56953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51727,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:3685,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:5315,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2767,hsa:5332,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:2099,hsa:221,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5330,hsa:3451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:5608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:81579,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5579,hsa:9368,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5582,hsa:56302,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:79799,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:952,cpd:C13050,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:3554,hsa:1147,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6898,path:map00960,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:3265,hsa:5894,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:51764,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:54658,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2953,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:83439,hsa:332,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:18,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:22808,hsa:5296,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5734,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:407024,hsa:9314,PPrel,inhibition,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5571,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5063,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8440,hsa:147179,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:6772,hsa:998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:54579,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5564,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:108,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3725,hsa:3576,GErel,expression,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:6772,hsa:9451,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:2778,hsa:115,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5567,hsa:778,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:22943,hsa:7471,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5293,hsa:6196,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5880,hsa:1051,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5602,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:113,hsa:5566,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5295,hsa:208,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:38,hsa:1737,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5582,hsa:775,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:223,hsa:124,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:31,path:hsa00640,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:54575,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23586,hsa:57506,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:107987478,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:1432,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1646,hsa:1549,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:1549,hsa:1902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:80326,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:2353,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2946,hsa:7478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3725,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1969,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:2057,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:10488,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5532,hsa:4776,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:18,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,4,0.5
hsa:1576,hsa:2952,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:4832,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:51806,hsa:816,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:3661,hsa:3456,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:55970,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5731,hsa:2771,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1789,hsa:262,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5468,hsa:2621,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:5567,hsa:4208,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:113,cpd:C00575,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:6472,path:map00460,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:2785,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1839,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:114,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10810,hsa:10095,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
cpd:C00547,hsa:154,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:3717,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:177,hsa:4893,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:6009,hsa:155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3600,hsa:3601,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
hsa:55970,hsa:54963,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:54657,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5053,path:map00940,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",2,0.5
hsa:38,hsa:30,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:7189,hsa:5600,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:8503,hsa:207,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5727,hsa:2565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22808,hsa:5291,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5663,hsa:316,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2550,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2773,hsa:23411,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:208,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:1946,hsa:2534,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5745,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2950,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5605,hsa:5594,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:22808,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5568,hsa:148327,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2790,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4548,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51380,hsa:224,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2788,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:1908,hsa:1909,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4780,hsa:119391,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5970,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5594,hsa:3486,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:112817,hsa:155,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00250,hsa:2752,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:885,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3460,hsa:3716,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:2940,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5595,hsa:64764,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:4357,hsa:56302,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5743,cpd:C00584,PCrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:3725,hsa:595,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:5599,hsa:3725,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:3445,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
cpd:C00076,hsa:4830,no_relation,no_relation,no_relation,no_relation,0.0
hsa:38,hsa:6344,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7483,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6237,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:842,hsa:836,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:64764,hsa:2353,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:2147,hsa:9002,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4852,hsa:4886,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:23236,hsa:5578,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:23646,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:654364,hsa:2549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7157,hsa:596,PPrel,inhibition,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3290,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2326,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3845,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2950,hsa:6885,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:1892,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:5925,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5608,hsa:55740,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:10488,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2778,hsa:113,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:119391,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5970,hsa:1435,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:2770,hsa:51764,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:4087,hsa:1278,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
path:hsa00770,hsa:2805,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:4214,hsa:5608,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3665,hsa:3451,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:1557,hsa:2940,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:57521,hsa:6199,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:373156,hsa:56288,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:57506,hsa:8717,PPrel,binding/association,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:1020,hsa:81,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7280,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5563,hsa:32,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:6300,hsa:84699,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8471,hsa:1559,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:1432,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:6898,path:hsa00360,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:7048,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:8613,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2885,hsa:6654,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5733,hsa:2778,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5534,hsa:85464,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2081,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:4259,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:594,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1564,hsa:54576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2949,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2949,hsa:8823,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,cpd:C05981,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:106821730,hsa:3984,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2791,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5535,hsa:182,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2939,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5291,hsa:6197,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5291,hsa:57571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1839,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5293,hsa:3690,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:972,hsa:3126,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:85465,hsa:391013,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1807,hsa:1806,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5568,hsa:10488,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:23646,hsa:7083,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:5535,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:377841,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1892,hsa:377841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:2081,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:4629,hsa:60,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:92483,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:10000,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:7097,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C13856,hsa:10449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,2,0.8
hsa:2308,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5792,hsa:1499,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5578,hsa:4893,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:808,hsa:5535,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00584,hsa:5733,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:6370,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:151,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
path:hsa00260,path:hsa00290,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:673,hsa:5137,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3708,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3716,hsa:6774,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2099,hsa:8651,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:2790,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:54659,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4893,hsa:369,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:810,hsa:4842,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1147,hsa:4790,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1442,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:112,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:79861,hsa:5563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5530,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5169,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2771,hsa:51764,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5595,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:5599,hsa:5602,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1553,hsa:7367,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:2783,hsa:7048,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:2788,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:572,PPrel,inhibition,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:160287,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:6776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5600,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:23646,hsa:255189,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3728,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:3939,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00518,hsa:6382,PCrel,binding/association,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:8639,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51733,path:hsa00410,maplink,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:221357,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:155,hsa:2778,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5925,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:6382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4087,hsa:1286,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2770,hsa:108,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2771,hsa:59345,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:8772,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79799,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:207,hsa:5970,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5604,hsa:5602,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:578,hsa:54205,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2326,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2776,hsa:221357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7364,path:hsa00130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57521,hsa:6199,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5567,hsa:9586,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8976,hsa:81873,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:4258,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:8310,path:hsa00640,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:207,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,path:map00680,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124583,hsa:22978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
path:hsa00020,path:hsa00630,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5594,hsa:148327,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:3265,hsa:1737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:594,hsa:587,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:8717,hsa:10010,PPrel,binding/association,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:223,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:6885,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1559,hsa:2939,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2773,hsa:113,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:1432,hsa:1029,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:219,hsa:377841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,hsa:5566,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:113675,path:hsa00600,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:6932,hsa:595,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:6885,hsa:1147,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2946,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3157,path:hsa00020,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5291,hsa:5170,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:6483,hsa:10331,ECrel,compound,path:hsa00512 Mucin type O-glycan biosynthesis,1,0.5
hsa:5337,hsa:8605,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10093,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:10891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:90993,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5608,hsa:6300,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3815,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84532,hsa:1737,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5568,hsa:1386,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3667,hsa:5293,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2731,hsa:6470,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
path:hsa00770,hsa:1036,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:6009,hsa:84335,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1901,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:51764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4217,hsa:5608,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:5603,hsa:3725,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:4205,hsa:10365,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:7099,hsa:2770,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:122618,hsa:5321,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6387,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:153,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5594,hsa:9021,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:27123,hsa:7484,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:122618,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:60,hsa:332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00250,hsa:5161,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5290,hsa:54600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6483,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5564,hsa:2475,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1557,hsa:2938,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:64902,hsa:56994,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10097,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:30814,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:221,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:9451,hsa:1965,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:29922,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5567,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:5169,hsa:8823,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:3486,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:151056,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8605,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2475,hsa:6199,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:183,hsa:186,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:10094,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4793,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:2353,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:8398,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3952,hsa:3953,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5566,hsa:148327,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5290,hsa:208,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:22943,hsa:51384,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2475,hsa:1978,PPrel,inhibition,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5571,hsa:31,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:8503,hsa:10000,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5600,hsa:90993,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:846,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:119391,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:224,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:113675,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:1020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5731,hsa:2784,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5608,hsa:5599,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:63916,hsa:1793,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:1543,hsa:4257,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5609,hsa:5601,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2147,hsa:2149,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1562,hsa:9446,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2932,hsa:4137,PPrel,activation,path:hsa05010 Alzheimer disease,2,0.8
hsa:207,hsa:108,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5970,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:4893,hsa:5293,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:4893,hsa:5291,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:107987478,hsa:2941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:1026,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:7188,hsa:54575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:4893,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5610,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2034,hsa:54658,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4833,hsa:957,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:23411,hsa:5087,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:6794,hsa:5565,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:10201,hsa:124583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:501,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:2771,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1562,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84693,hsa:5095,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:113675,hsa:63826,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:85465,hsa:4636,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00350,path:map00950,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:3643,hsa:4214,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283748,hsa:4700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1373,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7430,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7124,hsa:7132,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:27244,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:7253,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1549,hsa:7367,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5600,hsa:3725,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:29922,hsa:54947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:5603,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:207,hsa:5140,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:7371,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2773,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:143686,hsa:5565,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2786,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2773,hsa:2782,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:4830,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5747,hsa:9564,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5290,hsa:10000,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:3265,hsa:5291,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
cpd:C00122,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3448,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:3290,hsa:7364,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:369,hsa:5604,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5595,hsa:3725,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:10000,hsa:196883,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2790,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4893,hsa:369,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4258,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:153,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1388,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:207,hsa:57521,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:815,hsa:51,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,hsa:63826,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",3,0.5
hsa:1565,hsa:38,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:317,hsa:501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4357,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57571,hsa:2556,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2911,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:53632,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:222,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:377841,hsa:9583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10390,hsa:8681,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10390,hsa:391013,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:137362,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:255189,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1147,hsa:4790,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2785,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:2776,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2778,hsa:2785,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:5566,hsa:2916,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:23411,hsa:5970,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:11145,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2771,hsa:109,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
path:map00960,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:8517,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:4790,hsa:1514,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:714,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3659,hsa:3592,GErel,expression,path:hsa05133 Pertussis,1,0.5
hsa:468,hsa:54947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,cpd:C16844,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1559,hsa:4257,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5898,hsa:5881,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
path:hsa00240,hsa:217,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:3158,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9021,hsa:51422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2949,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6654,hsa:4217,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:10681,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:54963,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:953,hsa:22978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
cpd:C00076,hsa:5533,PCrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:6885,hsa:3551,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1549,hsa:54659,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5732,hsa:2771,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1616,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5604,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2949,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:84647,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5579,hsa:56302,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5829,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5568,hsa:9365,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:113,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:4893,hsa:673,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:2938,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
cpd:C00025,hsa:2891,PCrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:54657,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:92483,hsa:7478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00338,hsa:7099,PCrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:3665,hsa:3439,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:2353,hsa:6401,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:1737,hsa:23566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:5154,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2793,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:59345,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1576,hsa:653689,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3845,hsa:8503,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:85465,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:957,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5293,hsa:6714,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5534,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:4214,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:55902,path:hsa00071,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:369,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:9170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5601,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:8503,hsa:10000,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:39,hsa:586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:84335,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2731,hsa:1738,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:3265,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:3725,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2932,hsa:147700,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:1892,hsa:2787,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:84699,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5566,hsa:90993,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2309,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:810,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:31,hsa:1737,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C00076,hsa:810,PCrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:4088,hsa:3290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:391,hsa:63916,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:2782,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:94235,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:54575,hsa:56302,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1871,hsa:7084,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148022,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:9586,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5566,hsa:5207,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5331,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:941,hsa:940,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
hsa:27072,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:5610,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:1373,path:hsa00220,maplink,compound,path:hsa00910 Nitrogen metabolism,1,0.5
hsa:2771,hsa:7083,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1788,hsa:6382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6009,hsa:2475,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2771,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8639,hsa:501,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:189,hsa:189,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",3,0.5
hsa:54576,hsa:54658,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5136,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:501,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:125061,path:hsa00910,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2788,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00076,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:10645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57521,hsa:39,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:3290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:4702,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3553,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:122618,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:187,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:2309,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:5499,hsa:653857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1553,hsa:7422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7378,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:91860,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:203068,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:953,hsa:7371,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:2950,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23411,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00640,hsa:224,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
cpd:C00165,hsa:5578,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:407021,hsa:7364,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2767,hsa:54511,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:11145,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:1431,no_relation,no_relation,no_relation,no_relation,0.0
hsa:998,hsa:8976,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:5567,hsa:1388,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:801,hsa:5533,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:112714,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5535,hsa:3728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:11145,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6714,hsa:5881,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1500,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5175,hsa:5598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:1029,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:2939,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5734,hsa:54331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1147,hsa:3716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:6300,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5595,hsa:2100,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5533,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2778,hsa:111,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2571,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
cpd:C00547,hsa:154,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4651,hsa:60,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:3551,hsa:4792,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:2790,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:54658,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1892,hsa:1962,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:3665,hsa:3439,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:8717,hsa:8772,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5606,hsa:5600,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:2534,hsa:1499,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:259307,path:hsa00350,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:2788,hsa:109,PPrel,activation,path:hsa04740 Olfactory transduction,2,0.8
hsa:1956,hsa:1499,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:8797,hsa:8772,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:3845,hsa:57571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:2353,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:1545,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:8517,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:10095,hsa:6197,no_relation,no_relation,no_relation,no_relation,0.0
hsa:575,hsa:9844,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:221264,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1843,hsa:5603,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:27121,hsa:7484,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5594,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:221,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,4,0.5
hsa:2770,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,hsa:5568,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:6714,hsa:2212,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:30,hsa:57571,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4690,hsa:57144,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
path:map00940,path:map00960,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:4137,hsa:51079,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00951,hsa:567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55902,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:574537,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5600,hsa:2353,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:143686,hsa:53632,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5595,hsa:4190,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:2885,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
cpd:C00951,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:6773,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:10201,hsa:11040,no_relation,no_relation,no_relation,no_relation,0.0
hsa:407026,hsa:9314,PPrel,inhibition,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:673,hsa:10062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:112,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3708,hsa:57571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:3449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5530,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:6300,hsa:54579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9446,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3265,hsa:5296,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:10365,hsa:4259,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5606,hsa:5600,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:29922,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:109,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:163688,hsa:653857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:5320,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:115,path:hsa00760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3155,hsa:30,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:23417,hsa:4329,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:56924,hsa:3985,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5568,hsa:10488,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2322,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:5618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1388,hsa:2353,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:5291,hsa:10000,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:6470,hsa:2731,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:90993,hsa:3449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2939,hsa:54575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4357,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:143686,hsa:51422,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2793,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00334,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:39,hsa:3157,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:7186,hsa:23365,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3688,hsa:50484,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2730,hsa:6776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1564,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6352,hsa:1232,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4233,hsa:25,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00942,hsa:7484,no_relation,no_relation,no_relation,no_relation,0.0
hsa:196883,hsa:5567,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:6655,hsa:2783,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,path:map00680,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:501,hsa:127,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:883,path:hsa00260,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:207,hsa:3551,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5733,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112399,hsa:2034,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:339896,hsa:314,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:7040,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4792,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:207,hsa:1147,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5568,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57521,hsa:1978,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1545,hsa:1543,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2767,hsa:5330,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5566,hsa:468,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:339896,hsa:407021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:5063,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:207,hsa:9583,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C21012,hsa:177,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:387,hsa:5599,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:6654,hsa:125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5602,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:8613,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7704,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:5601,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1576,hsa:2948,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:163688,hsa:817,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:2770,hsa:1432,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:2549,hsa:1399,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:953,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5602,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:51806,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:112399,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9446,hsa:4724,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:18,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5578,hsa:56302,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3725,hsa:7422,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:6240,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1846,hsa:5595,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
cpd:C00745,hsa:1137,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:122618,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:808,hsa:5535,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5734,hsa:2784,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:275,hsa:6472,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:5167,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5970,hsa:598,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5290,hsa:10000,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:4137,hsa:4729,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6932,hsa:4609,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:10746,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5601,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
cpd:C00780,hsa:3360,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2326,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2778,hsa:54331,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:2791,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5568,hsa:5160,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C14818,hsa:1020,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:6714,hsa:6464,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:6464,hsa:2793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:54963,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2328,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:119391,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5568,hsa:224,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3157,hsa:3032,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5879,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54576,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:137362,hsa:1036,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:3661,hsa:3456,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:1548,hsa:10376,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:208,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:8936,hsa:10552,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:3665,hsa:3449,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:55970,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:219,hsa:127,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:7368,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,2,0.5
hsa:998,hsa:2949,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:207,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:51380,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:842,hsa:836,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2947,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:109,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:10758,hsa:4790,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
path:hsa00250,hsa:160287,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:130,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:7422,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5019,hsa:54511,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:6714,hsa:3059,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:3661,hsa:3444,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:54434,hsa:1073,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5609,hsa:5600,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:100526794,hsa:189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5167,hsa:30833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
path:hsa00250,hsa:5160,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2767,hsa:23236,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:801,hsa:2788,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64600,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00640,hsa:18,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:4214,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:4259,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5879,hsa:10163,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:1576,hsa:2946,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5603,hsa:3725,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5534,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:406933,hsa:1398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,hsa:5566,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:2778,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2328,hsa:54434,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:259307,path:hsa00360,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
cpd:C00008,hsa:10161,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:873,hsa:7367,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3661,hsa:3448,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:7372,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:7363,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5566,hsa:148327,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4790,hsa:6352,GErel,expression,path:hsa05163 Human cytomegalovirus infection,2,0.5
hsa:5562,hsa:84335,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3661,hsa:51384,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:1385,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:218,hsa:1806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:8613,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1557,hsa:9314,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:54498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84618,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:93034,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:84532,hsa:55902,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3451,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2947,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6655,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:1812,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:111,hsa:5566,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:55970,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5605,hsa:1846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1388,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,cpd:C00575,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:5568,hsa:1385,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:811,hsa:713,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:5481,hsa:83447,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5818,path:hsa00470,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:81029,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5533,hsa:1962,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:2947,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:9583,hsa:83549,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:4217,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:80326,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5058,hsa:3985,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:4137,hsa:7277,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5566,hsa:10488,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4790,hsa:7412,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:3032,path:hsa00020,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:65985,hsa:2793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:51380,hsa:219,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:112,hsa:5568,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:259307,hsa:6898,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2786,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10810,hsa:10097,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:3551,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2308,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1907,hsa:6196,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7046,hsa:219,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987479,hsa:3661,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:2784,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:810,hsa:816,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:1956,hsa:5290,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:7189,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:64764,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:108,hsa:10109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3945,hsa:3451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1959,hsa:2033,PPrel,binding/association,path:hsa05161 Hepatitis B,1,0.5
hsa:163688,hsa:5019,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:8517,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:84699,hsa:953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5600,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:4780,hsa:8878,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5970,hsa:79444,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:146,hsa:2776,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:4087,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100137049,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9181,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4191,hsa:7364,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1388,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:841,hsa:637,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2064,hsa:1499,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:2788,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5603,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54579,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:148327,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:7133,hsa:1616,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:54575,hsa:7879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3452,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:2932,hsa:4137,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,2,0.8
hsa:4790,hsa:3593,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:7368,hsa:9514,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:23411,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79924,hsa:953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:79799,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:64764,hsa:391013,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:2353,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:112817,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:10488,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:113,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51176,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:3122,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:597,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3688,hsa:5747,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:3827,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:55970,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:369,hsa:5605,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:8613,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1431,hsa:7476,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:595,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:377841,hsa:6655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:5063,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5091,hsa:567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:10000,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:56953,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3158,hsa:5019,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:151531,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5602,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:223,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
hsa:3134,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:4633,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:3290,hsa:54657,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:155,hsa:2773,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2771,hsa:55748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5727,hsa:3716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:94235,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:2572,hsa:7083,no_relation,no_relation,no_relation,no_relation,0.0
hsa:133,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10993,path:hsa00020,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:586,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00008,hsa:5030,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5315,hsa:3948,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:8605,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5566,hsa:1388,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:124583,hsa:1906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:4988,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:1491,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2625,hsa:5741,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:3725,hsa:55823,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5727,hsa:6608,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2768,hsa:4087,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:224,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:8936,hsa:10097,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:6416,hsa:6300,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:587,hsa:593,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2941,path:hsa00630,no_relation,no_relation,no_relation,no_relation,0.0
hsa:113,cpd:C00575,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5568,hsa:1385,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5733,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:8835,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:846,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2949,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5568,hsa:84699,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:84532,hsa:39,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4548,path:hsa00260,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:3665,hsa:3442,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:3948,hsa:5160,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5296,hsa:10000,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:957,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54947,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5601,hsa:54577,no_relation,no_relation,no_relation,no_relation,0.0
hsa:488,hsa:817,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:4301,hsa:5818,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
cpd:C00665,hsa:407024,no_relation,no_relation,no_relation,no_relation,0.0
hsa:972,hsa:3122,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
path:hsa00071,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:5921,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5338,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3444,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:22926,hsa:7494,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:2778,hsa:112,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:805,hsa:4217,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3441,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:218,hsa:5739,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:2787,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:846,hsa:2773,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:9826,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:7298,hsa:100526794,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:9475,hsa:58498,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:652,hsa:657,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:224,hsa:131,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1576,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,8,0.5
hsa:6776,hsa:3479,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:2308,hsa:9474,GErel,expression,path:hsa04211 Longevity regulating pathway,1,0.5
hsa:5443,hsa:4158,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5290,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:3945,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5566,hsa:53632,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
cpd:C00334,hsa:2554,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2932,hsa:1499,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2806,hsa:501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:8398,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:23236,cpd:C00165,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5091,hsa:4191,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5880,hsa:5063,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:5608,hsa:5213,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5532,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1548,hsa:7363,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5603,hsa:4842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:54567,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:1956,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:7248,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124583,hsa:100526794,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:810,hsa:818,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:391013,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148022,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4772,hsa:81,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,cpd:C00575,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5595,hsa:3486,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:27102,hsa:953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2475,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5293,cpd:C05981,PCrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:124583,hsa:10720,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00640,hsa:4329,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5567,hsa:84699,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:7852,hsa:2790,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2773,hsa:112,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:2322,hsa:5291,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:1562,hsa:2949,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:594,hsa:259307,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1548,hsa:54600,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5567,hsa:148327,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4790,hsa:5970,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:107987479,hsa:377841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:6464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
path:map01056,hsa:3157,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1139,hsa:408,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1545,hsa:2948,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5053,path:hsa00130,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:2782,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:373156,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3091,hsa:7039,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:6654,hsa:3265,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:153,hsa:2770,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5566,hsa:90993,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:7083,hsa:7298,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5605,hsa:5594,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:196883,hsa:26100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5819,hsa:30833,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1576,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,8,0.5
hsa:3446,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9217,hsa:22926,PPrel,inhibition,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:2785,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8174,hsa:8398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6470,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5296,cpd:C05981,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5578,hsa:369,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2475,hsa:3479,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:221,hsa:339896,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:207,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:4128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5604,hsa:5594,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:64064,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5603,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:387,hsa:9475,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:6416,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4128,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3455,hsa:7297,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:6483,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4929,hsa:8074,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:208,hsa:7248,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:339896,hsa:219,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:6898,hsa:10941,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00230,hsa:1610,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:3458,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2938,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7704,hsa:3728,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:10000,hsa:84335,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1559,hsa:2949,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:223,hsa:3440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:56302,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:4318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:113,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4301,hsa:60,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5604,hsa:1432,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5879,hsa:106821730,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:5568,hsa:148327,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:107987478,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1495,hsa:87,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:51422,hsa:160287,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51727,hsa:7371,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:4790,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:197322,hsa:81873,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:196883,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:5293,hsa:1141,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3554,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:355,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,cpd:C00575,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5970,hsa:330,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:317,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1591,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:805,hsa:5533,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:10810,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:51806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10810,hsa:10093,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:790,hsa:7364,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:107,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:208,hsa:109,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:22978,hsa:151531,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:2100,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:472,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3446,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:208,hsa:1147,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
cpd:C00745,hsa:30814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:2940,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2778,hsa:108,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:7421,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:64764,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4357,hsa:83549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5934,hsa:1869,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:3674,hsa:4715,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:4792,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:3665,hsa:3447,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:10673,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:3725,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:3717,hsa:6775,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5499,hsa:5934,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5568,hsa:84699,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5608,hsa:6300,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:189,hsa:6470,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:5568,hsa:3709,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2770,hsa:5600,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:2806,hsa:1565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:374875,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:7298,hsa:6241,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1738,hsa:594,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:27121,hsa:7474,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:4790,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:108,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:2786,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:85465,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,hsa:1143,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:8503,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5608,hsa:4089,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4055,hsa:9020,PPrel,activation,path:hsa04672 Intestinal immune network for IgA production,1,0.8
hsa:5162,hsa:6416,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5602,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2932,hsa:5604,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:8976,hsa:10094,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:7297,hsa:51020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:1432,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5296,hsa:208,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5595,hsa:1958,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:3667,hsa:2113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3939,hsa:5162,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5606,hsa:6300,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5338,hsa:53632,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:4329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5371,hsa:5914,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:9138,hsa:23586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5169,hsa:7084,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5241,hsa:182,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:255189,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2099,hsa:54567,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:6654,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:861,hsa:1050,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
cpd:C00681,hsa:1543,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:9138,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3440,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:1399,hsa:1793,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:219,hsa:18,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:107,hsa:5566,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5567,hsa:1385,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C00076,hsa:1072,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2941,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:823,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:10163,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7099,hsa:353376,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:998,hsa:10298,PPrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:5566,hsa:1388,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5058,hsa:8440,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:5608,hsa:1432,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:200186,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,cpd:C00575,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:64600,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5567,hsa:5562,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1147,hsa:3665,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5340,hsa:2150,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:10390,hsa:8605,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1906,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:3480,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3661,hsa:3445,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:6472,hsa:3984,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1147,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:5797,hsa:1500,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:7039,hsa:1956,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2017,hsa:1785,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5601,hsa:2353,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:377841,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2941,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3845,hsa:5290,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:4832,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:196883,hsa:5568,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
cpd:C05981,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:5532,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:51135,hsa:7372,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:10720,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5733,cpd:C00076,no_relation,no_relation,no_relation,no_relation,0.0
hsa:222,hsa:18,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:153,hsa:2771,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1562,hsa:2947,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:94235,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:119391,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2773,hsa:5291,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1565,hsa:4129,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:108,hsa:5899,no_relation,no_relation,no_relation,no_relation,0.0
hsa:259307,path:hsa00130,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:6885,hsa:5609,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:6777,hsa:8835,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:6777,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:100526794,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5604,hsa:5594,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:54600,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:50484,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2806,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2475,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:818,hsa:2308,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:54658,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:30814,hsa:7189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1003,hsa:1003,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:219,hsa:54498,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1576,hsa:2940,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:801,hsa:816,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:4594,path:hsa00020,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
cpd:C21014,hsa:177,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5566,hsa:2998,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:115004,cpd:C20640,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:207,hsa:8517,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:1559,hsa:2946,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:4833,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3443,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:4832,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:353376,hsa:148022,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:4792,hsa:4615,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:5894,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
path:map00960,path:hsa00360,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:5608,hsa:80326,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:2947,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1432,hsa:5601,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
cpd:C00076,hsa:5533,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2785,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4258,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10552,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:5295,hsa:597,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:223,hsa:130,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1555,hsa:1559,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2939,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:805,hsa:1258,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
hsa:53632,hsa:1491,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8772,hsa:841,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:10449,path:hsa00640,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:7365,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:314,hsa:219,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:823,hsa:3552,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:151531,hsa:1806,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:10000,hsa:113,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:10390,hsa:10891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54511,hsa:3032,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5290,cpd:C05981,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5606,hsa:5603,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:7298,hsa:30833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:2792,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:55748,hsa:56953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84693,hsa:5096,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:84618,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1559,hsa:2329,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2770,hsa:109,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5330,hsa:5578,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1956,hsa:5291,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2782,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6776,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5599,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:52,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:107,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2571,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1553,hsa:7365,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:85465,hsa:2913,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1960,hsa:356,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:1892,hsa:26275,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:3105,hsa:567,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:9475,hsa:1610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5601,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:10365,hsa:4790,PPrel,binding/association,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:23659,hsa:5467,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:374,hsa:1956,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2034,hsa:6513,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:54576,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1548,hsa:54490,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:107987479,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:56953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5601,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2932,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:339896,hsa:146,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2768,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:108,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:1111,hsa:7473,no_relation,no_relation,no_relation,no_relation,0.0
hsa:957,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:7365,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9370,hsa:51094,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1956,hsa:316,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,cpd:C00076,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5321,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2805,path:map00960,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:2952,hsa:7188,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:5530,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5894,hsa:5925,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2329,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5296,cpd:C05981,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2792,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1385,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5732,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5091,path:hsa00020,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4129,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:4137,hsa:4710,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5571,hsa:2308,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5337,hsa:5322,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4190,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:108,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4773,hsa:7124,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:84693,hsa:7412,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7157,hsa:10912,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2791,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5320,hsa:1500,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:92483,hsa:2787,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:2786,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3815,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:488,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:7378,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5320,hsa:4259,no_relation,no_relation,no_relation,no_relation,0.0
hsa:408,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:955,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:810,hsa:5532,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4907,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10672,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1892,hsa:34,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",3,0.5
path:hsa00640,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:998,hsa:1647,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:4137,hsa:4702,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:391013,hsa:219,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:8503,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:2571,hsa:57571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,3,0.5
hsa:154,hsa:2773,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:408,hsa:5894,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5608,hsa:6300,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:10298,hsa:3985,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:5605,hsa:5594,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:163688,hsa:5153,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:5595,hsa:2002,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:4088,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:50487,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3265,hsa:5290,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:652,hsa:4725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5603,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2731,hsa:10993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,path:hsa00130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:111,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2771,hsa:107,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:57506,hsa:7186,PPrel,binding/association,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:1943,hsa:1969,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2947,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:51380,path:hsa00250,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2778,hsa:115,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:51764,hsa:4696,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5062,hsa:8440,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:5566,hsa:10488,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4190,path:hsa00620,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,2,0.5
hsa:2534,hsa:3611,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6667,hsa:5741,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:84699,hsa:160287,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3030,hsa:1036,no_relation,no_relation,no_relation,no_relation,0.0
hsa:652,hsa:659,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:54490,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:9368,hsa:7430,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:51806,hsa:5530,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4776,hsa:7124,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:2805,path:hsa00350,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:5595,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3157,hsa:5608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00780,hsa:5579,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:107,cpd:C00575,PCrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
path:hsa00770,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:5290,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5568,hsa:1385,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:94235,hsa:4329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:3710,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:4907,path:map00940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1553,hsa:54659,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:801,hsa:5530,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:805,hsa:1500,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1869,hsa:331,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:941,hsa:374875,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:1385,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:4780,hsa:2949,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:124583,hsa:93034,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:221,hsa:8639,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:9475,hsa:377841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:84699,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1788,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:55102,hsa:55062,PPrel,binding/association,path:hsa05010 Alzheimer disease,1,0.5
hsa:2944,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
cpd:C01996,hsa:1136,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:84532,hsa:32,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4780,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3091,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:7280,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5291,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:347733,hsa:9181,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:8639,path:hsa00620,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:4137,hsa:4700,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:4773,hsa:3576,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:57180,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:2746,path:hsa00250,maplink,compound,path:hsa00910 Nitrogen metabolism,1,0.5
hsa:79888,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:103910,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3441,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
cpd:C00584,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:1728,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:54205,hsa:842,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2784,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5595,hsa:8651,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:8503,cpd:C05981,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3845,hsa:137362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10941,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:8936,hsa:10096,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:6794,hsa:7480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:3032,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,hsa:240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:6300,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:1386,hsa:1026,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:5894,hsa:5605,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3665,hsa:135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5925,hsa:3661,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:673,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:4790,hsa:3592,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:5330,cpd:C01245,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:2950,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:6387,hsa:7852,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,1,0.5
hsa:79888,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5747,hsa:1630,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:10000,hsa:2932,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,1,0.8
hsa:207,hsa:2475,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:115004,cpd:C20640,PCrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:3661,hsa:5091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6237,cpd:C16844,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2353,hsa:4318,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:6240,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C21011,hsa:177,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00533,hsa:4087,PCrel,inhibition,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:196883,hsa:5566,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:727,hsa:728,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5933,hsa:1871,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:51806,hsa:5535,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5602,hsa:3725,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
cpd:C00533,hsa:27330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:160287,hsa:5162,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2948,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:208,hsa:7046,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6898,path:hsa00350,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:4233,hsa:1499,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:218,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1737,hsa:5162,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:107987478,hsa:7363,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5881,hsa:5601,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5568,hsa:90993,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5608,hsa:5603,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3661,hsa:3447,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5338,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:207,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:5338,hsa:151056,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2944,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4893,hsa:5296,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
path:hsa00260,hsa:7084,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,hsa:5096,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5745,hsa:2768,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:9446,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5970,hsa:3569,GErel,expression,path:hsa05163 Human cytomegalovirus infection,2,0.5
cpd:C00942,hsa:5592,PCrel,activation,path:hsa04740 Olfactory transduction,2,0.8
hsa:5063,hsa:3984,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:6885,hsa:3551,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5053,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:1432,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:488,hsa:818,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:2792,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:10365,hsa:2950,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5595,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:6885,hsa:5604,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5533,hsa:4776,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3447,hsa:3454,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2773,hsa:2792,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:189,path:hsa00600,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",3,0.5
hsa:107987478,hsa:4129,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:1432,hsa:221357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6237,hsa:83593,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5568,hsa:5315,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:377841,hsa:4907,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
cpd:C00942,hsa:5593,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:801,hsa:816,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:3665,hsa:3447,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:594,hsa:1738,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5608,hsa:5603,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2885,hsa:6655,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:8471,hsa:5296,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5566,hsa:10488,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:208,hsa:1147,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2770,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:64805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5241,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3265,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2885,hsa:6655,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:883,hsa:2805,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2770,hsa:5599,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:4790,hsa:7124,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:3845,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1962,hsa:51,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5606,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5137,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:1557,hsa:5732,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5562,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:10390,hsa:5322,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:8440,hsa:5747,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:4217,hsa:10803,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:90993,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1564,hsa:54578,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:6885,hsa:6416,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:107,hsa:5567,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:10488,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00250,hsa:2034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:5599,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:2773,hsa:107,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:54575,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:25945,hsa:5818,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:5338,hsa:81579,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
path:map00940,path:hsa00360,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:5970,hsa:595,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:5568,hsa:4205,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:956,hsa:22978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5567,hsa:2997,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:10000,hsa:2099,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1565,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:9368,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3661,hsa:2889,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:3265,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:9138,hsa:387,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:2778,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100506013,hsa:187,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5970,hsa:7124,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5331,cpd:C01245,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5595,hsa:2113,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:83439,hsa:595,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:55902,hsa:38,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4357,hsa:3939,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5568,hsa:3441,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:2791,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5338,hsa:255189,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00334,hsa:2567,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:224,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2949,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5063,hsa:3985,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:51176,hsa:81,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:10488,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:51727,hsa:22978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
path:hsa00250,hsa:3945,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3458,hsa:3460,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:54583,hsa:2034,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:218,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:3274,no_relation,no_relation,no_relation,no_relation,0.0
hsa:972,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2309,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2793,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:5566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:6775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10163,hsa:10097,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:10163,hsa:79602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:955,hsa:93034,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6416,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:329,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:5747,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1646,hsa:7367,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:7222,hsa:659,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:207,hsa:4846,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2309,hsa:4088,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:1457,hsa:1499,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:2786,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5608,hsa:54490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5530,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00025,hsa:116444,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:8976,hsa:10094,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:5332,hsa:3710,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:2770,hsa:5595,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:1543,hsa:1545,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:10365,hsa:2948,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2778,hsa:114,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5734,hsa:2793,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5605,hsa:7132,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2309,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
cpd:C00665,hsa:5214,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5315,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,path:hsa00640,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5534,hsa:4773,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:6464,hsa:3440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:125061,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5818,hsa:25945,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:5578,hsa:9368,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:160287,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1892,hsa:51,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:4329,hsa:18,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:221,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1548,hsa:574537,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5335,cpd:C01245,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:3710,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:955,hsa:83549,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
cpd:C00575,hsa:5322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:5603,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:1499,hsa:4609,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:810,hsa:189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1562,hsa:2948,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:4193,hsa:7157,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:2790,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3446,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5606,hsa:5603,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:8936,hsa:10092,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5602,hsa:2353,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:593,hsa:586,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:2941,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
cpd:C00518,hsa:6385,PCrel,binding/association,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:57521,hsa:6198,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5290,hsa:208,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:39,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:1543,hsa:2997,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2556,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5315,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4772,hsa:3576,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:6237,hsa:8503,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:64902,path:hsa00260,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:7976,hsa:197322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:654364,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:377841,hsa:124583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5330,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5169,hsa:2786,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84532,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5534,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
cpd:C00547,hsa:152,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:805,hsa:5532,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:83593,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8795,hsa:8772,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5606,hsa:5602,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:50,hsa:1431,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:7976,cpd:C00076,PCrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5880,hsa:8826,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
path:hsa00900,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:26279,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00925,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22808,hsa:5894,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:586,hsa:2730,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5105,hsa:54490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:8503,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5608,hsa:6300,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5566,hsa:3441,no_relation,no_relation,no_relation,no_relation,0.0
hsa:154,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3456,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2983,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:3725,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:8772,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29110,hsa:3661,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4832,hsa:955,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:4137,hsa:4723,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:38,hsa:6240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1892,hsa:2792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:1559,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8976,hsa:10092,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:27306,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:814,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10720,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1496,hsa:7082,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:5330,cpd:C00165,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5566,hsa:84699,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3661,hsa:3440,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5566,hsa:90993,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5566,hsa:1385,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5600,hsa:1385,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C13856,hsa:1268,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5566,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51135,hsa:7189,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:883,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5175,hsa:5777,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:3667,hsa:5290,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1432,hsa:7157,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4790,hsa:56288,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5602,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5565,hsa:57521,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3661,hsa:377841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79888,hsa:3451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1496,hsa:81,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:5567,hsa:148327,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2783,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:8440,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:54600,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6885,hsa:5603,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:2475,hsa:1978,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1388,hsa:596,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:8471,hsa:5293,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:810,hsa:5535,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:65985,hsa:54511,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5568,hsa:2998,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:4790,hsa:6347,GErel,expression,path:hsa05163 Human cytomegalovirus infection,2,0.5
hsa:1956,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:955,hsa:284958,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5894,hsa:5604,PPrel,activation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:2946,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:39,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6608,hsa:6714,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:60,hsa:7414,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
path:hsa00250,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5732,hsa:2787,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:54576,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:53632,hsa:2308,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:8503,hsa:2952,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1386,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5582,hsa:2185,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5595,hsa:3725,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:2791,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5169,hsa:318,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:653857,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:4209,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:6416,hsa:5602,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:4214,hsa:5609,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5062,hsa:3985,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:207,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,cpd:C00575,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5880,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
path:map00940,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:8517,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2775,hsa:2786,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:2773,hsa:5599,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:6300,hsa:2353,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:10746,hsa:125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1907,hsa:1909,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4214,hsa:5602,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:10993,path:hsa00620,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:10941,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1388,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:1548,hsa:7366,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:2064,hsa:1500,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:5534,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1386,hsa:7424,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:8976,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:637,hsa:10097,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:347733,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2778,hsa:196883,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5320,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6483,hsa:3446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23411,hsa:581,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3290,hsa:54490,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6093,hsa:103910,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:5608,hsa:6300,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:3290,hsa:79799,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
cpd:C00083,hsa:1374,PCrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5970,hsa:3593,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:2099,hsa:2254,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
cpd:C00025,hsa:2893,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:27244,hsa:5564,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:94235,hsa:8503,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:122618,hsa:54578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4792,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,2,0.8
hsa:2932,hsa:3831,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:51727,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6416,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4128,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27306,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3157,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:339896,path:map00460,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2790,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:31,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2932,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:8976,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2147,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:5894,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5291,hsa:10000,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C05981,hsa:207,PCrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5819,hsa:25945,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:5733,hsa:7365,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27244,hsa:5565,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3265,hsa:5293,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5534,hsa:6241,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3265,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:978,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54575,hsa:957,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2534,hsa:1499,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:2773,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9217,hsa:22926,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:5567,hsa:779,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:373156,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:27121,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:57521,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4329,hsa:2788,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2147,hsa:56288,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2782,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,path:hsa00250,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5296,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5879,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:117,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:4259,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1646,hsa:54658,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5595,hsa:6300,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:3290,hsa:54577,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5731,hsa:2782,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3661,hsa:3449,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:2773,hsa:5603,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:4628,hsa:71,PPrel,binding/association,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:148327,hsa:1026,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:5566,hsa:90993,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5601,hsa:3725,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5106,path:hsa00020,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1432,hsa:119391,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:5290,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:10941,hsa:275,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:5578,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:3728,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:6778,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2941,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2793,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:957,hsa:83549,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:387,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:85464,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:7298,hsa:93034,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5734,hsa:10681,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5062,hsa:3985,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:1576,hsa:2949,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:36,hsa:3030,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:8743,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10810,hsa:1870,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:106821730,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1139,hsa:262,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:108,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5579,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79671,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5734,hsa:55970,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:111,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5106,hsa:5315,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:3554,hsa:4217,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5600,hsa:5162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:317,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3725,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:998,hsa:8826,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:90993,hsa:151056,no_relation,no_relation,no_relation,no_relation,0.0
hsa:38,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C16844,hsa:5606,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5594,hsa:148327,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5603,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:3375,hsa:10203,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3667,hsa:5290,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:7263,hsa:5091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:2783,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:5594,hsa:1388,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5595,hsa:3725,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:6416,hsa:5603,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:10095,hsa:60,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:26084,hsa:391,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:107987479,hsa:23365,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5530,hsa:4775,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:4790,hsa:3456,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:2771,hsa:5602,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:283748,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5568,hsa:51727,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:38,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7363,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:207,hsa:51,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,hsa:5295,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:107987479,hsa:4129,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:6416,hsa:1030,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2773,hsa:4325,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
cpd:C00518,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:114,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:91860,hsa:1258,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
cpd:C00122,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:107,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
path:map00460,hsa:189,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:2773,hsa:5925,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:6472,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:2775,hsa:51764,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:122618,hsa:3118,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2949,hsa:6241,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3446,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:2885,hsa:6655,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:1491,path:hsa00270,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:805,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7048,hsa:4087,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5606,hsa:1432,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4217,hsa:5608,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:644150,hsa:8976,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:3553,hsa:259307,no_relation,no_relation,no_relation,no_relation,0.0
path:map01056,path:hsa00020,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:1398,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6237,path:hsa00230,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:10000,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:2940,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1869,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:4257,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:10390,hsa:8611,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6772,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:10449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:54979,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:956,hsa:2793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:3939,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5566,hsa:64764,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10298,hsa:3984,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2787,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:55970,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1646,hsa:7364,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5295,hsa:10000,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:817,hsa:109,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
hsa:5567,hsa:64764,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:27072,hsa:54498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:71,path:hsa00630,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2212,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:10941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5337,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29119,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5564,hsa:31,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:501,hsa:130,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2938,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:4357,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5608,hsa:1432,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:10552,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5899,hsa:387,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2940,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:586,path:hsa00290,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:1543,hsa:4258,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:4833,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7366,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6416,hsa:5599,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4790,path:map01056,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:10000,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:108,cpd:C00575,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:8743,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:109,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4214,hsa:5608,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:377841,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5894,hsa:5604,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:65985,hsa:39,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:29922,hsa:9583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5608,hsa:259307,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3449,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:208,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:5595,hsa:2099,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5606,hsa:5602,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2778,hsa:114,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
cpd:C00665,path:hsa00130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2953,hsa:2277,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:2948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2939,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4832,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:6714,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:594,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2769,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2308,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:972,hsa:3113,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:3157,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5295,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:654364,hsa:7371,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:6752,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4217,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5534,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3440,hsa:3455,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2787,hsa:5291,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5567,hsa:148327,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5568,hsa:3709,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2770,hsa:998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5602,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5465,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:1496,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1549,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8639,hsa:54498,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:4831,hsa:377841,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:2983,hsa:1806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
path:hsa00640,cpd:C00533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:4257,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:6752,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:64764,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2572,hsa:9138,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:84335,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5533,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112817,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5106,path:hsa00010,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:219,hsa:130,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:222,hsa:339896,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2017,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4190,hsa:5153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:56994,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1495,hsa:5211,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:5290,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5562,hsa:2308,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:107987478,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3708,hsa:805,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5595,hsa:9021,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:85465,hsa:5819,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,hsa:5609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51380,hsa:55748,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:93034,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:10000,hsa:114,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5578,hsa:5894,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5332,cpd:C01245,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:7365,hsa:54490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4257,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:34,hsa:1629,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:84335,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:57506,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:957,hsa:30833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2791,hsa:151056,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:3709,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:10365,hsa:9170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5465,hsa:5608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5566,hsa:5563,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5567,hsa:5207,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5608,hsa:5603,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3845,hsa:5295,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:155,hsa:5829,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:5019,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:808,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00334,hsa:2561,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5606,hsa:5599,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5604,hsa:5595,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5290,hsa:10000,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5601,hsa:8660,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:6093,hsa:151531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8976,hsa:10109,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:653689,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:51727,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1540,hsa:3449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:1432,PPrel,activation,path:hsa05133 Pertussis,1,0.8
cpd:C00925,hsa:6383,PCrel,binding/association,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5568,hsa:90993,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:284958,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:7879,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00600,path:map00680,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:339896,hsa:223,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1499,hsa:998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:54579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:873,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:3815,hsa:6774,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2778,hsa:109,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
cpd:C00547,hsa:150,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:727,hsa:2100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5340,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:3718,hsa:7365,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6470,hsa:1136,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1553,hsa:3290,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:369,hsa:5604,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
cpd:C00681,hsa:9170,PCrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:8826,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:2353,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:842,hsa:840,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
cpd:C00584,hsa:5732,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:163688,hsa:1258,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
hsa:4357,hsa:1871,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3443,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:1956,hsa:5293,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:3718,hsa:87,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2950,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:217,hsa:131,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C00076,hsa:815,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1557,hsa:373156,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1849,hsa:318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1496,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1565,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54434,hsa:7478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3265,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:407021,hsa:9314,PPrel,inhibition,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:6300,hsa:3725,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5337,hsa:7365,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4775,hsa:7124,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:22808,cpd:C00027,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5663,hsa:2932,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00076,hsa:810,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:6237,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:823,hsa:8851,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5894,hsa:5604,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:818,hsa:2952,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2475,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2771,hsa:111,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:5566,hsa:5571,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:10681,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:207,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:6898,path:map00940,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",2,0.5
hsa:100526794,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:487,hsa:817,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:2769,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2788,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5330,cpd:C00165,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:811,hsa:4035,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:2773,hsa:2790,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:108,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:7472,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5313,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5602,hsa:3725,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5590,hsa:224,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:5599,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:54658,hsa:593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5601,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
cpd:C00780,hsa:3354,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
path:hsa00640,hsa:223,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:10488,hsa:81873,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:4776,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
cpd:C00584,hsa:5732,PCrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:3155,hsa:6472,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5731,hsa:2787,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:9365,hsa:3480,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4893,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1577,hsa:1557,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1956,hsa:5290,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
cpd:C00410,hsa:3440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3309,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4772,hsa:5743,GErel,expression,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:64902,hsa:223,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5562,hsa:1629,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:7297,hsa:6776,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:356,hsa:355,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:115,hsa:2937,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3725,hsa:6401,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:3157,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4257,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5296,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:2944,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:8976,hsa:10097,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:2771,hsa:114,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:6416,hsa:6300,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1557,hsa:4128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5602,hsa:2151,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5818,hsa:56288,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5169,hsa:56953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5595,hsa:2034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:51384,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5605,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:93034,hsa:1854,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1557,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54490,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:114,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
path:hsa00900,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55902,hsa:84532,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4214,hsa:5606,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:132158,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:5894,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3665,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9564,hsa:1398,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:57521,hsa:10095,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3709,hsa:51806,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:1892,hsa:8310,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:942,hsa:81579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5734,hsa:2773,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:51422,hsa:2475,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3945,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:84335,hsa:1978,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:23646,hsa:8399,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:574537,hsa:27006,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,hsa:3709,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:487,hsa:815,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:7186,path:hsa00260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:5934,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:673,hsa:3030,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2948,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:54490,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:718,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987479,hsa:54578,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:2770,hsa:196883,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
cpd:C00003,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5899,hsa:5880,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5106,hsa:4190,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5291,hsa:10000,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:6300,hsa:5601,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:468,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3439,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:5331,hsa:5579,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:6654,hsa:3845,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:6472,hsa:63826,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:3265,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:197322,hsa:224,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:4128,path:hsa00620,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:574537,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4257,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4594,hsa:7366,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:90993,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2773,hsa:8612,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05210 Colorectal cancer,2,0.8
hsa:5733,hsa:10720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:2793,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2773,hsa:113,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C02165,hsa:56413,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:113,cpd:C00575,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5295,hsa:2309,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:5175,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7473,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5568,hsa:468,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:7297,hsa:6773,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2769,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5337,hsa:151056,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5605,hsa:5579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:1499,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:107,cpd:C00575,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1548,hsa:7365,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5295,hsa:2277,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1555,hsa:1549,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1806,hsa:130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:2353,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:5879,hsa:10163,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:4257,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5868,hsa:57617,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:3685,hsa:4790,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:219,hsa:956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:5292,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:6472,hsa:275,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:10673,hsa:23495,PPrel,binding/association,path:hsa04672 Intestinal immune network for IgA production,3,0.5
hsa:2932,hsa:5605,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:10365,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:957,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56953,hsa:10627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:1129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:71,hsa:7082,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:63826,path:map00680,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5609,hsa:5603,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5332,cpd:C01245,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5579,hsa:779,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2770,hsa:113,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5175,hsa:54947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:6300,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:51380,hsa:6009,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5534,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2950,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5599,hsa:6714,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:84532,hsa:1431,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:224,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:2100,hsa:8823,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:956,hsa:406884,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1910,hsa:10720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2731,hsa:1543,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3939,path:hsa00230,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3709,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7366,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:2786,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:10941,hsa:3805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:369,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:10449,hsa:5095,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:55970,hsa:1230,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,path:map00950,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:5745,hsa:408,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5566,hsa:89780,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6775,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:1386,hsa:377841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:5894,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2885,hsa:6654,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00025,hsa:2902,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1564,hsa:5571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:489,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:5566,hsa:5062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:10000,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:8660,hsa:8503,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:128,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4357,hsa:1491,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:6714,hsa:4707,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283748,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6772,hsa:3726,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:4217,hsa:6416,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,2,0.8
hsa:7132,hsa:4217,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:91860,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:316,hsa:18,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2147,hsa:1902,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:259307,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:90993,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
path:map00680,path:hsa00630,maplink,compound,path:hsa00910 Nitrogen metabolism,1,0.5
cpd:C00076,hsa:51806,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1738,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:779,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2322,hsa:2885,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
cpd:C00681,hsa:9170,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1392,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51,path:hsa00640,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:10746,hsa:5606,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:51806,hsa:816,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:81873,hsa:71,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:122618,hsa:50487,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:4137,hsa:4539,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5970,hsa:5743,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:3661,hsa:38,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8826,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1386,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:10758,hsa:5970,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2475,hsa:6199,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1565,hsa:54577,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
cpd:C00704,hsa:4790,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4257,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:10000,hsa:2308,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:151531,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5571,cpd:C00003,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
path:map01056,hsa:30,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:314,hsa:223,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5568,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:4636,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:26007,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6772,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:51733,path:hsa00280,maplink,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5745,hsa:10672,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:113675,path:hsa00620,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:1500,hsa:5881,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:56994,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3265,hsa:369,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
cpd:C00334,hsa:2568,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:4193,hsa:7157,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1036,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1564,hsa:4129,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:5566,hsa:10488,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:4137,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3576,GErel,expression,path:hsa05163 Human cytomegalovirus infection,2,0.5
hsa:5530,hsa:4773,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5603,hsa:90993,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:983,hsa:891,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:9915,hsa:3091,PPrel,binding/association,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:2932,hsa:3685,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:5293,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6470,path:map00680,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:23411,hsa:4790,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2099,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:7378,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3444,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:956,hsa:81,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:2534,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5914,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5295,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5879,hsa:5058,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:1978,hsa:1977,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1549,hsa:7363,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:1548,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:8399,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:94235,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5567,hsa:148327,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00533,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4536,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:8976,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:4773,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:6093,hsa:3945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1788,hsa:217,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:4089,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:81579,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:84647,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1495,hsa:7082,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:1111,hsa:993,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:2770,hsa:7084,no_relation,no_relation,no_relation,no_relation,0.0
hsa:93034,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5566,hsa:64764,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:4773,path:hsa00760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:59345,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C00027,hsa:5606,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:387,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2914,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5535,hsa:4773,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:221357,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:208,hsa:3551,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:2786,hsa:10105,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:5169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:100526794,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00250,hsa:5162,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:221,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:207,hsa:1147,PPrel,phosphorylation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:54331,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:1545,hsa:373156,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:208,hsa:2309,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:5601,hsa:5601,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:7043,hsa:7048,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5331,cpd:C01245,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
cpd:C00076,hsa:4842,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1385,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:8471,hsa:8503,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:6416,path:map00680,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57506,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30,hsa:3451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:111,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
cpd:C00533,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:998,hsa:6347,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:84699,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:59345,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5533,hsa:4773,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:3718,hsa:6775,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:7378,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:4128,hsa:1557,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2792,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:7298,hsa:51020,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:1543,hsa:2948,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5095,hsa:240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6472,hsa:2628,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:377841,path:hsa00130,no_relation,no_relation,no_relation,no_relation,0.0
hsa:846,hsa:2787,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:2248,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:112,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2771,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:1869,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:2783,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5567,hsa:5153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:5331,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5535,hsa:572,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:163688,hsa:113675,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:4893,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
cpd:C05981,hsa:207,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5533,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124583,hsa:56953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
path:hsa00240,hsa:197322,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:683,hsa:7479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:3265,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:1543,hsa:373156,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:3030,hsa:36,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5290,hsa:3674,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3661,hsa:3444,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:810,hsa:817,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5371,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29922,hsa:3158,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5565,hsa:31,PPrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:218,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:1854,hsa:7298,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1565,hsa:7366,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5535,hsa:1814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7124,hsa:7132,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:54947,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:6885,hsa:5605,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5608,hsa:5599,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5734,hsa:2778,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5734,hsa:2783,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:208,hsa:2099,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:154,hsa:2771,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2571,hsa:501,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
cpd:C05981,hsa:208,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6885,hsa:5600,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:4907,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:6611,hsa:144811,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:10092,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:29922,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:10645,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3446,hsa:54577,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C04549,hsa:7083,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:1499,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:1557,hsa:653689,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3984,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:113,hsa:6197,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4259,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5609,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4193,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:7378,no_relation,no_relation,no_relation,no_relation,0.0
hsa:408,hsa:369,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5599,hsa:9252,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8398,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10000,hsa:8517,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5095,hsa:189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:3690,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:9446,hsa:5571,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00745,hsa:1143,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:808,hsa:5153,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:10645,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:468,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:9583,hsa:948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:114,hsa:5568,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:810,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10449,hsa:10993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:7297,hsa:1514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5599,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2950,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2767,hsa:5330,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
path:map00680,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3709,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",2,0.8
hsa:5732,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:84699,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:107,hsa:5567,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:51806,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:3551,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:7186,hsa:4217,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:2778,hsa:114,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:107987478,hsa:5468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5535,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:7456,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:5603,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:2475,hsa:6199,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:27123,hsa:7478,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:7189,hsa:5970,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:957,hsa:56953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2475,hsa:7157,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5879,hsa:8826,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:23236,hsa:5579,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5566,hsa:8976,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:5599,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5291,hsa:10000,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5534,hsa:54434,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:8936,hsa:2792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5797,hsa:2326,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3725,hsa:3458,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:1558,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:79799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:4129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:5295,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:1557,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29119,hsa:87,PPrel,binding/association,path:hsa04520 Adherens junction,2,0.5
hsa:51806,hsa:5534,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:10201,hsa:9583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:122618,hsa:26279,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:55902,hsa:31,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1386,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:85465,hsa:84647,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5881,hsa:5063,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:5881,hsa:5062,PPrel,activation,path:hsa04360 Axon guidance,4,0.8
hsa:5566,hsa:9586,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:1549,hsa:1548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4257,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2792,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5578,hsa:5894,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5169,hsa:30833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5731,hsa:2778,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2938,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1564,hsa:4128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:406933,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:27306,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:27121,hsa:89780,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2771,hsa:109,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:218,hsa:2571,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:189,hsa:10993,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",4,0.5
hsa:6093,hsa:10627,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5567,hsa:1385,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:6794,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:4205,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2770,hsa:107,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:2769,hsa:93408,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:93034,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5530,hsa:54961,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:57506,hsa:7189,PPrel,binding/association,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:54600,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2778,hsa:25945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7157,hsa:27244,GErel,expression,path:hsa04211 Longevity regulating pathway,1,0.5
hsa:55902,hsa:39,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:5781,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7414,hsa:7473,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2891,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:824,hsa:3552,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:9586,hsa:7364,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5741,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:5602,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:218,hsa:790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4214,hsa:5970,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:8503,hsa:10000,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:126,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:972,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2785,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:8835,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:9475,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:953,hsa:50484,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5291,hsa:208,PPrel,compound,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:5600,path:hsa00410,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:27330,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:1132,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3728,hsa:5609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:5137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2033,hsa:3091,PPrel,binding/association,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:1111,hsa:7157,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:10000,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:221357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6778,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:4780,hsa:2939,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2549,hsa:1399,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5605,hsa:5023,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:94235,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5319,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5481,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:189,hsa:275,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:5532,hsa:80326,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51727,hsa:6241,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1562,hsa:221357,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5338,hsa:1557,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:5154,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:4830,hsa:955,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:107987478,hsa:54579,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:3988,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7298,hsa:5566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6898,path:map00950,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:805,hsa:54577,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,hsa:1029,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5330,cpd:C01245,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
cpd:C00533,hsa:5160,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:10941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8772,hsa:841,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:6655,hsa:3265,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:5330,hsa:3710,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5567,hsa:5207,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
cpd:C00410,hsa:5241,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,2,0.8
hsa:8471,hsa:2946,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:54947,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:4129,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4780,hsa:5327,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:10365,hsa:2953,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:8826,hsa:71,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:51727,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:10000,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2776,hsa:23236,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:108,hsa:1647,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:3845,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:7040,hsa:7046,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:8503,hsa:208,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5567,hsa:468,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:259307,path:map00940,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",2,0.5
hsa:27102,hsa:1965,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5602,hsa:2353,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:6654,hsa:955,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7473,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:5601,hsa:8471,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6772,hsa:4938,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:10163,hsa:10095,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:262,hsa:6611,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:4137,hsa:7280,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:30814,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:8503,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:1559,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:100526794,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5606,hsa:217,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:5599,hsa:31,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:64764,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5293,hsa:2309,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:23646,hsa:5322,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5296,hsa:6472,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3552,hsa:4790,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5605,hsa:5595,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5568,hsa:90993,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3667,hsa:5291,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5609,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5868,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:107,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C01245,hsa:3709,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:22943,hsa:7480,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00076,hsa:1514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,hsa:3710,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:1956,hsa:284958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:32,path:hsa00640,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C00547,hsa:155,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:4137,hsa:5582,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2939,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00681,hsa:2846,PCrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:1844,hsa:5595,PPrel,inhibition,path:hsa04148 Efferocytosis,1,0.8
hsa:39,hsa:54511,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:2790,hsa:23236,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2767,hsa:5332,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5594,hsa:3726,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:1843,hsa:5602,PPrel,inhibition,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
path:hsa00330,hsa:54498,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:4790,hsa:7423,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:810,hsa:818,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:8503,hsa:3984,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:57180,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:2785,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,4,0.5
hsa:1557,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2475,hsa:1978,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:221264,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:998,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5732,hsa:94235,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:32,path:hsa00061,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5567,hsa:90993,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:92483,hsa:5160,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2322,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10810,hsa:81873,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
cpd:C00547,hsa:153,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:223,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:5734,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:10390,hsa:81579,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:10681,cpd:C00533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5106,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2948,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2626,hsa:3552,GErel,expression,path:hsa04218 Cellular senescence,1,0.5
hsa:1557,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5295,hsa:6197,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2953,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3665,hsa:3441,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:5879,hsa:56924,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:6093,hsa:4633,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
cpd:C00003,hsa:23411,PCrel,activation,path:hsa04148 Efferocytosis,1,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:3939,hsa:5161,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:6773,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5894,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:207,hsa:3551,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:91860,hsa:5535,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:39,hsa:1737,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5970,hsa:8835,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2941,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4313,hsa:1906,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00083,hsa:126129,PCrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2949,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:596,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:2805,hsa:5563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5169,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:5604,hsa:5603,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:208,hsa:572,PPrel,inhibition,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1432,hsa:2353,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1965,hsa:2785,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51380,hsa:501,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5599,hsa:2052,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:2353,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5608,hsa:6300,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:1491,hsa:64902,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5600,hsa:5140,no_relation,no_relation,no_relation,no_relation,0.0
hsa:222,hsa:131,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:113,hsa:5566,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:5567,hsa:4792,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:340061,hsa:29110,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:57571,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,5,0.5
hsa:122618,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1565,hsa:7364,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5566,hsa:10488,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2783,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
cpd:C01245,hsa:3709,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:208,hsa:572,PPrel,inhibition,path:hsa05161 Hepatitis B,1,0.8
hsa:5291,hsa:207,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:9586,hsa:2353,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:2773,hsa:5602,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:208,hsa:2475,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2790,hsa:55748,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:155,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5481,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1387,hsa:2034,PPrel,binding/association,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:1555,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,hsa:567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:545,hsa:1111,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:2475,hsa:6198,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5532,hsa:4775,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:22800,hsa:5296,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5371,hsa:890,GErel,expression,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:3845,hsa:124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:3945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:9134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:841,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:54361,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:54963,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:3845,hsa:7132,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27306,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:64764,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:391013,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:39,hsa:3158,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:7364,hsa:886,no_relation,no_relation,no_relation,no_relation,0.0
hsa:131,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:776,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:51727,hsa:956,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3716,hsa:6774,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:2308,hsa:847,GErel,expression,path:hsa04211 Longevity regulating pathway,1,0.5
hsa:1564,hsa:1557,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5175,hsa:8503,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:54600,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:222,hsa:4724,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5295,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:5095,path:hsa00640,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:38,hsa:3158,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:805,hsa:818,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:956,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54576,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2932,hsa:1499,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:652,hsa:92,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5322,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2940,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:189,hsa:2628,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:107987478,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:4988,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:9370,hsa:79602,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:54205,hsa:842,PPrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:387,hsa:6093,PPrel,activation,path:hsa04360 Axon guidance,3,0.8
hsa:4609,hsa:595,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:1443,hsa:2690,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10365,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4831,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:102723407,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:153,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8743,hsa:8795,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:160287,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:790,hsa:790,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
cpd:C00334,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:84790,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:163688,hsa:817,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5571,hsa:54578,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00083,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:2329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3845,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:10390,hsa:50487,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5568,hsa:90993,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:956,hsa:953,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1545,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5024,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2747,hsa:34,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:1432,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:7186,hsa:3551,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2770,hsa:112,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:18,hsa:2572,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5568,hsa:64764,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2846,hsa:10672,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:10096,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:898,hsa:30833,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9564,hsa:1399,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:54600,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5566,hsa:148327,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:9446,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4137,hsa:56901,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:4301,hsa:71,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:387,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:22953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3133,hsa:567,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5565,hsa:653857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4190,path:hsa00630,maplink,compound,path:hsa00620 Pyruvate metabolism,2,0.5
hsa:3725,hsa:3553,GErel,expression,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:5290,hsa:27330,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2885,cpd:C00533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148022,hsa:3661,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:10000,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:183,hsa:4142,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5291,hsa:2113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5530,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5293,hsa:5170,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5567,hsa:5565,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:9021,hsa:7297,PPrel,inhibition,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:1576,hsa:2944,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:3661,hsa:3451,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:956,hsa:6240,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
cpd:C12271,hsa:7442,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1147,hsa:5063,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2149,hsa:2768,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:1565,hsa:79799,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:3845,hsa:127,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5293,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5535,hsa:4775,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:4137,hsa:4725,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:4792,hsa:59345,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:468,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5600,hsa:3725,PPrel,phosphorylation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:4832,hsa:9583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2768,hsa:2806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64902,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5601,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:27123,hsa:7479,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00076,hsa:5532,PCrel,activation,path:hsa04360 Axon guidance,2,0.8
hsa:5290,cpd:C05981,PCrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:54490,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2939,hsa:54583,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6198,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:4830,hsa:9583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:189,path:hsa00630,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:6654,hsa:35,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05161 Hepatitis B,2,0.8
hsa:6416,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4775,hsa:405,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:5579,hsa:56302,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3551,hsa:4793,PPrel,phosphorylation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:387,hsa:5601,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5313,path:hsa00760,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:1496,hsa:4301,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:207,hsa:572,PPrel,inhibition,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2787,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:1500,hsa:387,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:2549,hsa:5295,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:54434,hsa:1072,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:2770,hsa:115,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5777,hsa:7189,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5095,hsa:4329,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5293,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:2784,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:9586,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:207,hsa:84335,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:8517,hsa:8471,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:2806,path:map00940,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",2,0.5
hsa:217,hsa:127,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5601,hsa:3667,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2787,hsa:51,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2534,hsa:1020,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:2309,hsa:4087,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
path:hsa00480,hsa:1491,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
cpd:C05981,hsa:221,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:208,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:51380,hsa:51733,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:3290,hsa:7367,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5332,hsa:5578,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:2791,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6934,hsa:332,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:54600,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221264,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:6774,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:6934,hsa:4609,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:5579,hsa:256435,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987479,hsa:2746,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2147,hsa:57121,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:55748,hsa:501,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:91860,hsa:815,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
cpd:C06124,hsa:1901,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:1553,hsa:7363,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:100526794,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1559,hsa:2328,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4214,hsa:5606,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:57571,hsa:217,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:805,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7263,hsa:92483,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:7263,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5603,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:208,hsa:2475,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5566,hsa:148327,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:1956,hsa:2571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,path:map00460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:54600,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:55970,hsa:115650,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:111,PPrel,inhibition,path:hsa04926 Relaxin signaling pathway,2,0.8
hsa:5053,path:map00950,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:218,hsa:7084,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:7132,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1491,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:218,hsa:18,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:8174,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:816,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:1960,hsa:1387,PPrel,binding/association,path:hsa05161 Hepatitis B,1,0.5
hsa:4257,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10390,hsa:9181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3725,PPrel,phosphorylation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:5898,hsa:5167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:594,hsa:5140,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:112,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
path:hsa00480,hsa:883,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
cpd:C05981,hsa:10000,PCrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:7263,hsa:3945,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:317,hsa:842,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5563,hsa:31,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:1553,hsa:54600,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
cpd:C00076,hsa:91860,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
cpd:C00008,hsa:1616,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2731,hsa:5571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54434,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:207,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:1788,hsa:262,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:1558,hsa:2944,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:4049,hsa:8764,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5609,hsa:5602,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2787,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:3845,hsa:5290,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5602,hsa:5601,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:2791,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5338,hsa:391013,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:3665,hsa:3449,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:6752,path:hsa00290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22800,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:6608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64135,hsa:4713,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5162,path:hsa00290,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5568,hsa:1499,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5535,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3290,hsa:54658,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:196883,cpd:C00575,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
cpd:C00076,hsa:51806,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1565,hsa:7363,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5732,hsa:10681,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5595,path:hsa00600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10390,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2784,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:8639,hsa:223,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:8440,hsa:7456,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:3134,hsa:3805,PPrel,binding/association,path:hsa04218 Cellular senescence,1,0.5
hsa:7852,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4088,hsa:1030,GErel,expression,path:hsa04218 Cellular senescence,1,0.5
hsa:5594,hsa:10092,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:775,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:808,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:84335,PPrel,phosphorylation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2770,hsa:113,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:4087,hsa:1288,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:6093,hsa:93408,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:4128,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5608,hsa:5603,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:2778,hsa:22926,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:1969,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:3716,hsa:6772,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,2,0.8
hsa:4257,hsa:8976,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:51422,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:208,hsa:3551,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:790,path:hsa00250,maplink,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1543,hsa:2941,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:5868,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1549,hsa:54490,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:3265,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:957,hsa:1020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:2017,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:3552,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7366,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:122618,hsa:391013,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:208,hsa:8517,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:805,hsa:4842,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:4137,hsa:2846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7124,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:4773,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51727,hsa:100526794,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:2790,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4049,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6199,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:6774,hsa:8835,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:6416,hsa:5602,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:10449,hsa:3033,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:107987478,hsa:54659,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5970,cpd:C00533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7476,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
cpd:C00681,hsa:23566,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5295,hsa:10000,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5568,hsa:8717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1036,hsa:137362,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2941,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5603,hsa:3725,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:221,hsa:18,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:3988,hsa:10062,PPrel,activation,path:hsa04148 Efferocytosis,1,0.8
cpd:C01245,hsa:3708,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5970,hsa:3726,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10810,hsa:653857,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5295,hsa:10000,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4257,hsa:2783,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3708,hsa:801,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:5532,hsa:4773,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5914,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112817,path:hsa00230,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:2778,hsa:109,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:30833,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:2775,hsa:115,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:340061,hsa:29110,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:35,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:4940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:4214,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5290,hsa:10000,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:2475,hsa:653857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:1500,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:1019,hsa:896,PPrel,binding/association,path:hsa04218 Cellular senescence,3,0.5
hsa:2770,hsa:810,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1855,hsa:2932,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:356,hsa:2949,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3454,hsa:3716,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5595,hsa:2277,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:6237,hsa:7371,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2948,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:1258,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
path:hsa00230,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:356,hsa:355,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2790,hsa:1962,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:2782,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5747,hsa:9564,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:122618,hsa:84647,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5499,hsa:1965,PPrel,inhibition,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:369,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:4318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23646,hsa:30814,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
cpd:C00547,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:9586,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:972,hsa:3125,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:4780,hsa:2947,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:217,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:5734,hsa:2782,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:957,hsa:7371,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1549,hsa:9583,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4831,hsa:54600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1051,hsa:5468,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:1564,hsa:54600,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
cpd:C00704,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6470,hsa:275,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5599,hsa:3725,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:30814,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:51727,hsa:4907,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:53632,hsa:2475,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:208,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3985,hsa:1072,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:219,hsa:131,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:106821730,hsa:3985,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:5332,hsa:2250,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1431,hsa:9368,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2938,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:207,hsa:109,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2944,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:23236,cpd:C01245,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5295,hsa:27330,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:221,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3553,hsa:4843,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:9021,hsa:3716,PPrel,inhibition,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
cpd:C00076,hsa:5582,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:208,hsa:2826,no_relation,no_relation,no_relation,no_relation,0.0
hsa:594,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1457,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284958,hsa:7372,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:107987479,hsa:54490,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:51176,hsa:595,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
hsa:5296,hsa:998,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
cpd:C20640,hsa:7378,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:84735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5371,hsa:27306,no_relation,no_relation,no_relation,no_relation,0.0
hsa:217,hsa:581,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3728,hsa:83439,PPrel,binding/association,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:64902,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9446,hsa:130,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5608,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2534,hsa:501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2322,hsa:1050,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:340061,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:53632,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:1545,hsa:2938,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:374875,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:1869,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3155,hsa:3032,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5296,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5770,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:163688,PCrel,binding/association,path:hsa04740 Olfactory transduction,1,0.5
hsa:5594,hsa:5603,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1565,hsa:54579,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:189,path:map00680,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",3,0.5
path:hsa00600,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:84618,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:1543,hsa:4259,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:2773,hsa:4190,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:207,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3717,hsa:6464,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2329,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2932,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6009,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:818,PPrel,activation,path:hsa04740 Olfactory transduction,1,0.8
hsa:2770,hsa:5602,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:409,hsa:369,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:3452,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:2790,hsa:5332,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:122618,hsa:64600,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5566,hsa:9586,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5567,hsa:1388,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4217,hsa:5608,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:5595,hsa:3725,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:9844,hsa:5567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:551,hsa:552,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3665,hsa:3448,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,2,0.5
hsa:5330,hsa:3708,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:259307,path:map00950,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:873,hsa:7365,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:1562,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:4792,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:6772,hsa:81873,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,cpd:C00076,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5293,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:3728,hsa:6932,PPrel,binding/association,path:hsa05221 Acute myeloid leukemia,1,0.5
hsa:2326,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:51176,hsa:332,GErel,expression,path:hsa05210 Colorectal cancer,1,0.5
cpd:C00076,hsa:3446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:1499,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:3845,hsa:5291,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:4594,hsa:84693,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:3845,hsa:369,PPrel,activation,path:hsa05219 Bladder cancer,1,0.8
hsa:4137,hsa:653689,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:817,hsa:3805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55102,hsa:55062,PPrel,binding/association,path:hsa05014 Amyotrophic lateral sclerosis,1,0.5
hsa:5595,hsa:2099,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2328,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:9564,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:2788,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4257,hsa:7422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:151531,hsa:5315,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5533,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:2771,hsa:109,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2782,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:10163,hsa:653857,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:805,hsa:5535,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:468,hsa:8600,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:3685,hsa:6714,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5595,hsa:6300,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1386,hsa:90,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:9586,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5914,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:596,hsa:578,PPrel,inhibition,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5733,hsa:55970,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2335,hsa:3678,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:5568,hsa:1388,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3665,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:1388,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
path:hsa00020,path:hsa00620,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:3265,hsa:8398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3845,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:1843,hsa:7378,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:468,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:84532,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:137362,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:8517,PPrel,phosphorylation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
path:hsa00640,hsa:10993,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5970,hsa:3443,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:5881,hsa:1564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:9618,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:4258,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:862,hsa:1050,PPrel,inhibition,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:3988,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5169,hsa:284958,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:4893,hsa:5293,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3661,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5592,hsa:683,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:59345,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:3985,hsa:1073,PPrel,phosphorylation,path:hsa04360 Axon guidance,1,0.8
hsa:5914,hsa:890,GErel,expression,path:hsa05221 Acute myeloid leukemia,2,0.5
hsa:3265,hsa:369,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:4833,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:7422,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:3665,hsa:3444,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:1432,path:hsa00620,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5315,hsa:5160,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:10163,hsa:10093,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:6885,hsa:5606,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
cpd:C00334,hsa:2569,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:797,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:51701,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
cpd:C01996,hsa:56994,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:2099,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5733,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:3551,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:953,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
path:hsa00260,hsa:113675,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:8503,cpd:C05981,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:189,path:hsa00230,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",2,0.5
hsa:113,cpd:C00704,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7083,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:7278,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:196883,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2326,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:3448,hsa:3454,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:55970,hsa:5296,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:9475,hsa:29895,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:8471,hsa:5295,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:38,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:10683,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:4088,hsa:107987479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5604,PPrel,phosphorylation,path:hsa05219 Bladder cancer,1,0.8
hsa:5594,hsa:90993,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:85465,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:2940,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:151531,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5330,hsa:3709,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:107987478,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83549,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2534,hsa:5880,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:4833,hsa:2768,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8398,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:998,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:122618,hsa:8398,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:2770,hsa:55970,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,3,0.5
hsa:3718,hsa:6772,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5567,hsa:1388,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
cpd:C00165,hsa:5578,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5290,hsa:6196,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4831,hsa:128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5598,hsa:4780,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2949,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:57571,hsa:2572,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5921,hsa:3845,PPrel,inhibition,path:hsa04360 Axon guidance,1,0.8
hsa:5330,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:5062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6470,hsa:189,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:5290,hsa:207,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
cpd:C21011,hsa:18,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:1147,PPrel,activation,path:hsa05222 Small cell lung cancer,1,0.8
hsa:1432,hsa:2353,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
cpd:C00076,hsa:817,PCrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:10681,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5590,hsa:5598,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:1565,hsa:574537,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:137362,hsa:3945,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:355,hsa:8772,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
cpd:C00076,hsa:5293,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5567,hsa:148327,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:5594,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56953,hsa:54963,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10092,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:32,path:map01056,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4137,hsa:4712,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:223,hsa:128,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:4137,hsa:4715,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2771,hsa:115,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4259,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4790,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5562,hsa:32,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:3265,hsa:8503,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:2791,hsa:5332,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:3717,hsa:3667,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:6885,hsa:1147,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:673,hsa:92483,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5321,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:1499,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:22800,hsa:5293,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:10746,hsa:7846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:373156,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5595,hsa:1385,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:369,hsa:5605,PPrel,phosphorylation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:94235,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:5600,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:1576,hsa:1571,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:91860,hsa:5533,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:5602,hsa:3667,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:2572,hsa:224,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2950,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5293,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2948,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2792,hsa:5293,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5290,cpd:C05981,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
cpd:C00025,hsa:2892,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5970,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5533,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5605,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2953,hsa:318,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:9586,PPrel,phosphorylation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5747,hsa:3984,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,cpd:C00076,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:2185,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
cpd:C21012,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:2788,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:208,hsa:572,PPrel,inhibition,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:5732,hsa:2784,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:801,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:2353,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4830,hsa:3441,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:1432,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5970,hsa:6352,GErel,expression,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5293,hsa:2903,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10062,hsa:7040,GErel,expression,path:hsa04148 Efferocytosis,1,0.5
hsa:2786,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2572,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5105,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55626,hsa:8678,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:222,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:10672,hsa:5566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4216,hsa:5608,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:208,hsa:115,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:200186,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:4775,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:8503,hsa:208,PPrel,compound,path:hsa05222 Small cell lung cancer,1,0.5
hsa:805,hsa:223,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C04549,hsa:55062,PCrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:998,hsa:5062,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:111,hsa:5568,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:810,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5881,hsa:387,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:128,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284958,hsa:200186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:10000,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
path:map01056,hsa:54600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:7474,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1843,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5604,PPrel,activation,path:hsa05211 Renal cell carcinoma,1,0.8
hsa:2100,hsa:26281,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
hsa:5594,hsa:6300,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:5105,path:hsa00020,maplink,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C05981,hsa:208,PCrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:4893,hsa:332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57506,hsa:7187,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5167,hsa:284958,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:39,hsa:3155,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:6885,hsa:5608,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:6416,hsa:107987478,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:810,PCrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:1549,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:79861,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:6654,hsa:4893,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:374875,hsa:10720,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6300,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57144,hsa:8440,PPrel,binding/association,path:hsa04360 Axon guidance,1,0.5
hsa:1646,hsa:54600,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5291,hsa:2565,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:5095,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5578,PCrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",2,0.8
hsa:5970,hsa:4313,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2793,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:7364,hsa:107987478,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:6752,hsa:2771,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
path:hsa00480,hsa:6195,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6416,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:487,hsa:8651,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:2778,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:222,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:3693,hsa:5747,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:2322,hsa:8503,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:7850,hsa:6885,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:3665,hsa:3445,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:221357,hsa:125,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:7368,hsa:8613,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5290,cpd:C05981,PCrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5567,hsa:9586,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:2771,hsa:114,PPrel,inhibition,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:7189,hsa:5601,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5293,hsa:27330,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:816,hsa:5603,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:5566,hsa:90993,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:6416,hsa:5600,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:53632,hsa:998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:7046,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:5599,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:5567,hsa:1388,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4790,hsa:7188,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:2534,hsa:340061,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1843,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5610,hsa:8471,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:153,hsa:79799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112817,hsa:189,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:1576,hsa:1565,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,8,0.5
hsa:2949,hsa:1962,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:7482,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107987478,hsa:4128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,3,0.5
hsa:54658,hsa:7423,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:5602,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:8503,hsa:207,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2791,hsa:5330,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5567,hsa:775,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:377841,hsa:54498,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:5330,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:4907,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:189,hsa:2565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9586,hsa:2353,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:3661,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,hsa:5567,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:837,hsa:834,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:5734,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4541,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:53632,hsa:2309,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:55970,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:221264,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:3845,cpd:C16844,PCrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:7099,hsa:5595,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:4137,hsa:10381,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:957,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2982,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1962,hsa:3033,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5595,hsa:4318,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:2534,hsa:6093,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:5295,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1576,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:2113,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:4780,hsa:222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2941,hsa:218,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2773,hsa:6300,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:112,cpd:C00575,PCrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:2952,hsa:222,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:54,hsa:5169,ECrel,compound,path:hsa00740 Riboflavin metabolism,1,0.5
hsa:4831,hsa:9583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:3448,hsa:7082,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85465,hsa:5321,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:107987479,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:255189,hsa:254531,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:468,hsa:1026,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:160287,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6352,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5207,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:2770,hsa:5296,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5970,hsa:7412,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:5293,hsa:6197,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5568,hsa:90993,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2932,hsa:89953,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:4842,cpd:C00533,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:4088,hsa:1026,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:7186,hsa:10096,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9583,hsa:22978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:22808,hsa:2251,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5290,PPrel,activation,path:hsa05221 Acute myeloid leukemia,2,0.8
hsa:10449,hsa:2948,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:815,PCrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:85465,hsa:7378,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,hsa:5567,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:9181,hsa:387,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:801,hsa:5533,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:1564,hsa:7364,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:6608,hsa:10203,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7132,hsa:957,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5534,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:2783,hsa:5331,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5331,cpd:C01245,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:54331,hsa:5291,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5535,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:10094,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1548,hsa:1646,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:163688,hsa:818,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:219,hsa:84735,ECrel,compound,path:hsa00410 beta-Alanine metabolism,2,0.5
hsa:654364,hsa:9583,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:1946,hsa:5921,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:207,hsa:2099,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
cpd:C00076,hsa:5579,PCrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5781,hsa:7189,PPrel,inhibition,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:3845,path:hsa00470,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:3363,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283748,hsa:2034,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5321,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1738,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5315,hsa:6416,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:5594,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:5566,hsa:776,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:10163,hsa:10552,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,2,0.8
hsa:2778,hsa:196883,PPrel,activation,path:hsa04970 Salivary secretion,1,0.8
hsa:5601,hsa:5601,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:3091,hsa:7042,GErel,expression,path:hsa05211 Renal cell carcinoma,2,0.5
hsa:5594,hsa:2752,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2056,hsa:2057,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2790,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4830,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
cpd:C00165,hsa:3728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:3553,GErel,expression,path:hsa05130 Pathogenic Escherichia coli infection,1,0.5
hsa:1499,hsa:6934,PPrel,activation,path:hsa05210 Colorectal cancer,2,0.8
cpd:C00002,hsa:5029,PCrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:2785,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:217,hsa:26100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:52,hsa:5167,ECrel,compound,path:hsa00740 Riboflavin metabolism,1,0.5
hsa:10000,hsa:1548,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2904,PCrel,activation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:5533,hsa:54434,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5600,hsa:3725,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5534,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:814,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:148327,hsa:1029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:2806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5535,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:207,hsa:956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:208,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:9181,hsa:387,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:10552,hsa:2783,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3133,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:2353,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:5608,hsa:501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:1649,GErel,expression,path:hsa05014 Amyotrophic lateral sclerosis,1,0.5
hsa:1545,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:10681,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:8503,hsa:2309,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:2932,hsa:673,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:57180,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7124,GErel,expression,path:hsa05010 Alzheimer disease,1,0.5
hsa:5602,hsa:3725,PPrel,phosphorylation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:1564,hsa:54575,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:1511,hsa:2149,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:2621,hsa:558,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:55902,hsa:38,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:5601,hsa:3725,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:983,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56953,hsa:1890,ECrel,compound,path:hsa00240 Pyrimidine metabolism,2,0.5
hsa:873,hsa:574537,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
cpd:C00076,hsa:801,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:91860,hsa:5579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6470,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:339896,path:hsa00250,maplink,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5608,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5600,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:221357,hsa:728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:2785,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:5568,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4773,hsa:2775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374875,hsa:574537,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:84699,hsa:4259,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:64764,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:84532,hsa:56288,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00038,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:8517,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:115,hsa:4190,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:978,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5728,cpd:C05981,PCrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
hsa:1738,path:hsa00250,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:3032,hsa:5096,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5601,hsa:3667,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:189,path:hsa00260,maplink,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:374875,hsa:55823,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:57180,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7099,hsa:2770,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:2778,hsa:55970,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:5295,hsa:6714,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:2932,hsa:369,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:51764,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:29851,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3444,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:5564,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:2475,hsa:6199,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:8517,hsa:1495,no_relation,no_relation,no_relation,no_relation,0.0
hsa:956,hsa:7084,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:6898,hsa:5053,ECrel,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:5567,hsa:10488,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:85465,hsa:26279,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:31,hsa:3945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:5291,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:1854,hsa:5153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:898,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5731,hsa:3456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:2549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2534,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5899,hsa:5879,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5290,hsa:9261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:387,hsa:1073,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:5465,hsa:254531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:377841,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:8639,hsa:219,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:5338,hsa:64600,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5567,hsa:84699,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:10000,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8976,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,hsa:5567,PPrel,compound,path:hsa04912 GnRH signaling pathway,1,0.5
hsa:1558,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:1500,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:5567,hsa:5091,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:5894,PPrel,phosphorylation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:2771,hsa:5293,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:54511,hsa:10449,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:5535,hsa:953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1540,hsa:65082,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1553,hsa:54490,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,2,0.5
hsa:2947,hsa:126,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5970,hsa:7185,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
hsa:85465,hsa:83593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1147,PPrel,phosphorylation,path:hsa05161 Hepatitis B,1,0.8
hsa:10092,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:103910,PPrel,activation,path:hsa04520 Adherens junction,1,0.8
hsa:5534,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:4790,hsa:3553,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:7852,hsa:55970,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
path:hsa00600,hsa:218,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,path:hsa00600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:440275,hsa:7476,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27306,hsa:128,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2771,hsa:107,PPrel,inhibition,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:163688,hsa:5532,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:2949,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:10000,hsa:2475,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:4780,hsa:4846,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,3,0.5
hsa:5567,hsa:10488,PPrel,activation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:953,hsa:30833,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:5331,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:1813,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3665,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5571,hsa:2475,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5594,hsa:2002,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:959,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:7414,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa04218 Cellular senescence,1,0.8
hsa:5313,hsa:92483,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:5594,hsa:3725,PPrel,phosphorylation,path:hsa05133 Pertussis,1,0.8
hsa:55970,hsa:23236,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:23646,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56924,hsa:84618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:8651,GErel,expression,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.5
hsa:6300,hsa:9586,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:3845,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,activation,path:hsa05221 Acute myeloid leukemia,1,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:1629,hsa:35,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",2,0.5
hsa:4907,hsa:5167,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:2770,hsa:196883,PPrel,inhibition,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:5606,hsa:5603,PPrel,phosphorylation,path:hsa05014 Amyotrophic lateral sclerosis,1,0.8
hsa:5601,hsa:5602,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:805,hsa:5535,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:30,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:1432,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5594,hsa:4842,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
path:hsa00240,hsa:219,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:219,hsa:124,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
hsa:2322,hsa:7248,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3446,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:3654,hsa:7189,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:2731,hsa:275,ECrel,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:6794,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:5290,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
cpd:C00575,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,3,0.8
hsa:10681,hsa:56953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1398,hsa:1793,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:955,hsa:100526794,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:8399,hsa:54947,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1491,path:hsa00290,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:2776,hsa:5330,PPrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",2,0.8
hsa:3665,hsa:3443,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
path:hsa00270,hsa:113675,maplink,compound,"path:hsa00260 Glycine, serine and threonine metabolism",1,0.5
hsa:2572,hsa:3486,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:6775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23130,hsa:26100,PPrel,binding/association,path:hsa05010 Alzheimer disease,1,0.5
hsa:999,hsa:1499,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:808,hsa:5534,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:218,hsa:127,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:54331,hsa:5295,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:2778,hsa:3449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2946,hsa:221,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:332,hsa:126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10365,hsa:2938,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:54575,hsa:57571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:5290,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:972,hsa:7185,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:10000,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:1147,hsa:5970,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:9265,hsa:382,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,1,0.8
hsa:810,hsa:5532,PPrel,binding/association,path:hsa05163 Human cytomegalovirus infection,1,0.5
hsa:5291,hsa:207,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:3459,hsa:3716,PPrel,binding/association,path:hsa05168 Herpes simplex virus 1 infection,1,0.5
hsa:5604,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:84699,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:5970,hsa:6401,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
hsa:2778,hsa:2784,PPrel,binding/association,path:hsa04926 Relaxin signaling pathway,2,0.5
hsa:5530,hsa:54434,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:1459,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
path:map00680,hsa:10390,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4695,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:255189,hsa:10390,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:7414,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:1131,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9844,hsa:1793,PPrel,binding/association,path:hsa04148 Efferocytosis,1,0.5
hsa:5293,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:3845,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:5564,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4259,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:2885,hsa:6655,PPrel,activation,path:hsa04912 GnRH signaling pathway,1,0.8
hsa:1565,hsa:10941,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:4214,hsa:5600,PPrel,activation,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.8
hsa:54583,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:2475,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:3440,hsa:131,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:85464,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5091,hsa:54490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:6300,PPrel,phosphorylation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
cpd:C00388,hsa:3274,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:3265,hsa:5595,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:54600,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:9475,hsa:2628,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5533,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:107987479,hsa:7365,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:387,hsa:60,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,1,0.8
hsa:2771,hsa:5291,PPrel,activation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:3158,hsa:10449,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:6655,hsa:3265,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:2330,hsa:441925,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5734,hsa:2786,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:29119,hsa:1499,PPrel,binding/association,path:hsa04520 Adherens junction,1,0.5
hsa:978,hsa:7378,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
cpd:C05981,hsa:208,PCrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5578,hsa:6416,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:574537,hsa:107987479,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:4893,path:hsa00620,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1565,hsa:54575,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:801,hsa:1258,PPrel,inhibition,path:hsa04740 Olfactory transduction,1,0.8
hsa:824,hsa:8851,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:207,hsa:8517,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:94235,hsa:5295,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5338,hsa:5321,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1543,hsa:2052,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,3,0.5
hsa:873,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2327,hsa:1564,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:2534,hsa:1500,PPrel,inhibition,path:hsa04520 Adherens junction,1,0.8
hsa:2571,hsa:219,ECrel,compound,path:hsa00410 beta-Alanine metabolism,1,0.5
hsa:2783,hsa:8503,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:5933,hsa:1870,PPrel,inhibition,path:hsa04218 Cellular senescence,1,0.8
cpd:C00076,hsa:8639,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54579,hsa:1576,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:1564,hsa:7365,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:3265,hsa:391013,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:50487,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00430,hsa:1036,maplink,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5500,hsa:1965,PPrel,inhibition,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:10000,hsa:4846,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:2731,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56953,hsa:978,ECrel,compound,path:hsa00240 Pyrimidine metabolism,4,0.5
hsa:9138,hsa:387,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:10109,hsa:71,PPrel,activation,path:hsa05130 Pathogenic Escherichia coli infection,4,0.8
hsa:2730,hsa:2937,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,1,0.5
hsa:5295,hsa:5170,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:3717,hsa:6777,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:25759,hsa:2885,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:7157,hsa:581,GErel,expression,path:hsa05161 Hepatitis B,1,0.5
hsa:54979,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:574537,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4087,hsa:1281,GErel,expression,path:hsa04926 Relaxin signaling pathway,1,0.5
hsa:8976,hsa:10096,PPrel,activation,path:hsa05100 Bacterial invasion of epithelial cells,2,0.8
hsa:207,hsa:8517,PPrel,phosphorylation,path:hsa05163 Human cytomegalovirus infection,2,0.8
hsa:6093,hsa:58498,PPrel,phosphorylation,path:hsa04520 Adherens junction,1,0.8
hsa:81579,hsa:4313,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107,hsa:5566,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,3,0.8
hsa:5091,hsa:3948,ECrel,compound,path:hsa00620 Pyruvate metabolism,1,0.5
cpd:C20640,hsa:340061,PCrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5241,hsa:2941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:53632,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5568,hsa:84699,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:369,hsa:6240,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5320,hsa:56994,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:1943,hsa:2534,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
hsa:5600,hsa:9261,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:5732,hsa:2791,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:93034,hsa:5169,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:5321,hsa:79888,ECrel,compound,path:hsa00565 Ether lipid metabolism,1,0.5
hsa:5567,hsa:1386,PPrel,phosphorylation,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:957,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,cpd:C00575,PCrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
cpd:C00681,hsa:79888,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:653689,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:5443,hsa:4157,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:5241,hsa:604,GErel,expression,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.5
cpd:C01996,hsa:1141,PCrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:5595,hsa:9586,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:5741,hsa:5745,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:955,hsa:54963,ECrel,compound,path:hsa00240 Pyrimidine metabolism,1,0.5
hsa:30814,hsa:2846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:5933,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3845,hsa:587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1536,cpd:C00704,PCrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:5608,hsa:5602,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4137,hsa:4540,PPrel,inhibition,path:hsa05010 Alzheimer disease,1,0.8
hsa:3665,hsa:3451,GErel,expression,path:hsa04622 RIG-I-like receptor signaling pathway,1,0.5
hsa:7099,hsa:353376,PPrel,activation,path:hsa05161 Hepatitis B,1,0.8
hsa:841,hsa:836,PPrel,activation,path:hsa05168 Herpes simplex virus 1 infection,1,0.8
hsa:5970,hsa:329,GErel,expression,path:hsa05222 Small cell lung cancer,1,0.5
cpd:C00575,hsa:5566,PCrel,activation,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.8
hsa:5567,hsa:776,PPrel,activation,"path:hsa04935 Growth hormone synthesis, secretion and action",1,0.8
hsa:4833,hsa:51727,ECrel,compound,path:hsa00240 Pyrimidine metabolism,3,0.5
hsa:116,hsa:117,PPrel,activation,path:hsa04080 Neuroactive ligand-receptor interaction,1,0.8
hsa:107987478,hsa:574537,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,2,0.5
hsa:5499,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6898,path:hsa00130,maplink,compound,"path:hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis",1,0.5
hsa:5734,hsa:50487,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5291,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:3290,hsa:7363,ECrel,compound,path:hsa05204 Chemical carcinogenesis - DNA adducts,1,0.5
hsa:6714,hsa:5880,PPrel,activation,path:hsa04360 Axon guidance,1,0.8
cpd:C00083,hsa:1375,PCrel,inhibition,path:hsa04922 Glucagon signaling pathway,1,0.8
hsa:5601,hsa:3690,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5095,hsa:84693,ECrel,compound,path:hsa00630 Glyoxylate and dicarboxylate metabolism,1,0.5
hsa:59345,hsa:5296,PPrel,activation,path:hsa04926 Relaxin signaling pathway,3,0.8
hsa:1491,hsa:883,ECrel,compound,path:hsa00270 Cysteine and methionine metabolism,2,0.5
hsa:5604,hsa:3155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:4636,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:8600,GErel,expression,"path:hsa04928 Parathyroid hormone synthesis, secretion and action",1,0.5
hsa:6794,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:4775,PPrel,activation,path:hsa04218 Cellular senescence,1,0.8
hsa:26279,hsa:5921,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3157,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57571,hsa:5566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:89780,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:90993,PPrel,phosphorylation,path:hsa05207 Chemical carcinogenesis - receptor activation,1,0.8
hsa:4893,hsa:369,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa04148 Efferocytosis,1,0.8
hsa:2770,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3725,PPrel,activation,path:hsa05161 Hepatitis B,2,0.8
hsa:30,path:hsa00020,maplink,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:64902,hsa:217,ECrel,compound,"path:hsa00280 Valine, leucine and isoleucine degradation",1,0.5
hsa:6237,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:3725,PPrel,phosphorylation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:5898,hsa:5880,PPrel,activation,path:hsa05210 Colorectal cancer,1,0.8
hsa:6898,hsa:5062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2309,PPrel,inhibition,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:5567,hsa:2565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,cpd:C16844,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:10105,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:23236,PPrel,activation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3439,hsa:7248,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2949,hsa:124,ECrel,compound,path:hsa00982 Drug metabolism - cytochrome P450,1,0.5
hsa:5595,hsa:6667,PPrel,activation,path:hsa05163 Human cytomegalovirus infection,1,0.8
hsa:2932,hsa:5605,PPrel,phosphorylation,path:hsa05010 Alzheimer disease,1,0.8
hsa:3690,hsa:5970,PPrel,activation,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.8
hsa:6300,hsa:2353,PPrel,activation,path:hsa05133 Pertussis,1,0.8
hsa:8471,hsa:8503,PPrel,activation,path:hsa04211 Longevity regulating pathway,1,0.8
hsa:727,hsa:1629,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:6300,PPrel,activation,path:hsa04926 Relaxin signaling pathway,1,0.8
hsa:10365,hsa:445,GErel,expression,path:hsa05418 Fluid shear stress and atherosclerosis,1,0.5
